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CHAPTER 1 
Introduction 
 
BACKGROUND ON DIABETES 
Diabetes is described as an aging accelerator. It precipitates decline in several aspects of 
life, including physical, mental, and cognitive health. Between 1980 and 2011, the number of 
Americans aged 18 and older with diagnosed diabetes has more than tripled, and by 2050, it is 
estimated that between 25% and 28% of the U.S. population will live with diabetes (Boyle, 
Thompson, Gregg, Barker, & Williamson, 2010). Currently 29.1 million Americans live with 
diabetes (Centers for Disease Control and Prevention, 2014). While mortality from type 2 
diabetes has decreased in the past two decades as with cancer, stroke, and heart disease (Centers 
for Disease Control and Prevention, 2014), an ever increasing number of Americans are being 
diagnosed with pre-diabetes and diabetes.  
Diabetes is unequally distributed in the population, and social groups exhibit differential 
vulnerability. It is highly prevalent in the older population, in ethnic and racial minorities, and 
among the poor and less educated segments of the population (Centers for Disease Control and 
Prevention, 2013). The cost of diabetes is also a major societal concern. According to NHANES 
(National Health And Nutrition and Examination Survey) data, the cost of caring for diabetics is 
2.3 times higher than caring for patients without the condition (Centers for Disease Control and 
Prevention, 2014). Even more convincing is the study by Dall and colleagues, which showed that 
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every American, regardless of age and diabetes status, contributes $700 a year to care for 
diabetics (Dall et al., 2010). The financial cost of diabetes entails a significant loss of human 
capital. Diabetes is the seventh leading cause of death. It is also the leading cause of non-
traumatic lower-limb amputation, kidney failure, and blindness (Centers for Disease Control and 
Prevention, 2014). People with diabetes are at higher risk of macro-vascular and micro-vascular 
complications, nephropathic, and neuropathic complications, which can hinder a person’s 
physical functioning (Chiu & Wray, 2010b; Chiu, Wray, & Ofstedal, 2011; Gregg, Beckles, et 
al., 2000; Gregg et al., 2002), mental functioning (Anderson, Freedland, Clouse, & Lustman, 
2001; Golden et al., 2008; Nouwen et al., 2010), and cognitive functioning (Allen, Frier, & 
Strachan, 2004; Awad, Gagnon, & Messier, 2007; Biessels, Kerssen, de Haan, & Kappelle, 
2007; Cukierman, Gerstein, & Williamson, 2005; Reijmer, van den Berg, Ruis, Kappelle, & 
Biessels, 2010; Rosebud, Knopman, & Przybelski, 2014; Stewart & Liolitsa, 1999). Finally, 
diabetes and its management generate a greater need for informal care (Langa et al., 2002), 
increase the psychological burden upon caregivers, and are associated with job loss and 
diminished ability to work (Breton et al., 2013). 
Age-related outcomes of diabetes, including physical, mental, and cognitive impairments, 
are important issues for policy and research for several reasons. First, both their prevalence and 
incidence are increasing in the oldest age groups. Second, the U.S. population is aging at 
unprecedented rates. Finally, obesity, one of the most important risk factors for diabetes, is also 
rising in both prevalence and incidence. Therefore the prospect of reduced functional 
independence, higher healthcare costs, and heightened morbidity in late life, all highlight the 
need for improved understanding of the link between diabetes and health outcomes in old age.  
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COMPARATIVE STUDIES OF DIABETES AND HEALTH  
Overview of the literature 
Medical sociologists, health services researchers, and epidemiologists are interested in 
the impact of diabetes on health so that they can find new methods of intervention and care. In 
earlier studies “people with diabetes” were consistently contrasted with “people without 
diabetes”; and methodologically cross-sectional design or conventional methods of regression 
over two or three waves of data were favored. However, more recent studies rely on a 
longitudinal design and perform trajectory analyses, in which age or time (arbitrary study wave) 
is used to define the levels and rate of health change among people with diabetes. In general, 
earlier comparative studies found a strong relationship between diabetes, poor health, and health 
decline with time or age. A brief review of this research is provided below. 
Diabetes is linked to higher levels and accelerated decline in physical functional with age 
(Chou & Chi, 2005; Gregg, Beckles, et al., 2000; Kalyani, Saudek, Brancati, & Selvin, 2010; 
Maty et al., 2004; Ryerson et al., 2003; Sinclair, Conroy, & Bayer, 2008). It is further linked to 
persistent difficulties in climbing, taking 10 steps, and walking ¼ mile over 3.5 years (Figaro et 
al., 2006; Gregg, et al., 2002; Wray, Ofstedal, Langa, & Blaum, 2005). Trajectory analyses using 
study wave as the measure of time agree with these cross-sectional findings. Functional health 
declines with time in older adults (Chiu & Wray, 2010b; Chiu, et al., 2011).  
Related to mental health, clinical and subclinical expressions of depression are higher in 
people with diabetes than in diabetes-free adults. However, longitudinal examinations of the 
relationship between diabetes and mental health, and population-based trajectory analyses in 
particular, are lacking. The few that describe change in mental health among diabetics use non-
representative clinical samples, rely on two or three data points, or are interested in the 
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directionality of the relationship between diabetes and depression. Studies of transitions in and 
out of depressive states find that depression is highly recurrent over time (Lustman, Griffith, 
Freedland, & Clouse, 1997; Peyrot & Rubin, 1999). They further find a link between diabetes 
and mental status over time. Earlier studies reported an increased risk of diabetes-specific 
depressive symptoms one year after diagnosis (Skinner et al., 2010), a rise in incident depression 
over a period of 2.5 years (Nefs, Pouwer, Denollet, & Pop, 2012), and a U-shaped relationship 
between diabetes duration and depression with higher levels in the first 5 years and after 10 years 
(Egede & Zheng, 2003). These results suggest that among people with diabetes, depressive 
symptoms are dynamic, and may accelerate over time. 
Reviews of case-control (Brands et al., 2007; Chau et al., 2011; van Harten, Oostermn, 
Muslimovic, van Loon, & Weinstein, 2007), prospective, and longitudinal studies (Elias et al., 
1997) of cognitive health among people with diabetes found an average effect size of 0.2 to 0.8 
on cognitive health, specifically in memory and executive functioning, and a positive association 
with cognitive decline (Stewart & Liolitsa, 1999). The effect of diabetes on cognition is stronger 
with time or age (Bruce et al., 2003; Gregg, Yaffe, et al., 2000; Kanaya, Barrett-Connor, 
Gildengorin, & Yaffe, 2004; Nooyen, Baan, Spijkerman, & Verschuren, 2010; Okereke et al., 
2008; Stewart, Prince, & Mann, 2003; Wu et al., 2003). It is also stronger when diabetes lasts 
longer (Elias, et al., 1997; Fontbonne, Berr, Ducimetiere, & Alperovitch, 2001; Gregg, Yaffe, et 
al., 2000), and among those receiving insulin treatment compared with those who are not 
receiving it (Ott, Stolk, & van Harskamp, 1999). Yet a few studies failed to find a link between 
cognitive performance and diabetes (Cosway, Strachan, Dougall, Frier, & Deary, 2001; Scott, 
Kritz-Silverstein, Barrett-Connor, & Wiederholt, 1998). Nevertheless, in general review articles 
tend to corroborate the finding that people with type 2 diabetes are at increased risk of cognitive 
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decline or incidence dementia, compared with those who do not have diabetes (Awad, et al., 
2007; Biessels, Staekenborg, Brunner, Brayne, & Scheltens, 2006; Cukierman, et al., 2005; 
Stewart & Liolitsa, 1999). They further suggest that the risk of poor cognition increases with age 
(Biessels, et al., 2007) and with a longer duration of diabetes (Cosway, et al., 2001; Elias, et al., 
1997; Gregg, Yaffe, et al., 2000; Saczynski et al., 2008).  
 
Social stratification in diabetes and health 
Stratification in the distribution of physical, mental, and cognitive health among diabetics 
is well documented. Diabetes widens the racial gap (Kim & Miech, 2009) and the gender gap 
(Barberger-Gateau, Rainville, Letenneur, & Dartigues, 2000; Gorman & Read, 2006; Liang et 
al., 2008; Verbrugge, 1989) in functional status, and this gap persists over time (Chiu & Wray, 
2010b). However, it does not seem to have a significant effect on functional health among ethnic 
groups (Chiu & Wray, 2010b), despite persistent inequality or a Hispanic advantage in functional 
health compared with whites in the general population (Carrasquillo, Lantigua, & Shea, 2000; 
Liang, et al., 2008). Finally, the adverse effect of diabetes on functional status is greater among 
those with little education, and this gap widens with time (Chiu & Wray, 2010b). This fact 
supports the hypothesis that higher education confers a functional advantage upon diabetics who 
have higher education.  
As concerns mental health, trajectory analysis dealing with social variations in depressive 
symptoms among diabetics is lacking. Analysis of NHIS data using a cross-sectional design 
failed to show a link between depressive symptoms and race or ethnicity. However, the study 
included respondents with both type 1 and type 2 diabetes (Egede & Zheng, 2003). Other studies 
reported a link between black race and higher initial and transient depression in a sample of 246 
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patients in Baltimore (Peyrot & Rubin, 1999). The same study suggested that sex was associated 
with initial levels of depressive symptoms, but not with persistent depression (Peyrot & Rubin, 
1999). Studies of the link between social position and mental health among diabetics further 
found that lower education is associated with both higher initial levels of depression and 
persistent depressive symptoms (Peyrot & Rubin, 1997, 1999) in type 1 and type 2 diabetes 
(Engum, Mykletun, Midthjell, Holen, & Dahl, 2005). In addition, lack of employment was linked 
to major depression (Egede & Zheng, 2003).  
The negative influence of ascribed and attained social status extends to cognitive health. 
Compared to whites, being black adversely influences cognitive performance among people with 
diabetes (Obidi et al., 2008; Reijmer, et al., 2010; Sachs-Ericsson & Blazer, 2005), especially in 
more complex tasks (Obidi, et al., 2008). As it relates to gender, while in the general population 
women experience higher levels of cognition at baseline, but faster decline with time 
(Karlamangla et al., 2009), among diabetics, no gender differences were found in cognition after 
a 7-year follow-up in a small cohort study (Bruce et al., 2008) and in a community sample of 
older adults (Okereke, et al., 2008). However, one study found a faster decline in cognitive 
health among men in gender-stratified analysis (Maggi et al., 2009). Lower education also results 
in faster cognitive decline in older people (Bruce, et al., 2008), and can adversely influence risk 
factors for dementia, including diabetes incidence, and medical compliance and treatment 
(Reijmer, et al., 2010). 
In sum, the literature reports that diabetes adversely affects physical, mental, and 
cognitive health, and this link seems to be socially patterned, with greater vulnerability in 
women, blacks, Hispanics, and people with lower socioeconomic status (SES). 
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RESEARCH QUESTIONS 
According to the biomedical literature, the natural history of diabetes is characterized by 
biological, physiological, and health change with longer duration of diabetes (Ramlo-Halsted & 
Edelman, 2000); these events form a “diabetes trajectory” or “diabetes career” (Figure 1). 
Several studies modeling trajectories of biomarkers including hemoglobin A1c and fasting 
plasma glucose support this proposition (Haianza et al., 2012; Schroeder, Bayliss, Newcomer, & 
Steiner, 2011). However, a person’s location on his or her disease trajectory at any point in time 
is an important marker of not only metabolic outcomes, but also of health status because of the 
link between health status, diabetes complications, and the severity of clinical outcomes 
(Gebregziabher, Egede, Lynch, Echols, & Zhao, 2010; Helgeson et al., 2010; Schroeder, et al., 
2011). The time of the onset of diabetes, the patterns of health change after diabetes has been 
diagnosed, and the social context in which these health changes occur are all important research 
questions. But comparative studies cannot isolate the net effect of diabetes from that of people’s 
prior experiences, their location on their diabetes career or location on their life course. At any 
point in time and at any age in cross-sectional studies and in an age-based or time-based analysis, 
the group of people with diabetes included is made of diverse of individuals who are at different 
stages of their disease. Consequently, reported health gaps between older adults with diabetes 
and those without diabetes are confounded by the dynamic nature of diabetes and the experience 
of illness; that is, the cumulative damages upon diabetics’ biological, psychological, and social 
health, and the social, behavioral, and medical interventions implemented to bend the health 
curve among diabetics.  
Yet this dynamic aspect of diabetes is consistently ignored in studies of people’s 
experience of illness, if diabetes is conceptualized as a time-constant personal attribute. 
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Assuming that diabetes can create common experiences in people affected according to the 
natural history of diabetes, the literature on diabetes and health leaves several questions 
unanswered. First, on average, how does health change after a chronic illness is diagnosed; in 
other words, how does health change with a longer duration of diabetes? Does it decline 
exponentially or linearly, or do people recover within the first years after diagnosis? Are these 
health changes similar for different health outcomes? Second, how does the timing of diabetes; 
that is, people’s location on their life course, affect their health trajectory after diagnosis? Do 
people of different age groups experience illness similarly or are there differences that can 
inform clinical decision and policy? How does birth cohort influence health change with 
diabetes? Do people in younger cohorts have better outcomes than older people with diabetes? 
Finally, what is the role of social structure on health trajectories after diagnosis? Do individuals 
in socially disadvantaged groups experience chronic illnesses similarly to their more 
socioeconomically advantaged counterparts? If so, are health disparities between social groups 
exacerbated over the course of illness, or do they diminish or remain constant?  
As mentioned earlier, demographic and epidemiologic changes are expected to 
significantly influence the age structure, diabetes prevalence, and the importance of chronic 
illnesses in the U.S. population. Therefore, expanding our understanding of people’s experience 
of diabetes in middle-age and old age is an imperative research agenda. To address these 
questions, the existing research could be improved by: 1) focusing on people with diabetes, 
especially in later adulthood; 2) incorporating elements of the natural history of diabetes into the 
study of health change associated with diabetes, including the timing and duration of diabetes; 3) 
assessing the extent to which patients’ social and demographic characteristics predict health 
change with diabetes; and 4) investigating mutiple dimensions of health. Addressing these issues 
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is the main goal of this study, which presents findings from an analysis of a nationally 
representative sample of U.S. adults aged 50 and older with self-reported incidence of diabetes. 
The dissertation uses diabetes as the model of chronic illness for several reasons. First, its 
prevalence is relatively high in the population, and it increases in middle-age and older 
adulthood (Centers for Disease Control and Prevention, 2014). Second, diabetes in old age 
generates major health changes that can be easily investigated. Finally, diabetes is beset with 
health inequalities (Centers for Disease Control and Prevention, 2013), and therefore can permit 
the study of the role of social position on health change after diagnosis.   
 
THEORETICAL ORIENTATION 
In his essay on the sociology of disease, Timmermans argued that since Parson’s sickness 
role model, medical sociologists have invested their efforts in understanding strictly the social 
aspects of health-related topics. This paradigm shift occurred at the expense of the sociology of 
disease (Timmermans & Haas, 2008). Rarely is disease at the center of inquiries in modern 
medical sociology, as can be seen repeatedly in comparative studies of people with diabetes and 
those without it; these studies consistently treat the disease as time-constant. Consequently 
medical sociologists are missing an opportunity to understand patients’ experience of diabetes, to 
address what probably matters most to patients and their healthcare providers, and to identify 
new means of improving the management of diabetes.   
The current study attempts to bridge the gap between the biomedical literature and 
medical sociology by incorporating elements of both schools of thought in the assessment of 
people’s experience of diabetes. It adopts the natural history of diabetes from the medical 
literature to illustrate the dynamic nature of the disease and identifies key time-related variables 
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necessary to describe the progression of diabetes. It further adopts several elements from the 
sociology of illness, including the Illness Career Model, the Disablement Process Model, and the 
theory of social stratification to illustrate the dynamic nature of the experience of illness and the 
influence of the social context on this experience. We hypothesize that health changes with time, 
not just because of the effects of aging, but also because of the progression of diabetes and the 
medical and social environment in which this progression occurs. The current study aligns the 
disease, the person, and the social context in which they interact, to elucidate health change with 
diabetes. 
 
The natural history of diabetes 
The natural history of diabetes is not a theory per se; rather it illustrates the concept of 
health change with, and the clinical course of, a chronic illness from the perspective of the 
disease itself. The natural history of diabetes is used in this research because it supports our 
concept of diabetes as a dynamic phenomenon.  
Originating in the medical literature, the natural history of type 2 diabetes is 
conceptualized as a series of transitions between successive and non-linear phases (Ramlo-
Halsted & Edelman, 2000). Figure 1, which presents a model of the natural history of type 2 
diabetes, shows clearly that each phase in this natural history is defined by physiological and 
metabolic norms. In addition, empirical studies link these phases to the onset of diabetes 
complications, to the severity of clinical outcomes such as retinopathy, to mortality, and finally 
to the psychological and behavioral responses to the illness by people affected and by society at 
large (Gebregziabher, et al., 2010; Helgeson, et al., 2010; Schroeder, et al., 2011). From the 
natural history of diabetes, we adopt the concept that health change necessarily co-occurs with 
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the progression of disease. Consequently time should be measured from both the patient and the 
disease. Although age, age at diagnosis, and birth cohort allow the location of a person on his or 
her own life trajectory, the onset and duration of diabetes provide the keys to describing the 
disease and its progression.  
Unfortunately the biomedical view of the natural history of diabetes does not explicitly 
incorporate time-relevant factors—e.g. age, the timing of diabetes, birth cohort—from the 
patient’s perspective. It further fails to include role of the social determinants of health on the 
progression of diabetes and to acknowledge the impact of the natural history of diabetes on 
longer-term outcomes, in particular, on the precursors of loss of independence, including loss of 
physical, mental, and cognitive functioning.  
 
The Illness Career Model 
The Illness Career Model is a sociological model of health and illness rooted in symbolic 
interactionism. It applies a trajectory perspective to the study of chronic illness, and explores the 
long-term interconnectedness between chronic illnesses and different dimensions of life. The 
theory was derived from the social constructionist view centered on labeling and on the 
definition of the self as presented in Goffman’s description of the “moral career” of mental 
health patients (Goffman, 1961; Scheff, 1966; Thoits, 1999). The theory has since evolved into a 
concept that includes any long-term social experiences during an individual’s life (Aneshensel, 
1999, 2013). In contrast to the life-course perspective on health and aging, which emphasizes 
connections among different trajectories including a person’s education, occupation, and family 
life as he or she ages (Ben-Shlomo & Kuh, 2002; Kuh & Ben-Shlomo, 1997), the career 
perspective isolates one of these trajectories starting with a life-changing event, and describes its 
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internal organization. According to Aneshensel, “careers” are “formed around the experience of 
unusual and unpleasant or unwanted thoughts, feelings, and behaviors." This model has been 
successfully used in studies of deviant behaviors (Scheff, 1966), chronic illness (Gerhardt, 1990), 
caregivers’ health (Aneshensel, Botticello, & Yamamoto-Mitani, 2004), and mental health in 
youth (Potter, 2013) to describe people’s experiences with these events over time.  
Several aspects of the career model are of interest in this research. First, it informs us that 
the experience of illness is a dynamic process, which starts with the unpleasant feeling of being 
ill. Second, medical diagnosis is the culminating moment of the career. Finally, it acknowledges 
that social and medical factors create and maintain the health career, and shape the impact of this 
career on diabetics and their families. In a sense, and in agreement with our own perspective on 
diabetes, the career model takes a natural history approach to chronic illness, an approach which 
postulates that illness and its diagnosis initiate a new trajectory, that illness is dynamic, and is 
shaped by social factors that also vary with time. Although individual differences in the 
pathways through this trajectory exist, the model also acknowledges that  “cumulative 
experiences” with a chronic illness “merge into a holistic entity” (Aneshensel, 1999) in which 
the level and rate of change can be measured.  
The Illness Trajectory Model is a clinical variant of the Career Model. It emphasizes the 
role of medicine and medical professionals in people’s experience of chronic illness (Corbin, 
1998; Corbin & Strauss, 1985, 1991; Strauss et al., 1984; Strauss & Glaser, 1975). According to 
this view too, illness trajectories begin with the onset of an illness; and they are shaped by 
interactions between the disease, a person’s characteristics, their psychological and behavioral 
responses to the illness, the actions of healthcare providers, and finally the treatment regimen 
prescribed. The Illness Trajectory Model also takes into account the involvement of others in 
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disease management, including a patient’s family and support network, as well as the social 
environment in which they are all embedded. This model also postulates that a patient’s position 
on the disease trajectory determines the effectiveness of disease management and the probability 
of recovery. The model is therefore highly relevant to diabetes care. For this reason, it is widely 
used in clinical settings to locate patients on their disease trajectory before the development of 
end-stage renal failure (Schell & O'Hare, 2013), or in functional decline at the end of life 
(Lunney, Linn, & Foley, 2003). The model is particularly useful as a means of identifying ways 
to optimize disease management (Strauss, et al., 1984).  
 
The Disablement Process Model 
The third model of interest is the Disablement Process Model (Verbrugge & Jette, 1994), 
which is also a sociological model of the progression of chronic illness. According to this model, 
the experience of illness or of an injury evolves from clinically imperceptible physiological 
changes to functional impairments and disability. The model therefore describes a theoretical 
pathway linking chronic illnesses to physical functioning; it further places this pathway within a 
social context. Verbrugge identified three sequential stages in the alteration of physical 
functioning. Impairments occur at the physiological level and can begin even before clinical 
symptoms are manifest. Functional limitations, the second stage, entail restrictions in basic 
physical and mental activity. Finally, disability represents loss or reduction in the ability to 
perform expected or specified activities associated with assigned social roles for extended 
periods of time, and as a result of illness or impairment. Disability is situational and depends on 
the social context.  
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Several concepts of the Disablement Process Model are pertinent in the current study. 
First, similar to our concept of the experience of diabetes, Verbrugge defined disablement from 
the perspective of the ill person, as a dynamic, non-linear, and time-variant process. Second, this 
model clarifies our definition of physical health, which we operationalize based on the concept 
of functioning; that is, the extent to which people are able to function normally and carry on their 
routine daily activities. Functional disability is further conceptualized as the ability to perform 
self-care, self-maintenance, and physical activities on a daily basis. Third, the model supports 
our hypothesis that besides aging, disease can initiate a change in health. Finally, the model 
places the disease process within a social context. We adopt the concept of disability as a social 
phenomenon, which is contextual and dependent on the social and physical environment. The 
model proposes that personal characteristics of the ill person (socio-demographic characteristics, 
lifestyle and behaviors, psychosocial status, and adaptive accommodations), and factors external 
to the ill person (medical care, social support, physical environment and social environment) can 
shape people’s experience of illness. 
Despite the clear identification of disease diagnosis or injury as the starting point of 
pathological changes, the model is consistently used in conjunction with the life-course 
perspective on aging with diabetes, a perspective in which the starting point of health trajectories 
is conceptualized as age or study wave (Chiu & Wray, 2010b). However, although the model is 
useful in the assessment of the impact of diabetes on health, it does not describe general health 
changes after a diagnosis of diabetes. To the author’s knowledge, the Disablement Process 
Model has never been applied in the context of the Illness Career Model, which is the object of 
this research. 
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Theory of social stratification 
The theory of social stratification also guides this study. According to this theory, 
systems of dominance and subordination based on ascribed characteristics such as race or 
ethnicity (Williams & Collins, 1995), age (Riley, 1987), and gender (Bird & Rieker, 1999; 
Rieker & Bird, 2000) and partially mediated by socioeconomic status (Robert & House, 2000), 
create a series of dualisms in established social structures. This dualism leads to a systemically 
unequal allocation of both resources and risks, which in turn leads to poorer health in 
disadvantaged groups (House, Lantz, & Herd, 2005; House et al., 1994; Lantz et al., 2001; Link 
& Phelan, 1995). Lower-status persons have less access to resources that can mitigate risks to 
health. They are also exposed to higher levels of risk, which can exacerbate the onset and 
progression of disease.   
Empirical research consistently finds evidence of disparities in the determinants of 
diabetes based on race, ethnicity, gender, and socioeconomic status.   
Race – Blacks have lower health literacy (Sentell & Halpin, 2006), weaker adherence to 
medication regimens (Heisler et al., 2007), poor diabetes control (Heisler, et al., 2007), and low 
self-efficacy for reducing cardiovascular risk factors (Smedley & Syme, 2001). They also 
experience poorer patient-provider communication (Saha, Arbelaez, & Cooper, 2003), and worse 
healthcare access and use (Gary, McGuire, McCauley, & Brancati, 2004; Lanting, Joung, 
Mackenbach, Lamberts, & Bootsma, 2005; Smedley, Stith, & Nelson, 2003). In addition, they 
face residential segregation (Williams & Collins, 2001; Sampson, Morenoff, Gannon-Rowley, 
2002; Morenoff, 2003; Diez-Roux, 2007) and discriminatory practices that can adversely affect 
functioning and diabetes management by reducing access to adequate health services, foods, and 
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healthful environments (Williams, 1995 #181) and by increasing vulnerability to stress (Pearlin, 
1989).  
Ethnicity – Compared to Caucasians, Hispanics also experience greater diabetes-related 
distress (Heisler, et al., 2007). They also hold beliefs that can hinder diabetes management 
(Jezewski & Poss, 2002), and they have behaviors that worsen diabetes management 
(Nwasuruba, Khan, & Egede, 2007) and diabetes control (Harris, Kovar, Suzman, Kleinman, & 
Feldman, 1989; Hertz, Unger, & Ferrario, 2006; Quandt et al., 2005). Finally, they have worse 
patient-physician communication (Lipton, Losey, Giachello, Mendez, & Girotti, 1998). On the 
favorable side, one study found that Mexican Americans had better controlled diabetes, were 
more likely to be treated, and to be more aware of diabetes than whites, after controlling for 
socio-demographic characteristics and access to care (Hertz, et al., 2006).  
Gender – Both differential vulnerability and differential access to materials and resources 
that promote health can lead to gender differences in diabetes outcomes (Bird & Rieker, 1999; 
Legato et al., 2006; McDonough & Walters, 2001; Rieker & Bird, 2000; Shalev, Chodick, 
Heymann, & Kokia, 2005; Szalat & Raz, 2007; Verbrugge, 1985). Gender differences in factors 
relevant to diabetes management and risk factors for diabetes outcomes have been empirically 
observed. Women experience worse glycemic control and body fat composition, high blood 
pressure, and more diabetes complications than men (Juutilainen et al., 2004). They report more 
barriers to the adherence to treatment regimens (Glasgow, McCaul, & Schafer, 1986; Walker et 
al., 2006), more depressive symptoms (Gucciardi, Wang, DeMelo, Amaral, & Stewart, 2008; 
Ponzo et al., 2006), weaker perception of family support, and worse diabetes-specific self-
efficacy (Brown et al., 2000) (Brown, et al., 2000; Gucciardi, et al., 2008; Ponzo, et al., 2006; 
Umberson, 1992).  
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Socioeconomic status – People of lower social status are at a disadvantage compared with 
others, on important diabetes self-management behaviors, access to healthcare, process of care, 
and biological processes (Anderson et al., 1995; Baker, Watkins, Wilson, Bazargan, & Flowers, 
1998; Beckles et al., 1998; Brown et al., 2004; Fiscella, Goodwin, & Stange, 2002).  
Poor understanding of the hemoglobin A1c testing process (Beckles, et al., 1998) and 
lower health literacy are linked to hypoglycemia (Williams, Baker, Parker, & Nurss, 1998), 
higher HbA1c levels and the risk of retinopathy, even among those who undergo conventional 
diabetes education (Schillinger et al., 2002). The education gap in functional status could be 
reduced if—as studies of managed care organizations have found—inequities in access to 
healthcare were reduced (Fiscella, et al., 2002).  
Finally, the paradigm of intersectionality is used (in Chapter 2) to investigate the 
combined effects of race and gender on functional trajectories after a diagnosis of diabetes. This 
sociological paradigm assumes that race, gender, and class mutually construct one other 
(Mullings & Schulz, 2006; Schulz & Mullings, 2005; Thornton & Zambrana, 2009).  
Health disparities in race or ethnicity, on the one hand, and gender, on the other, are well 
documented. Compared to whites, racial and ethnic minority groups exhibit poorer health and 
functioning (Hayward & Heron, 1999; Read & Gorman, 2006). Longitudinal studies of disability 
also found that in old age, each gender within a racial or ethnic group showed different levels of 
disability. The lowest levels of disability were found in white men, followed by men of racial 
and ethnic descent, then white women and finally, black and Mexican American women (Warner 
& Brown, 2011). Recent investigations of the combined role of gender and race using trajectory 
analysis show that disability trajectories of race and ethnicity by gender vary at initial 
assessment, with similar rates of change. The exception to this finding was observed in black 
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women, who exhibited accelerated decline in functioning (Warner & Hayward, 2011). To our 
knowledge, the intersection of race, ethnicity, gender, and disability has not been studied in the 
context of late-onset diabetes.  
 
Theoretical framework 
Figure 2 provides a visualization of the theoretical framework that guides the current 
study. From the natural history of diabetes we borrow the concept of diabetes as a time-variant 
condition on a time continuum, beginning with the diagnosis of diabetes and ending with death. 
From the Illness Career Model and the Disablement Process Model, we borrow the concept of 
the experience of diabetes as a dynamic phenomenon, in agreement with our own view. From 
these theories and the Theory of Social Stratification, we borrow the perspective that links 
micro-level and macro-level determinants of health disparities. We expect that health will 
decline as diabetes continues; and that ascribed characteristics including race, ethnicity, gender, 
and age will directly and indirectly, through their impact on attained social status and diabetes 
timing, influence the levels and rate of change in physical, mental, and cognitive health as the 
disease progresses.  
 
NEW PERSPECTIVE: EVENT-BASED APPROACH TO DIABETES AND HEALTH 
Based on the sociological and medical concepts of illness and disease, this research is 
grounded in the belief that the severity of physical, mental, and cognitive health change 
associated with a chronic illness varies not only with age and time, but also with the progression 
of the disease. Therefore to quantify the course of diabetes in terms of physical, mental, and 
cognitive change after a diagnosis of diabetes, we adopt an event-based approach to the study of 
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diabetes and health. This approach has various conceptual, analytic, and practical advantages 
over age-based and time-based approaches, which are discussed below. 
 
Conceptual advantages  
In an event-based approach, the goal is not to describe health differences with aging 
among people with diabetes and people without diabetes, as it has been done by comparative 
studies of diabetes and health. Rather, it is to focus specifically on people with diabetes, and 
describe how their health changes as their disease progresses. In contrast to age-based and time-
based approaches, an event-based approach is a disease-centered perspective. It fits the 
biomedical model of health and illness, with the conceptualization of diabetes as a dynamic 
phenomenon. Nevertheless, this approach does not conflict with the sociological view of health 
and illness, a view which holds that a patient is an active agent in his experience of diabetes; nor 
does it conflict with the view that health change occurs within a social context. In fact, health 
change occurs alongside the natural history of diabetes, incorporates measures of change from 
both the disease (diabetes duration) and the patient’s characteristics (cohort, age at diagnosis). 
Moreover, health change is influenced by social, medical, behavioral, and psychological factors 
along the way. An event-based approach can therefore provide a better description of the course 
of diabetes in terms of physical, mental, and cognitive health.  
 
Analytic advantages  
Analytically an event-based approach requires that 1) health trajectories begin with the 
disease itself; 2) that they are defined by the duration of diabetes; and 3) they are modeled as a 
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function of time-variant and time-invariant social determinants of health change with longer 
diabetes duration. The distinction between an event-based approach to diabetes and health and an 
age-based and time-based approach is displayed in Table 1.  
In an event-based approach, four measures of time are necessary to accurately capture 
health change with diabetes. Age- and time-based studies have focused mainly on age, which 
measures the aging process, and at times birth cohort, which measures historical and social 
trends relevant to the experience of diabetes. However, the event-based approach locates 
patients’ position on their life course, which can be interpreted as age at diagnosis, and their 
position on their diabetes career, conceptualized as diabetes duration. Both are key elements in 
the study of diabetes and health change.   
The distinction between age, diabetes timing, diabetes duration, and birth cohort as 
different measures of time is important for ascertaining the social causation of health change 
with diabetes, and assessing the relative role of each measure of time. This distinction is also 
important for policy and clinical interventions. If the study is unable to find differences in health 
with longer diabetes duration across measures of time, medical interventions could be equally 
applied to everyone with diabetes. On the other hand, the effects of time on the progression of 
the disease suggest that differential exposure to social risks and benefits are specific to 
individuals diagnosed at different ages and belonging to different cohorts; and that the 
experience of diabetes varies for different people. Therefore the management of diabetes will 
require interventions tailored to the needs of patients at different positions along their disease 
trajectories. 
Earlier studies have routinely incorporated individual measures of time to capture the 
dynamic nature of diabetes, and their findings are discussed below. 
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Time-variant chronological age 
Time-variant chronological age captures developmental changes in aging (Riley, 1987). 
As described in the section on the comparative studies of people with diabetes and people 
without diabetes, older age is a major risk factor for poor health. However, in these studies, age 
cannot accurately describe the experience of illness, since at any point in time, people of the 
same age who have diabetes can be at different stages of their illness. For instance, when Chiu 
and Wray estimated the functional status of a person aged 60 with diabetes, the estimate reflected 
the functional status of people aged 60 who were diagnosed 20 years earlier (at age 40), and 
those diagnosed 2 years earlier (at age 58). Depending on the case mix at every age, this estimate 
could be larger or smaller than the true population parameters of health and health change with 
diabetes (Chiu & Wray, 2010b). 
On the other hand, using the event-based perspective, the physical, mental, and cognitive 
health of people with diabetes can be more accurately estimated at every age by considering both 
the duration of diabetes and the age at diagnosis. For instance, we are able to accurately predict 
the physical, mental, and cognitive health of a patient diagnosed at age 50, when he or she 
reaches 60 or 70 years of age. Similarly, the health of a person diagnosed at age 70 can be 
predicted 5 or 10 years later.  
In the current study there is no designated indicator of aging; therefore we were unable to 
determine the extent to which health levels and health change were attributable to diabetes alone, 
or to the process of aging. But again, our interest is not so much in describing the effect of 
diabetes on people with the condition compared to those without it, as it is in describing the 
course of diabetes among middle-aged and old-aged adults with diabetes. 
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Duration of diabetes 
A limited number of studies incorporated duration as a proxy for the natural history of 
diabetes and as an attempt to capture its dynamic nature. These studies showed that a longer 
duration of diabetes is a key predictor of functional change because of the adverse effects of the 
disease on functional status and on the determinants of function (De Gauw et al., 1999; Mitchell, 
Stern, Haffner, Haduza, & Patterson, 1990; Park et al., 2006). A link also exists between the 
duration of diabetes and an increased risk of diabetes-related depressive symptoms (Skinner, et 
al., 2010) and depression (Egede & Zheng, 2003; Nefs, et al., 2012; Thoolen, de Ridder, 
Bensing, Gorter, & Rutten, 2006), as well as poor cognitive performance (Elias, et al., 1997) and 
reduced processing speed and executive functioning (Cosway, et al., 2001; Saczynski, et al., 
2008; Spauwen, Kohler, Verhey, Stehouwer, & Van Boxtel, 2013).  
In addition to its direct effects on health, the duration of diabetes can mediate the link 
between the disease and health outcomes through poor diabetes control (Benoit, Fleming, Philis-
Tsimikas, & Ming, 2005; Blaum, Velez, Hiss, & Halter, 1997) and result in a higher risk of 
complications from diabetes (Selvin, Coresh, & Brancati, 2006), including retinopathy 
(Henricsson, Nilsson, Groop, Heijl, & Janzon, 1996) and cataract (Chuang et al., 2006). Finally, 
longer duration is linked to greater resistance to diabetes medications, despite improved self-care 
skills (Benoit, et al., 2005; Blaum, et al., 1997; Chiu & Wray, 2010a).  
Methodologically studies incorporating the duration of diabetes have additional 
limitations. First, cross-sectional studies are unable to distinguish between intrapersonal and 
interpersonal differences in health outcomes. Therefore we do not know how many of the 
estimates are due to personal differences in health over time or represent true effects of the 
duration of diabetes. Second, studies relying on two or three time points provide little 
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information about the underlying growth curve of health change with the duration of diabetes. 
Yet according to the natural history of diabetes, the disease is defined by transitions between 
different health phases, which can form an average trajectory (Ramlo-Halsted & Edelman, 
2000). Finally, multiple underlying trajectories exist, for patients’ physical, mental, and cognitive 
health status vary at diagnosis and with a longer duration of diabetes, yet are not captured. We 
conclude that the inclusion of the duration of diabetes as a time-invariant covariate does not 
capture changes in the different areas of life that can influence health as the disease unfolds. On 
the contrary, it merely provides a qualitative measure of diabetes without revealing the nature of 
health change as diabetes progresses.  
In sum, earlier studies which provided cross-sectional evidence of the negative link 
between longer diabetes duration and health do not inform us about the nature of health change 
after diabetes has been diagnosed, nor do they inform us about the respective roles played by the 
timing of diabetes, by cohort differences, or by the social context within which health changes 
occur.  
As patients journey through their disease career, diabetics of the same age continue to age 
simultaneously. We postulate that the duration of diabetes conceived as a time-variant predictor 
measures more accurately, the time since diabetes was diagnosed. This perspective makes it 
possible to capture health change as the disease progresses and as people age, and thus to capture 
the dynamic nature of both the disease and the patient’s experience of it. For this reason, the 
current study uses time-variant diabetes duration as the measure of time in order to define health 
trajectories after diabetes diagnosis. Estimates of physical, mental, and cognitive health status for 
a particular patient, with a given diabetes duration, conditional on age at diagnosis, allows us to 
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depict the average course of diabetes among middle and old-age adults who have incident 
diabetes.  
 
Diabetes timing (age at diagnosis) 
The timing of diabetes; that is, a patient’s age when diabetes was diagnosed, measures 
patients’ position on their life course at the time of diagnosis. The timing of diabetes in middle 
age and old age is an important aspect of the experience of the disease. Sociological theories 
acknowledge that illnesses, particularly acute illnesses, disrupt a person’s life (Bury, 1982). This 
disruption arises from a host of physical, psychological, cognitive, and social changes. These 
changes, in turn, affect a person’s experience of the disease. Disruptions in self-perception are 
characterized by negative self-appraisal of one’s life prospects, and by corresponding 
modifications in relationships with family members and others. Empirical findings suggest that 
the impact of this disruption on the person’s life results from many factors, including the type of 
illness, the age at which the illness arises, and the medical and social contexts in which it occurs 
(Faircloth, Boylstein, Rittman, Young, & Gubrium, 2004). A recent study of older adults with 
chronic illness found that manifestations of biographical disruptions are not only tied to the event 
itself, but continue throughout the person’s life (Larsson & Grassman, 2012). Therefore both the 
timing of acute or chronic illness and health changes that occur during the illness adversely 
affect people’s lives.   
Clinical and epidemiological studies have investigated the effect of diabetes timing upon 
the health of adult diabetics. Most of these studies found that in contrast to people who received 
a diagnosis of diabetes when they were older, people diagnosed at younger ages were at 
heightened risk of diabetes complications (Hillier & Pedula, 2003; Selvin, et al., 2006), and poor 
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diabetes control (Benoit, et al., 2005; Blaum, et al., 1997; Nichols, Javor, Hillier, & Brown, 
2000). For instance, a study of 7,844 Health Management Organization (HMO) enrollees 
reported that people with early onset diabetes (ages 18-44) are at greater risk of 
microalbuminuria, macrovascular complications including myocardial infarctus, higher BMI, 
and worse diabetes control than their older counterparts (Hillier & Pedula, 2003). A similar study 
by the same authors conducted among 2,437 HMO enrollees with incident diabetes found a 
greater risk of cardiovascular complications and poor diabetes control among respondents with 
early onset diabetes (Hillier & Pedula, 2001). A third study further reported an association 
between diabetes diagnosed before age 40 and poor clinical and cardiovascular risk compared to 
people diagnosed after age 40 (Hatunic, Burns, Finucane, Mannion, & Nolan, 2005). 
Cumulatively these findings suggest that early onset type 2 diabetes may be a more 
aggressive disease than late onset diabetes. However, none of these studies took into account the 
duration of diabetes, which is a strong confounder of the link between age at diagnosis and 
health. Younger age at diagnosis can result in longer diabetes duration in older age, thus can 
explain the strong link between age at diagnosis and diabetes complications. The two studies that 
accounted for the role of diabetes duration in the link between age at onset and diabetes 
complications corroborated earlier studies, with a stronger, independent and negative effect of 
younger age at diagnosis on retinopathy (Henricsson, et al., 1996; Wong, Moluneaux, 
Constantino, Twigg, & Yue, 2008). Unfortunately since both studies were limited to retinopathy, 
they cannot be generalized to the diabetes outcomes of interest in the current study.  
One clinical study conducted in several Asian countries investigated the link between age 
at onset, diabetes duration, and diabetes complications in adults aged 18 and older with type 2 
diabetes (Chuang, et al., 2006). This study found that age at diagnosis may confer different levels 
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of risk depending on the type of complications investigated. After adjusting for diabetes 
duration, Chuang and colleagues found that the risk of complications increased for every added 
year of age from onset: by 13% for cataract, 7% for diabetes foot (amputations, absence of foot 
pulse, or healed ulcer), and 7% for microvascular complications (photocoagulation, retinopathy, 
or end-stage renal failure). The risk did not differ for macrovascular (myocardial infarct/coronary 
angioplasty bypass graft/angioplasty, cerebral stroke or peripheral bypass/angioplasty) or 
neuropathic complications. While these findings are consistent with our assumptions, the study 
used a clinical sample, with age spanning from young adults to older-aged adults and used cross-
sectional analyses relying on mean differences. Therefore this research cannot confirm the role 
of age at diagnosis on health change in middle age compared to older adulthood. 
To our knowledge, only one population study tested the link between age at diagnosis 
and health in middle-aged compared to older-aged adults (Selvin, et al., 2006). Using a cross-
sectional design to analyze 1999-2002 NHANES data, the study found a greater risk of 
microvascular disease, poor diabetes control, and lower risks of taking glucose-lowering drugs 
with the onset of diabetes in middle-age compared to its onset in old age. However, the risk of 
macrovascular disease did not significantly differ between the two groups. Here too, the possible 
link between diabetes complications and age at diagnosis is confounded by the duration of 
diabetes, which was not accounted for. Thus the role of diabetes timing on health change with 
longer diabetes duration in middle-aged and old-aged adults with incident diabetes remains 
unclear.  
On the basis of this literature, and in agreement with Bury’s concept of illness as a 
biographical disruption (Bury, 1982) and Larsson’s finding that the disruption in people’s life 
trajectory due to chronic illness persists over time (Larsson & Grassman, 2012), we hypothesize 
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that the timing of diabetes is an important correlate of diabetes complications and diabetes 
control. 
 
Birth cohort 
Birth cohort or time-constant chronological age assesses cohort differences in health and 
health change. Cohort effects represent social changes and reflect the impact of exogenous social 
factors on health change as opposed to developmental and aging processes or disease 
progression. According to Ryder (1965), cohort effects are surrogates for common experiences 
among individuals of different age groups. Therefore as with social class, cohort membership 
can result in social variations in health. For diabetes, educational changes between cohorts, 
changes in the diagnostic criteria and in treatment modalities can influence patients’ experience 
of diabetes (American Diabetes Association, 2014). 
Studies of cohort differences in depressive symptoms generally found improvement with 
successive cohorts, attributed to better education (Clarke, Marshall, House, & Lantz, 2011) and 
to improved socioeconomic and marital status (Yang, 2007). These results are mirrored by 
reports of improved cognitive health with each cohort (Dodge, Zhu, Lee, Chang, & Ganguli, 
2013; Karlamangla, et al., 2009; Salthouse, 2013) coupled with a slower decline in younger 
cohorts, also partly due to higher education (Dodge, et al., 2013). Similar trends were reported 
for physical health, with a decline in more recent cohorts, and among the oldest old in particular 
(Seeman, Merkin, Crimmins, & Karmalanga, 2010). These trends were also attributed to 
improved education, medical care, and to assistive and mainstream technologies (Schoeni, 
Freedman, & Martin, 2008).  
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However, findings from two seminal studies suggest that functional status did not decline 
in younger cohorts of peri-retirement populations aged 60-69 (Seeman, et al., 2010) and 50-64 
(Martin, Freedman, Schoeni, & Andreski, 2010). These studies of the general population contrast 
with Chiu & Wray’s (2010b) analysis of Health and Retirement Study data, which supports the 
view that older cohorts of people with diabetes show greater physical disability and faster decline 
over time. However, since the authors did not account for diabetes duration or age at diagnosis, 
their reported cohort effects are inconclusive.  
Similar studies among older adults with diabetes are lacking for mental and cognitive 
health. Nevertheless, changes related to diabetes diagnosis, diabetes management, and risky 
behaviors all support the hypothesis that there is a positive link between younger cohort and 
improved health among people with diabetes. First, expansion of the diagnostic criteria for 
diabetes (Koopman, Mainous, Diaz, & Geesey, 2005) can lead to diagnosis at a younger age, and 
healthier individuals in more recent cohorts. Second, changes in the recommendations for 
diabetes management reduce the burden of treating diabetes in older adults. For instance, the 
American Diabetes Association recommends lower glycemic cutoff values among older adults 
with high frailty, lower life expectancy, and severe comorbid conditions (American Diabetes 
Association, 2014). While research on the effects of such recommendations on adherence to 
treatment and to diabetes outcomes in older adults are still forthcoming, it is likely that the 
recommendatons will have a positive impact on both adherence and outcomes. Finally, 
improvement in behaviors, such as cessation of smoking and steps to minimize cardiovascular 
risk, also have a positive effect on the health of people with diabetes (Schoeni, et al., 2008). 
Therefore although the extent to which cohort membership may influence older adults’ 
experience of diabetes has been very little studied, it is reasonable to assume that the physical, 
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mental, and cognitive health of older adults with incident diabetes also improves with successive 
cohorts. 
 
Practical applications 
Currently, comparative studies are unable to describe health change over the clinical 
course of diabetes. Conceptualizing health change along the diabetes career addresses this issue; 
for it puts all patients on an equal footing with regard to their disease, allowing people with the 
same disease history to age together. Therefore it is possible to accurately predict physical, 
mental, and cognitive levels of health at every point along a person’s diabetes career, depending 
on the person’s age when the disease was diagnosed. The study can further describe and predict 
social variations in the clinical course of diabetes, thereby allowing the creation of individualized 
diabetes management plans. Individualized management plans are important for at least three 
reasons.  
First, from a clinical point of view, heterogeneity among patients poses a serious barrier 
to high-quality diabetes management. At any given age people with diabetes comprise a diversity 
of individuals with prevalent or incident diabetes, with variable levels of diabetes complications, 
physical disability, and with a diversity of social backgrounds—all of which can influence 
diabetes outcomes and management. As a consequence, clinical recommendations for older 
adults with diabetes are non-specific (American Diabetes Association, 2014; American 
Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus, 2013; 
International Diabetes Federation, 2010; Sinclair et al., 2011). Nevertheless, one common 
concern is the need for an individualized approach to diabetes care and management. This 
individualized plan allows to compare patients’ clinical and functional statuses, comorbid 
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conditions, and life expectancies, against the time frame within which benefits are expected from 
different treatment options for clinical decision. The current study can help clinicians identify 
each patient’s location on the clinical course of diabetes, thereby minimizing the effect of 
patients’ heterogeneity at clinical presentation. 
Second, the literature supports the view that shared decision-making regarding diabetes 
management between clinicians and patients is important for successful diabetes care (Kirkman 
et al., 2012). Yet lack of agreement between clinicians and patients on treatment goals for 
diabetes has been documented (Huang, Gorawara-Bhat, & Chin, 2005). For physicians, clinical 
improvement is the most important outcome of diabetes care. But for patients, functional status 
and functional independence are the most important treatment goals (Huang, et al., 2005). 
Furthermore, older patients with diabetes perceive diabetes treatment as having an adverse 
impact on their quality of life; an adverse impact similar to that of diabetes complications 
(Huang, Brown, Ewigman, Foley, & Meltzer, 2007). Disagreement on treatment goals between 
clinicans and patients as well as patients’ perception that medical treatment poses a burden, may 
result in minimal adherence to recommended lifestyle changes and medical regimens. The results 
from the current study could improve patient-physician agreement on the goals for diabetes 
management in two ways. To a clinician receiving a patient newly diagnosed, visualization of the 
clinical course not in terms of biomedical and physiological markers, but in terms of outcomes 
most important to the patient may offer an opportunity to highlight the importance of medical 
care and treatment adherence for functional independence. On the other hand, for patients newly 
diagnosed with diabetes, being able to understand, foresee and visualize the clinical course they 
are likely to experience, starting with diabetes diagnosis, may be of much greater interest than 
linking their functional health and diabetes status to their age or to randomly assessed time. With 
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visual graphs of health change over the clinical course of diabetes from the study estimates, 
clinicians may gain patients’ trust and thereby their willingness to adhere to a prescribed medical 
regimen.  
Finally, the study’s findings can be useful to policy makers interested in projecting the 
clinical course of diabetes at a population level in order to plan for the allocation of resources 
and for the development of medical and behavioral management plans to prevent and slow down 
health decline with diabetes in middle-aged and older-aged adults. 
 
HYPOTHESES AND OUTLINE OF THE DISSERTATION 
Four main hypotheses are tested, and are spelled out in greater detail in the appropriate 
Chapters. First, we expect that health trajectories will decline with longer diabetes duration as 
complications arise and the demands of diabetes management increase. Second, older age at 
diagnosis will result in worse health trajectories with longer diabetes duration because diabetes 
and its progression increase people’s vulnerability in old age. Third, due to general 
improvements in education, in physical, mental, and cognitive health, and in diabetes diagnosis 
and management in recent years, people in recent cohorts will have better health trajectories as 
diabetes lasts longer. Finally, health trajectories over the course of diabetes will be worse among 
socially disadvantaged groups due to significant sociocultural and medical disadvantages in 
diabetes management.  
The study consists of three empirical analyses of HRS data, a representative biennial 
panel survey of Americans aged 50 and older, beginning in 1992 (Juster & Suzman, 1995). It 
uses Hierarchical Linear Modeling to estimate the levels and growth in physical, mental, and 
cognitive health trajectories, beginning with the diagnosis of diabetes and for every subsequent 
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year following diagnosis (Raudenbush & Bryk, 2002). This technique is most appropriate for the 
HRS data for several reasons. First, it allows both interpersonal and intrapersonal variations in 
health over time to be estimated, thus accounting for the hierarchical structure of the data. 
Second, it allows estimation of the effect of both time-constant and time-variant covariates on 
the levels and rate of change in the outcome. Finally, it provides estimates of both the fixed 
effects of diabetes duration and other covariates on health trajectories, and random variations 
related to individual variabililty at baseline, and over time. 
 The first study models the change in ADL/IADL and mobility disability beginning with 
a diagnosis of diabetes at age 50 and older (Chapter 2). It further assesses time-related and social 
variations within these estimates. The second study investigates similar research questions for 
depressive symptoms (Chapter 3). The third and final study estimates cognitive changes after 
late-onset diabetes among individuals aged 65 and older. Policy and research implications are 
discussed in the last chapter (Chapter 5).  
 
RELEVANCE 
Earlier studies, using diabetes as a time-invariant personal attribute, found that diabetes 
generally increases the risk of poor health over time or with age. However, these studies did not 
describe the trajectories of health changes with longer diabetes duration. On the other hand, 
studies that included diabetes duration and age at diagnosis to capture the dynamic nature of the 
disease from the patient’s perspective treated these measures as if they were cross-sectional. 
These studies were therefore unable to separate the respective roles of diabetes duration and 
diabetes timing from that of aging and cohort in the levels and nature of physical, mental, and 
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cognitive health trajectories. Therefore the temporal effects of diabetes on physical, mental, and 
cognitive health after diabetes is diagnosed in middle-age or older age, remains unknown. 
The current study contributes to this literature by 1) conceptualizing the experience of 
diabetes as a dynamic phenomenon that manifests as a trajectory or career, beginning with the 
diagnosis of diabetes; 2) aligning health change, disease progression, and the social context in 
which they interact; and 3) disentangling the role of diabetes duration from that of diabetes 
timing (age at diagnosis) and cohort differences in the experience of diabetes.  
Methodologically the study uses analytic techniques which take into account both 
interpersonal and intrapersonal differences in health with longer diabetes duration. It provides 
quantitative estimates of the level at diagnosis and rate of change in physical, mental, and 
cognitive health as individuals journey through their illness careers, and the effects of time-
related factors on both. Finally, it estimates the growth parameters of health trajectories after 
diagnosis across social groups over an extended period of time and uses a nationally 
representative sample of older adults with self-identified diabetes. Cumulatively these elements 
of our approach provide a more accurate account of the experience of diabetes among older 
adults.  
Understanding the natural course of type 2 diabetes has three advantages: 1) It can guide 
healthcare providers in formulating effective treatment regimens that address health change over 
the course of diabetes, and for specific social groups. 2) It provides a means for clinicians and 
their patients to formulate identical treatment goals. 3) It can inform policy makers by allowing a 
more accurate prediction of the health and healthcare needs of people with incident diabetes in 
middle age and old age. 
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Figure 1: Natural History of Type 2 Diabetes 
 
  
 
Ramlo-Halsted, B. A., & Edelman, S. V. (2000). The natural history of type 2 diabetes: Practical points to consider in developing 
prevention and treatment strategies. American Diabetes Association, 18(2), 1-10. Used with permission. 
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Table 1: Distinctive characteristics of an event-based and an age- or time-based approach to diabetes and health 
 Event-based approach  Age or time-based approach 
 
Approach • Disease-centered 
• Patient-centered 
 
• Patient-centered 
Subjects under investigation • People with incident diabetes only • People with both incident and prevalent 
diabetes  
• People without diabetes 
 
Research goal • Describes health change with longer diabetes 
duration, along the natural history of diabetes 
• Describes differences in health between 
people with diabetes and people without 
diabetes at every age 
 
Starting point of health 
trajectories (baseline) 
• Diabetes diagnosis (year since diabetes 
diagnosis=0) 
• Arbitrary age (e.g.age 50) 
• Arbitrary study wave (e.g.1994) 
 
Measure of time defining health 
trajectories 
• Diabetes duration, measured as year since 
diabetes diagnosis 
• Time since baseline age or time since first 
study wave 
 
Other measures of time  • Diabetes duration (defines health trajectory) 
• Age at diagnosis 
• Birth cohort  
• Age (not explicitly measured; can be deducted 
from age at diagnosis & diabetes duration) 
 
• Age or study wave (defines health trajectory) 
• Birth cohort 
 
Characteristics of people with 
diabetes 
• All diabetics are at the same stage on their disease 
trajectory at any point in time (same diabetes 
duration) 
• Age differences are controlled at diagnosis 
• Cohort differences are controlled at diagnosis 
• Mixture of people with diabetes at any point 
in time and at any wave 
• Diabetics are at different stage on their 
disease trajectory (diabetes duration) 
• Cohort difference are controlled at diagnosis 
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Figure 2: Theoretical Framework 
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CHAPTER 2 
Disability Trajectories after Diabetes Diagnosis in Middle and Old Age:  
Do Diabetes Timing and Social Position Matter? 
 
INTRODUCTION 
Background 
The prevalence of diabetes is rising, particularly in older adults, making it a major public 
health concern. About one in four U.S. residents aged 65 and older lives with diabetes (Centers 
for Disease Control and Prevention, 2014). And between 1980 and 2010 the increase among 
those aged 65-74 was 11 times higher than that of people aged 45 and younger (20.7% versus 
1.8%; CDC Data Trends December 27, 2011c). Longitudinal studies of diabetes and functional 
status (Blaum, Ofstegal, Langa, & Wray, 2003; Figaro et al., 2006; Gregg et al., 2002; Park et 
al., 2006) found that diabetes doubles the prevalence and risk of developing limitations in 
instrumental activities of daily living (IADL), mobility, muscle strength and quality of life. 
Findings concerning activities of daily living (ADL) are less conclusive, but the effects reported 
are generally similar to those reported on other functional measures (Bruce, Davis, & Davis, 
2005; Chou & Chi, 2005; Wray, Ofstedal, Langa, & Blaum, 2005). Recent comparative studies, 
which model functional change in older adults with and without diabetes, find that diabetes 
increases the level and rate of functional decline with age (Chiu & Wray, 2010; Chiu, Wray, & 
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Ofstedal, 2011). These studies further report wider, yet persistent racial and gender gaps, and 
increasing educational inequalities with time.  
Earlier studies conceptualized diabetes as an individual attribute; which does not vary 
with time. As a consequence, the impact of diabetes on functional status was estimated by 
comparing individuals with diabetes to those without diabetes. This method overlooked the fact 
that diabetes itself has a natural history characterized by biochemical (Ramlo-Halsted & 
Edelman, 2000), psychological (Nouwen et al., 2011), behavioral, and social changes with time 
(Fischer, 2006; Tunceli et al., 2005); and these changes can in turn alter the progression of the 
disease. Moreover, the changes can affect the link between diabetes and disability, the 
development of complications, and the quality of diabetes management (Benoit, Fleming, Philis-
Tsimikas, & Ming, 2005; Blaum, et al., 2003; Selvin, Coresh, & Brancati, 2006). To date, the 
dynamics of health change after a diagnosis of diabetes remains unknown and is the object of 
this study.  
 
Theoretical framework 
In agreement with the concept of the natural history of diabetes, which stipulates that 
diabetes is characterized by biomedical, physiological and clinical changes with longer diabetes 
duration, we postulate that health changes not only because of chronological age or arbitrary 
time (study wave), but also because of the clinical course of illness (Ramlo-Halsted & Edelman, 
2000). We view diabetes as a dynamic phenomenon. Therefore estimates from earlier studies 
which used diabetes status as a time-constant measure and as an individual attribute for each 
respondent were confounded by the dynamic nature of the disease; that is, cumulative changes to 
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biological, psychological, and social health, as well as the cumulative effects of social, 
behavioral, and medical interventions devised to address health change resulting from diabetes.  
Four theoretical models of health change also inform this study. The Illness Career 
Model and its more clinical variant, the Illness Trajectory Model, is a sociological model of the 
experience of illness from the patient’s perspective, which also affords a dynamic view of 
chronic illness in line with the natural history of diabetes (Aneshensel, 2013; Corbin, 1998; 
Corbin & Strauss, 1991; Goffman, 1961; Ramlo-Halsted & Edelman, 2000; Strauss et al., 1984). 
Both models regard illness and its diagnosis as the starting point of a new trajectory, which 
“forms around the experience of unusual, unpleasant, or unwanted thoughts, feelings, and 
behaviors” (Aneshensel, 1999). Therefore health change is best portrayed as an “illness career,” 
emphasizing the dynamic characteristics of the disease, of the ill person, and of the medical and 
social environments.  
Another model being used in the study is Verbrugge’s Disablement Process Model, 
which specifically applies to functional change (Verbrugge & Jette, 1994). This model identifies 
chronic and acute conditions as the precursors of functional change and the starting point of 
disablement. According to this model, the course of the experience of illness and its impact on 
health begins with the onset of the illness or with its diagnosis, and varies—in the case of 
diabetes—with the duration of the illness and with the social environment in which it progresses. 
The model further identifies personal and environmental factors as determinants of health change 
after the onset of an illness. This model has been widely used in conjunction with the life-course 
perspective on aging and health (Chiu & Wray, 2010); however, to the author’s knowledge, it 
has never been applied in the context of the illness career. 
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The Social Stratification Theory is the third model used in the study. It proposes that 
race, ethnicity, gender, and age, through their effect on attained social status (education, income, 
marital status) can unequally distribute risks as well as resources that could mitigate the effects 
of disease, resulting in poor health in socially disadvantaged groups (Bird & Rieker, 1999; 
House, Lantz, & Herd, 2005; Lantz et al., 2001; Link & Phelan, 1995; Rieker & Bird, 2000; 
Riley, 1987; Williams & Jackson, 2005). The literature finds strong evidence for social 
disparities in the experience of diabetes. Blacks, Hispanics, and women bear a greater burden of 
diabetes, and face more barriers to self-management, to healthcare and to a satisfactory quality of 
healthcare. In addition, their control of the disease is inadequate, and they experience worse 
psychological outcomes such as depressive symptoms, diabetes-specific distress, and more 
comorbities, as well as weak family support and inadequate diabetes-specific self-efficacy 
(Brown et al., 2000; Glasgow, McCaul, & Schafer, 1986; Gucciardi, Wang, DeMelo, Amaral, & 
Stewart, 2008; Heisler et al., 2007; Jezewski & Poss, 2002; Lanting, Joung, Mackenbach, 
Lamberts, & Bootsma, 2005; Ponzo et al., 2006; Quandt et al., 2005; Sentell & Halpin, 2006; 
Szalat & Raz, 2007; Walker et al., 2006). 
 Finally, the paradigm of intersectionality at the crossroads of social stratification and 
gender studies assumes that race, gender, and class interact and mutually construct one another, 
to produce social disparities (Mullings & Schulz, 2006; Thornton & Zambrana, 2009). This 
perspective allows us to investigate how structures of power and domination such as sexism and 
racism have an impact on diabetes outcomes.  
From these theories we may infer that health will decline with longer diabetes duration, 
and that ascribed characteristics such as race, ethnicity, gender, and age will directly and 
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indirectly, through their impact on attained social status and diabetes timing, influence the levels 
and rate of change in physical, mental, and cognitive health. 
 
EVENT-BASED APPROACH TO THE STUDY OF DIABETES AND HEALTH  
The study is grounded in the assumption that the severity of physical, mental, and 
cognitive health change associated with diabetes varies not only with age or time, but also with 
progression of the disease. We therefore propose an event-based approach to diabetes and health, 
an approach in which the impact of diabetes on physical, mental, and cognitive health is 
conceptualized as an experience shared by all affected persons, beginning with the diagnosis of 
diabetes. Health change resulting from diabetes can therefore be quantified and modeled as a 
trajectory or “diabetes career,” which links the experience of the illness with 1) disease 
progression (diabetes duration); 2) measures of time which locate patients on their life course, 
including actual age, birth cohort, and age at diagnosis, and 3) the social, medical, and 
psychological contexts within which these changes occur.  
In categorizing diabetes as an illness career, we model disability trajectories only for 
patients who have been newly diagnosed with the condition, and begin the trajectories from the 
time of diagnosis onward. Within this framework we are particularly interested in how diabetes 
duration shapes functional trajectories, and how age at diagnosis, birth cohort, and agents of 
social stratification influence functional change with longer diabetes duration. Four measures of 
time are important to our inquiry. 
 
 
	   54	  
Chronological age 
Time-variant chronological age measures developmental changes in health resulting from 
aging. Being older correlates with greater functional impairment and accelerated decline in both 
the general population (Liang et al., 2008) and among diabetics (Chiu & Wray, 2010; Chiu, et 
al., 2011). However, age alone cannot accurately describe the experience of illness; for at any 
point in time, people of the same age are at varying stages of their illness depending on their age 
at the time the illness was diagnosed. The event-based approach places every individual on his or 
her disease trajectory, and is able to project average health change at any specific time after 
diagnosis. However, a designated indicator of time-variant chronological age was not included in 
the study, because the study focuses on the experience of illness according to the progression of 
the disease.  
 
Diabetes duration 
A few studies captured the dynamic nature of diabetes by incorporating the duration of 
diabetes as a main predictor or a covariate. These studies showed that longer diabetes duration is 
a key predictor of functional health due to its adverse effects on functional status and its 
determinants (De Gauw et al., 1999; Mitchell, Stern, Haffner, Haduza, & Patterson, 1990). 
Longer duration correlates with increasing limitations in functioning of the lower and upper 
extremities, and with diminished muscle strength (Park, et al., 2006). It also correlates with an 
increase in the risk of complications of the disease (Selvin, et al., 2006), and with worsened 
diabetes control (Benoit, et al., 2005). However, the inclusion of diabetes duration as a time-
invariant covariate is problematic for several reasons. First, cross-sectional studies are unable to 
distinguish between intrapersonal and interpersonal differences in health outcomes. Second, 
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studies relying on two or three time points provide little information on the underlying growth 
curve of health change with the duration of diabetes (Ramlo-Halsted & Edelman, 2000). Finally, 
several underlying trajectories exist, because among patients the level of functioning varies both 
at diagnosis and over time, yet these trajectories are not captured in conventional methods of 
analysis.  
In sum, earlier studies which provide cross-sectional evidence of the link between 
diabetes duration and physical health do not inform us of the course of physical health change 
with diabetes, nor do they inform us of the role of diabetes timing, cohort differences, or social 
context on these health changes. On the other hand, conceptualizing diabetes duration as a time-
variant predictor can allow us to depict the growth curve of physical health over the course of 
diabetes and identify time-constant and time-invariant predictors of the curve. The current study 
thus uses diabetes duration as the measure of time for defining the growth curve of physical 
health after diabetes has been diagnosed.  
 
Diabetes timing (age at diagnosis) 
According to the biographical disruption theory, the event of illness and its timing can 
significantly alter people’s life trajectory, as well as generate and maintain new life trajectories 
(Bury, 1982; Faircloth, Boylstein, Rittman, Young, & Gubrium, 2004; Larsson & Grassman, 
2012). Empirical studies identify age at diagnosis as a risk factor for both diabetes complications 
and poor diabetes control. Clinical and epidemiological studies suggest that early onset type 2 
diabetes may be more aggressive than late onset diabetes, manifesting a higher risk of 
complications and poor diabetes control when the disease is diagnosed at a younger age (Benoit, 
et al., 2005; Blaum, Velez, Hiss, & Halter, 1997; Hatunic, Burns, Finucane, Mannion, & Nolan, 
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2005; Hillier & Pedula, 2001; Hillier & Pedula, 2003; Nichols, Javor, Hillier, & Brown, 2000). 
However, these studies did not account for the role of diabetes duration or compare young adults 
to middle-aged and older-aged adults. The only study that did include diabetes duration as a 
covariate found a greater risk of complications in later onset diabetes; but here too, the age range 
of the sample, which included younger adults, limits its generalizing capability in older 
adulthood (Chuang et al., 2006). This research cannot confirm the impact of diabetes timing on 
health. We contend that our approach, along with the findings of Chuang and colleagues 
(Chuang, et al., 2006), allows us to hypothesize that an older age at diagnosis will correlate with 
a worse clinical course of diabetes, measured as worsened physical health if the duration of 
diabetes is longer.    
 
Birth cohort 
 According to Ryder, birth cohort can result in variations in health due to differential 
exposure to health risks and benefits among people born at the same time, and with a shared 
history. Studies of physical health between cohorts found improvement in younger cohorts, but 
little or no improvement in peri-retirement populations (Martin, Freedman, Schoeni, & Andreski, 
2010; Schoeni, Freedman, & Martin, 2008; Seeman, Merkin, Crimmins, & Karmalanga, 2010). 
Among adults with diabetes, improvement in education and behaviors such as lower rates of 
smoking, changes in diagnostic criteria, and improvement in treatment modalities can positively 
influence patients’ experience of diabetes in younger cohorts (American Diabetes Association, 
2014; Koopman, Mainous, Diaz, & Geesey, 2005; Schoeni, et al., 2008). We therefore expect 
that younger cohorts of people with diabetes will have better physical health trajectories than 
their older counterparts. 
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Hypotheses 
We hypothesize that the longer the time since diabetes has been diagnosed, the greater 
the physical disability in middle-aged and older adults with diabetes (Hypothesis 1). In addition, 
given the higher risk of complications reported with older age at diagnosis and the strong link 
between physical disability and old age, older age at diagnosis will be associated with higher 
physical disability at diagnosis, and with accelerated increase with longer duration compared to 
people diagnosed at a younger age (Hypothesis 2). Given recent ameliorations in behaviors, 
diabetes diagnosis and therapies in younger cohorts of older adults, we hypothesize that older 
birth cohort will be tied to worse physical health trajectories with longer diabetes duration 
compared to younger birth cohorts (Hypothesis 3). Exposure to risks before and during the 
course of diabetes among vulnerable social groups will result in functional disparities at the time 
of diagnosis, and the disparities will become greater over time. Therefore women (but not men), 
blacks and Hispanics (but not whites) and individuals of lower socioeconomic status (but not 
those of higher socioeconomic status) will experience greater physical disability as the duration 
of diabetes lasts longer (Hypothesis 4). Finally, compared to white men, minority women will 
experience greater physical disability at diagnosis, and a faster decline in health thereafter 
(Hypothesis 5). 
 
METHODS 
Data and sample 
Data were obtained from the Health and Retirement Study (HRS), a biennial panel survey 
of Americans aged 50 and older, which began in 1992 (Juster & Suzman, 1995). Respondents 
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were included in our study if they were interviewed between 1995 or 1996 and 2010.1 The 
analysis is limited to respondents aged 50 years and older who reported being diagnosed with 
diabetes during the study period. Given the relatively late age at diagnosis, we infer from the data 
that this subsample represents individuals aged 50 years and older in the U.S. with type 2 
diabetes (Kenny, Aubert, & Geiss, 1995). Similarly, while the HRS does not include 
institutionalized adults at study entry, it does follow and interviews respondents as they move in 
and out of institutional setting.2 
Diabetes status was assessed by means of a question regarding whether or not a doctor 
had told the respondent he or she had a series of conditions, including diabetes (1=yes, 0=no). 
Respondents with self-reported incident diabetes documented by consecutive negative and 
positive responses to the diabetes question were included in the analyses. Conflicting answers to 
the diabetes question (88 total) were addressed by recoding diabetes status to positive if 
respondents reported taking diabetes medication or insulin (Liang, Quinones, Bennett, & Ye, 
2011). 
 The data were stacked starting with the year diabetes was reported for the first time (year 
of diagnosis) between 1995 and 2010, yielding a total of 3,307 observations at baseline. Time 
since the diagnosis of diabetes was recorded every wave thereafter. 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Baseline years are 1996 for HRS and 1995 for AHEAD because the functional limitation 
questions for HRS did not include difficulties using a toilet in the prior waves (1992 and 1994). 
The wording, structure and coding of the questions were also different. Beginningin 1996, 
however, the question measuring functional limitations was consistent in both wording and 
coding. In addition, responses to the diabetes question in the years 1994 HRS and 1993 AHEAD 
were used to confirm that respondents reported being diabetes free prior to the initial assessment 
in 1996 HRS and 1995 AHEAD. 2	  http://hrsonline.isr.umich.edu/sitedocs/sampleresponse.pdf	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Measures 
Physical disability – Limitations in mobility and the ability to perform activities of daily 
living were assessed with the disability index, which combines Katz’s Activities of Daily Living 
(ADL) index and Lawton & Brody’s Instrumental Activities of Daily Living index; it has been 
widely used (Katz, Ford, Moskowitz, Jackson, & Jaffe, 1963; Lawton & Brody, 1969). This 
combined index measures difficulties in dressing, bathing, eating, transferring, walking across 
the room, and toileting. It also measures the ability to perform more advanced tasks, including 
preparing a hot meal, shopping, making telephone calls, taking medications, and managing 
money (1=yes; 0=no). Positive answers to these questions were summed. Higher scores represent 
greater disability (range 0-11). The validity and hierarchy of this index have been previously 
discussed (Spector & Fleischman, 1998). In addition, separate analyses for ADL and IADL 
measures yielded similar results; therefore the two measures were combined. 
Mobility disability was measured as difficulty walking one block and climbing one flight 
of stairs (Rosow & Breslau, 1966), walking several blocks, climbing several flights of stairs 
(Nagi, 1976), and walking across the room (Katz, et al., 1963). A summary score was computed 
with a range of 0 to 5; higher scores reflected greater impairment.  
Chiu and Wray (Chiu & Wray, 2010; Chiu, et al., 2011) combined measures of 
ADL/IADL, mobility disability, and muscle strength because of the hierarchical structure of 
functional status, whereby mobility disability predicts future ADL limitations (Bruce, et al., 
2005). However, in diabetes, the pathways connecting diabetes to these dimensions of 
functioning vary (Bruce, et al., 2005; Gill, Williams, & Tinetti, 1995). Age is closely associated 
with both functional and mobility disability. But while diabetes complications and degenerative 
diseases are predictors of impaired mobility, health behaviors (smoking) and more severe 
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cardiovascular diseases (e.g. stroke), are predictors of ADL/IADL disability. We therefore 
studied functional change separately for these outcomes.  
Time measure (diabetes duration) – Diabetes duration was operationalized as time since a 
diagnosis of diabetes was assessed, after aligning the data so that the baseline for all respondents 
was the year diabetes was reported for the first time. Seven waves, based on the year since 
diabetes was diagnosed, were generated every two years from the baseline (0-14).  
Other measures of time – Diabetes timing was operationalized as a respondent’s age at 
diagnosis and measured interpersonal age differences in physical health over the course of 
diabetes. Birth cohort, on the other hand, was measured by age in 1995. It assessed 
intergenerational age differences due to historical changes in risks and benefits to physical 
health. Both were included as time-constant covariates. 
Measures of social stratification – Race and ethnicity (1=non-Hispanic white, 2=non-
Hispanic black, 3=Hispanic, 4=other), gender (1=female, 0=male), and education (1=less than 
high school, 2=high school graduate, 3=college graduate) were included as time-constant 
covariates. 
Time-variant covariates – Comorbid conditions are important risk factors for functional 
decline in both diabetic and non-diabetic populations (Chiu & Wray, 2010). People’s self-rated 
health status, obesity, and depression are also powerful correlates of functional impairment and 
diabetes (Anderson, Freedland, Clouse, & Lustman, 2001; Egede, Zheng, & Simpson, 2002; 
Katon et al., 2004). The complexity of the treatment regimen for diabetes is further tied to its 
severity (Benoit, et al., 2005); however, being married has a positive effect on diabetes 
management (Van Dam et al., 2005). Finally, while the mediating, moderating, or independent 
role of social status on health is still debated, the literature shows that social status widens the 
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functional gap between diabetics and non-diabetics with age (Chiu & Wray, 2010). To account 
for these potential confounders, marital status (1=married, 0=not married), self-rated health on a 
5-point Likert scale (1=very good health, 5=very poor health), mean number of comorbidities 
(range 0-11) including kidney problems or proteins in urine, stroke, heart problems, trouble with 
eye sight, trouble with hearing, heart disease, hypertension, cancer, arthritis, lung problems, 
psychiatric problems, and incontinence, depressive symptoms assessed with the Center for 
Epidemiologic Studies Depression rating scale – CESD (Radloff, 1977), and treatment burden 
(1=no treatment; 2=oral; 3=insulin injection; 4=oral and insulin injection) (Benoit, et al., 2005) 
were all included in the multivariate analyses. BMI (body mass index in kilograms per squared 
meter) was also included in the mobility disability models because of the strong association 
between increased weight and impaired mobility. Continuous covariates were centered on their 
grand mean. 
Mortality and attrition at any point in the study were addressed by including two time- 
constant indicators in the models (death: 1=yes, 0=no; attrition: 1=yes, 0=no). A time-variant 
indicator of proxy interview status was included to account for the differential effects of 
responses obtained from proxy individuals.  
 
Data analyses 
Hierarchical Linear Modeling (HLM) was used to estimate average functional trajectories 
with longer diabetes duration (Raudenbush & Bryk, 2002). This technique allows both fixed and 
random effects to be estimated; the technique thus models dependence and unobserved 
heterogeneity stemming from the longitudinal nature of the data. The level 1 model estimates 
intrapersonal differences in physical disability for each respondent every year after diagnosis. 
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For each person, this model provides estimates of physical disability levels at baseline (intercept) 
and the linear and non-linear slopes with every added year after diagnosis. Time-variant 
covariates can be included at this level to assess the expected outcome at any given point in time 
for every change in value of the time-variant covariate. 
For both ADL/IADL and mobility disability, a linear, quadratic, and cubic model was 
used to test for both linear and non-linear increase in the outcome. Nested models were 
compared using the log-likelihood ratio test in order to select the curvature that best described 
the data. In addition, Akaike Information Criteria (AIC) and Bayesian Information Criteria (BIC) 
were used in the selection process. The level of statistical significance of the estimates was also 
included to obtain the most parsimonious model. In the end, the data best fit the quadratic model. 
This was therefore used in subsequent analyses.  
The level 2 models, on the other hand, assess interpersonal differences in the intercept, 
linear, and quadratic slopes. They allow estimation of the effects of time-constant covariates on 
the intercept and on the linear and quadratic estimates obtained from the level 1 model.  
A model was first estimated with only diabetes duration and its squared value, followed 
by a model accounting for death, attrition, and the use of a proxy respondent (Model 1). 
Consecutive models estimated the effect of time-constant and time-variant covariates in this 
order: age at diagnosis (Model 2), socio-demographic characteristics (Model 3), education 
(Model 4), and marital and health status (Model 5). These nested models were also compared 
using the Likelihood Ratio Test and penalty-driven criteria, including AIC and BIC. The level 1 
and level 2 models are described below. 
PHYSDISABti = π0i + π1i*(diabetes duration) + π2i*(diabetes durationti)2 + Σπki*Xkti + eti 
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PHYSDISABti is the level of physical disability for each individual i at time t; π0i is the 
level of physical disability for each individual at time of diagnosis; π1i and π2i are the linear and 
quadratic rates of change in physical disability for each individual; diabetes durationti is the year 
since diabetes diagnosis, and diabetes durationti2 its squared value; πki are the effects of the kth 
time-variant covariates Xk for individual i on the trajectory; Xkti are the kth time-variant 
covariates in the model. 
π0i = β00 + Σβ01q*Xqi + r0i 
π1i = β10 + Σβ11q*Xqi + r1i 
π2i = β20 + Σβ21q*Xqi + r2i 
πki = βk0 
π0i, π1i, π2i, and πki are the same as above; β00, β10, β20 , and βk0 are the fixed effects or 
expected count of physical disability in a year at mean diabetes duration, and expected linear and 
quadratic growth and the effect of time-variant covariates; β01q, β11q, and β21q are the effects of 
the qth time-constant covariates X for each i on the intercept, linear, and the quadratic slope; Xqi 
is the qth time-constant covariate for each i; r0i and r1i, and r2i are random outcome variations at 
the intercept and linear and quadratic slope. 
To address missing items, the data were imputed using the multiple imputation procedure 
in Stata® assuming that the data were missing at random (Little & Rubin, 2002; Rabe-Hesketh 
& Skrondal, 2008). Five imputed data sets were generated and the modeling approach described 
above was then applied to the imputed data sets. All analyses were conducted using Stata® 
software (Version 12).  
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RESULTS 
The majority of the 3,307 respondents were females (52%) and white (68%); 17% were 
black and 12% Hispanic (results not shown). Most respondents had at least a high school degree 
(67.8%), with a mean age of 68.96 years at diagnosis and a mean age of 60.67 years in 1995. The 
mortality and attrition rates were 27.15% and 16.07%, respectively. A total of 39% of the sample 
reported no mobility disability at the time diabetes was diagnosed, while 70% of the sample 
reported no ADL/IADL disability. On average, respondents had lived with diabetes for 3.56 
years during the period of observation. Table 2 presents a statistical description of the sample.  
 
Trajectories of physical disability with longer diabetes duration in middle and old age 
In agreement with our first hypothesis, ADL/IADL disability increased after diabetes was 
diagnosed according to a quadratic function with longer diabetes duration (intercept=0.824, 
p<0.001; linear slope=0.110, p<0.001; quadratic slope=0.006; p<0.001; M1 in Table 3). Mobility 
disability also increased quadratically (intercept=1.482, p<0.001; linear slope=0.087, p<0.001; 
quadratic slope=0.003; p<0.01; M1 in Table 4). For both outcomes, the fixed parameters 
associated with the intercept and linear slope were reduced in magnitude after time-constant and 
time-variant covariates (M5 in Tables 3 & 4) were included. In particular, in the third models, 
controlling for race, ethnicity, and gender variations significantly reduced the intercept. 
The model fit improved with each subsequent model, as demonstrated by significant log 
likelihood statistics. This improvement was observed even after penalties were applied for the 
increasing number of parameters, with decreasing AICs and BICs.  
The results also show a significant unexplained variability in the intercept (1.906; 
p<0.001), linear (0.237; p<0.001), and quadratic coefficients (0.028; p<0.001) for ADL/IADL 
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disability, and in the intercept (1.247; p<0.001) and linear slope for mobility disability (0.111; 
p<0.001). This variability remained robust to the inclusion of social and health variables. 
 
Diabetes timing (age at diagnosis) 
Our findings also lend support for the second hypothesis, that older age at diagnosis is 
associated with worse disability trajectories. We found higher ADL/IADL disability and greater 
linear increase with older age at diagnosis (intercept=0.064, p<0.001; linear slope=0.008; 
p<0.001; M2 in Table 3). We also found a modest acceleration in the quadratic slope with older 
age at diagnosis (quadratic slope=0.0001; p<0.05). For individuals diagnosed at age 50, after 
adjusting for mortality, attrition, proxy interview, age at diagnosis and age in 1995 (results not 
shown), ADL/IADL disability increased from 0.652 to 3.578 in 14 years, whereas for someone 
aged 60 at diagnosis, disability levels increased from 1.292 to 5.534 (Figure 3). These results 
were replicated in the models for mobility limitations, which suggest a robust effect on disability 
trajectories of diabetes duration and age at diagnosis (Figure 4). 
The inclusion of age at diagnosis in the level 2 models for the intercept and slope reduced 
the level of disability at diagnosis by 20.9% (from 0.824 to 0.652) and 6.3% (from 1.482 to 
1.389) and the linear slope of disability trajectories by 11.8% (from 0.110 to 0.097) and 3.7% 
(from 0.081 to 0.078) for ADL/IADL and mobility disability, respectively (M2, Tables 3 and 4).  
 
Birth cohort  
We found that being from an older cohort (older age at diagnosis), raised disability levels 
by 0.049 (p<0.001) at baseline. The increase was further tied to a 0.008 (p<0.001) increase in the 
linear slope, and 0.001 (p<0.001) increase in the quadratic term (results not shown). However, 
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after age at diagnosis was added in the model, the cohort effects were reversed: People from 
younger cohorts had a 0.049 lower risk of physical disability at diagnosis (-0.049; p<0.001), and 
the risk remained largely unchanged with longer diabetes duration (0.001, p>0.5 for the linear 
slope, and 0.001, p<0.10 for the quadratic slope). These trends remained in the final models after 
the health measures were included, with -0.052 (p<0.001) at baseline, and -0.002 (p>0.05) and 
0.001 (p<0.10) for the linear and quadratic slopes, respectively. Therefore our third hypothesis, 
that younger cohorts would manifest less physical disability, was not substantiated.   
 
Social stratification  
Our fourth hypothesis postulated that gender and racial differences in functional status, as 
evident at diagnosis, would increase with longer duration of diabetes. The results, however, 
suggested that, although significant racial and gender gaps in physical disability existed at the 
time of diabetes diagnosis, these differences remained stable over time. However, our hypothesis 
was supported when Hispanics were compared to whites: Hispanics were the only social group 
that experienced accelerated physical disability trajectories with longer diabetes duration 
(intercept=0.445, p<0.001; linear slope=0.058; p<001; Table 3, M3); and this ethnic difference in 
the rate of functional decline was fully explained by education (M5).  
Social differences in the trajectory of mobility disability were not nearly as noticeable, 
with the exception of a persistent gender gap (intercept=0.678; p<0.001; linear slope=0.003; 
p>0.05, M3, Table 4).  
Although there were no racial differences in the trajectories for mobility disability, ethnic 
differences were nevertheless harder to disentangle as covariates were added to the model. The 
analysis of race and ethnicity by gender provided more details on the combined effects of race 
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and ethnicity, on the one hand, and gender on the other, on functional status. Although gender 
and racial differences in physical disability trajectories were duplicated, ADL/IADL and 
mobility disability accelerated faster for Hispanic men (ADL/IADL: linear slope=0.100, p<0.01; 
Mobility: linear slope=0.049, p<0.05, Figures 5 & 6), followed by Hispanic women, who 
experienced a more modest increase (ADL/IADL: linear slope=0.054, p<0.05). Heterogeneity in 
education accounts in large measure for racial and ethnic gaps at diagnosis among men, and over 
time for Hispanic women. Education did not explain the functional decline for Hispanic men. 
However, higher education was the only socio-demographic characteristic to positively affect the 
slope of the mobility disability trajectory. 
 
DISCUSSION 
Building upon the Illness Career Model and the Disablement Process Model, and relying 
on the event-based approach in the study of diabetes and health, this study is the first to 
demonstrate that the clinical course of diabetes is characterized by a quadratic acceleration in 
ADL/IADL and mobility disability with longer diabetes duration among middle-aged and old-
aged adults with incident diabetes. Earlier reports using diabetes as a personal attribute found 
that being diabetic can increase the risk of functional limitation over time (Chiu & Wray, 2010; 
Chiu, et al., 2011). Rather than focusing on age or arbitrary time, which provides a cross-
sectional view of people’s experience of diabetes from the disease perspective, the event-based 
approach mirrors the clinical course of diabetes. It is therefore more useful to clinicians and 
patients but also to policy makers interested in understanding the course of diabetes after 
diagnosis.  
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Conceptually and methodologically, the current study’s strength lies in 1) its 
conceptualization of diabetes as a career, which allows for aligning functional change with 
disease progression; 3) its incorporation of several measures of time relevant to both the disease 
(diabetes duration) and to the patient (age at diagnosis and cohort); 2) its use of a national 
representative sample of middle-aged and older adults with self-identified incident diabetes and 
their physical disability over an extended period of time; 4) its statistical technique, which allows 
differentiation of the respective roles of intrapersonal and interpersonal variations on physical 
health change in diabetes; and 5) its ability to quantify social differences in the experience of 
diabetes among different social groups.  
 
Trajectories of physical disability with longer diabetes duration 
The study results confirm our first two hypotheses, that among middle-aged and older 
adults, diabetes is a dynamic aging accelerator in that physical disability, conceptualized as 
ADL/IADL and mobility disability, increases quadratically after diagnosis, and this increase 
accelerates with older age at diagnosis. The findings confirm a long-held assumption from cross-
sectional and age-based or time-based studies that longer diabetes duration is associated with 
worsening physical health (De Gauw, et al., 1999; Mitchell, et al., 1990; Park, et al., 2006). 
However, the study goes one step further by estimating the shape of this relationship. We 
confirm that the relationship between diabetes duration and physical disability is not time- 
invariant; rather, it changes with time, in that disabling effects are stronger with longer diabetes 
duration. On average, and after adjusting for age at diagnosis and cohort effects, there is a 25% 
loss in people’s ability to function physically every year following a diagnosis of diabetes, and a 
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2.17% quadratic increase with every additional year from an initial level of 0.415 limitations at 
diagnosis (results not shown).  
Socio-demographic and health status differences over the course of diabetes, including 
the burden of diabetes treatment, explained some of the levels as well as the rate of change in the 
physical health trajectories, but overall, these remained significant. These results highlight the 
need for further investigation of the reasons for the remaining levels and increase in physical 
disability with longer diabetes duration. In addition, substantial interpersonal variability in the 
disability trajectories at baseline and in the slopes further suggests the need to investigate 
population heterogeneity in the experience of diabetes, and to identify factors that potentially 
could set people with healthy trajectories apart from those with relatively unhealthy trajectories.  
 
Diabetes timing (age at diagnosis) 
Contrary to studies reporting a greater clinical burden of diabetes among people with 
younger age at onset compared to their older counterparts (Hatunic, et al., 2005; Hillier & 
Pedula, 2001; Hillier & Pedula, 2003; Selvin, et al., 2006; Wong, Moluneaux, Constantino, 
Twigg, & Yue, 2008), we found that individuals who were of older age at diagnosis are at 
greatest risk of losing physical functioning once diabetes has been diagnosed. This finding is one 
of the most important contributions of the study. Age at diagnosis is a significant risk factor for 
not only the levels of physical disability, but also the rate of change with longer diabetes 
duration. Therefore it may be clinically erroneous, from the perspective of functional prognosis, 
to treat people identically, if they are of different ages at diagnosis, even if they are of the same 
age at the time of clinical presentation. Thus identical treatment of older people with incident 
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diabetes diagnosed at different ages may contribute to greater functional disparities among older 
people with diabetes.  
That there are age differences in health at diagnosis is not surprising, because old age has 
negative effects on health. However, that physical and mental health decline faster among people 
diagnosed at older age can be due to clinical vulnerability, psychosocial vulnerability, or to 
delays in diabetes diagnosis. For instance, varying experiences with diabetes may stem either 
from a different pathogenesis of diabetes by a person’s age at the time when diabetes was 
diagnosed (Stewart & Liolitsa, 1999) or from greater vulnerability to diabetes in older age 
(Biessels, Deary, & Ryan, 2008). It is further possible that psychosocial pathways, including 
social isolation and involuntary role exit—both of which are reported in the literature (Blazer, 
Bruce, Service, & George, 1991; Mirowsky & Ross, 1992)—increase the burden and 
management of diabetes (Nicklett & Liang, 2010), especially when it occurs in older age. 
Finally, delayed diagnosis among people with older age at diagnosis may also explain our 
findings, for 26.9% of older adults with diabetes go undetected, and may have entered the study 
at a later stage of diabetes (Centers for Disease Control and Prevention, 2011). In sum, our study 
supports the need for different treatment goals according to a person’s age at diagnosis, because 
of the greater risk of physical disability when the disease is diagnosed later among middle-aged 
and older adults.  
 
Birth cohort 
The current study does not support our third hypothesis of worse disability trajectories 
with older cohorts; to the contrary, disability trajectories show evidence for persistent inequality 
with longer duration, with fewer ADL/IADL limitations at baseline among people in older 
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cohorts. These findings could be explained by recent research suggesting that while functional 
health has improved in almost all age groups, there were no functional gains in the middle-aged 
group with recent cohorts (Seeman, et al., 2010). The results may therefore reflect general trends 
in the U.S. population, which place middle-aged adults in recent cohorts at a functional 
disadvantage compared to their counterparts from older cohorts. Alternatively, the cohort gap in 
the disability trajectory may stem from lifestyle differences, which can affect functional status –
including sedentary lifestyle, lack of physical activity, and obesity. Higher obesity rates with 
more recent cohorts (Reynolds & Himes, 2007) are reported in the literature. Yet the inclusion of 
BMI along with other measures of health status and diabetes comorbidities in the mobility 
disability models did not fully explain the gap in the disability trajectories by cohort. Therefore 
although BMI may explain some of the reasons why younger cohorts are at greater risk of 
physical disability with diabetes, its contribution may be marginal. The impact of other measures 
of lifestyle should be investigated in subsequent studies. 
 
Social stratification  
The study contributes to the literature on the relationship between social stratification and 
diabetes by showing that socio-demographic predictors explained over half of observed physical 
disability at diagnosis, but explained little of the overall increase. It also highlights important 
differences in how various social groups experience diabetes. Overall, the disability trajectory of 
diabetics is best described in terms of persistent inequality among most social groups (Figures 5 
& 6) with the exception of Hispanics. For Hispanics (especially Hispanic men) both ADL/IADL 
and mobility disability trajectories diverged from those of white men, due to low education and 
declining health. These findings are significant, for previous studies generally found support for 
	   72	  
persistent inequality in functional status between Hispanics and non-Hispanic whites with age, or 
a Hispanic advantage, in the general population (Carrasquillo, Lantigua, & Shea, 2000; Liang, et 
al., 2008), and in diabetics (Chiu & Wray, 2010). Future studies are therefore needed to confirm 
these results. In addition, since education fully mediated the effect of ethnicity on functional 
change, there is also a need to identify the aspects of education that put Hispanics at greater risk 
of functional decline after a diagnosis of diabetes.  
The fact that these results are consistent across different functional measures only 
strengthens the argument for a functional disadvantage for Hispanics over the course of diabetes. 
 
Study limitations 
First, the use of self-reported year of diabetes diagnosis can introduce bias due to possible 
inaccuracies and to uneven distribution of diagnosis services in the population. A recent analysis 
of the Women’s Health Initiative data reported false-positive self-reported diabetes cases in only 
5.5% of the sample (Jackson et al., 2013), suggesting that self-reports are robust measures of 
diabetes status for those with diabetes. Nevertheless, about 28% of diabetes cases in the 
population are believed to be undiagnosed (Centers for Disease Control and Prevention, 2014), 
hence are not included in the study. It is likely that these individuals are healthier than the 
sample, or have greater difficulties accessing diagnosis services; therefore our estimates may be 
larger than the “true” parameters of trajectories representing the population of older diabetics. 
Second, people assigned a diagnosis year could have been diagnosed any time between two 
consecutive observation periods, leading to potentially greater levels of physical disability at 
baseline. There is, however, no reason to suspect a systematic bias toward specific social groups. 
Third, as mentioned above, factors related to functional change and social stratification, 
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including social, behavioral, biological, and psychological determinants, could partially explain 
our findings; therefore our models may suffer from omitted variable bias. Further analyses 
should attempt to assess the impact of these covariates on the disability trajectories. Finally, one 
important limitation is related to the assumptions for the use of a linear model. Preliminary 
analyses show that both the linearity and collinearity assumptions between the outcome and the 
predictors are met at level-1. However, the distribution of the level-1 residuals did not meet the 
normality requirement; consequently, homoskedasticity assumptions were also violated. 
Therefore, while our estimates are unbiased, the standard errors may be less efficient. Poisson 
analyses for negative binomial distribution reveals that the overall story did not significantly 
change, with two exceptions. 1) The quadratic acceleration was weaker and became statistically 
marginal. 2) The acceleration in the trajectory among Hispanics began strong, but became 
smaller with longer diabetes duration, a fact which suggests that the Hispanic disadvantage is 
stronger earlier in the diabetes career (Appendix A). However, the necessity of testing for 
linearity assumptions in multilevel models when large samples are used is debated (Gelman & 
Hill, 2007). In addition, most published studies using the ADL/IADL measure adopt a linear 
model. Therefore to facilitate comparability of our results to the existing research, we presented 
the results from the ordinary least square models. 
 
Policy implications 
From policy and clinical perspectives, efforts to limit physical disability in late-onset 
diabetes should be undertaken in conjunction with broader policies for early detection of diabetes 
and early prevention of functional decline during the illness. The study supports the importance 
of strategies implemented early in the illness career to prevent increasing physical disability and 
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disparities over the course of diabetes. But once diabetes is diagnosed, interventions to maintain 
and improve physical health are the most suitable options to bend the disability curve in middle-
aged and older adults.  
Incorporate measures of disability as an integral part of patient monitoring – Overall, the 
study highlights the necessity to include measures of physical disability as an integral part of any 
comprehensive diabetes management plan as a secondary preventive measure. People with 
diabetes experience increased physical disability with every added year. While physical health is 
often included either as a criterion for treatment or as a legitimate outcome to address (American 
Diabetes Association, 2014; American Geriatrics Society Expert Panel on the Care of Older 
Adults with Diabetes Mellitus, 2013), the recommendations are limited to the point of care. 
Given the relatively large rate of change in physical disability on an annual basis, and the link 
between functional decline, mental health, cognitive health, diabetes outcomes, and diabetes 
management (Ciechanowski, Katon, & Russo, 2000; Feil et al., 2009; Feil, Zhu, & Sultzer, 2012; 
Okura, Heisler, & Langa, 2009; Rosen et al., 2003), more sensitive tools and more frequent 
monitoring at home could help prevent poor diabetes outcomes. These measures could be 
undertaken by incorporating self-screening tools into electronic devices including smart phones, 
tablets, e-readers, and the internet with e-mail reminders, and by involving family caregivers and 
case managers who may be more likely to catch subtle changes in physical functioning.  
Develop visual graphs of the course of diabetes in terms of physical disability – The 
study can potentially improve the quality of care by addressing the lack of congruence between 
patients’ goals for diabetes treatment and those of their treating clinicians. So far, a patient’s goal 
of functional independence (Huang, Gorawara-Bhat, & Chin, 2005) has never been incorporated 
into the natural history of diabetes. With the current study estimates, visual graphs of the course 
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of diabetes in measures important to patients can be developed and used as promotional tools and 
supporting material during diabetes assessment and follow-up visits. They can offer an 
opportunity for clinicians to discuss the implications of life-style changes, medical treatment, and 
metabolic outcomes, on functional independence, and possibly on the timing of 
institutionalization. Physicians and patients can therefore ”speak the same language” and share a 
common goal in diabetes treatment. Future studies can determine the effectiveness of such steps 
in ensuring patient-physician congruence in setting goals for diabetes management. 
Incorporate age at diagnosis as a criterion for diabetes care and management – Diabetes 
duration and chronological age are consistently used as criteria for diabetes care, but age at 
diagnosis is not seen as a risk factor for poor diabetes outcome in any of the published 
recommendations. Therefore the study contributes to clinical care and policy by demonstrating 
that age at diagnosis is an important criterion for diabetes care. According to our results, a 70- 
year-old person recently diagnosed with diabetes is not just at greater risk of physical disability 
at diagnosis, but she or he is also at greater risk of increased physical disability compared to a 
70-year-old with longer diabetes duration, who was diagnosed 5 or 10 years earlier; and this 
difference needs to be taken into account in clinical decisions. 
Address the upcoming cohorts of older adults with increasing diabetes – The finding that 
people in older cohorts have lower physical disability over the course of diabetes underscores the 
risk that future cohorts of older adults with diabetes may suffer greater physical disability. The 
prospect of unhealthy older adults, in light of the aging of the population and increased incidence 
of diabetes, paints a bleak picture for future generations. If the trends in diabetes and related 
physical disability are not addressed, we can expect an overload of the U.S. health system, 
including Medicare and Medicaid, as well as a proliferation of families left to care for large 
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numbers of disabled older adults with diabetes. Ultimately the economic impact of diabetes in 
middle-aged and older adults can be great, because of an expected higher demand for care and 
reduced ability to contribute to the labor force and thus to the national and local tax bases. 
Primary prevention – In addition to monitoring and addressing the increasing disability 
trajectory over the course of diabetes, primary intervention to prevent diabetes itself is a 
preferred policy option, and it has been adopted worldwide. Empirical studies have found that 
lifestyle intervention programs such as the Diabetes Prevention Program can prevent and delay 
type 2 diabetes (Diabetes Prevention Program Research Group, 2009). About 500 such programs 
have already been implemented throughout the U.S. Therefore funding and expanding these 
evidence-based programs in communities seem to be adequate policy options (American 
Diabetes Association, 2014). For instance, expanding these programs to local lifestyle programs 
including gyms, yoga clubs, Weightwatchers®, and Curves® can connect middle-aged and older 
adults to diabetes prevention and screening. Funding could come from a public-private sector 
combination involving insurers, Medicare and Medicaid, the Department of Defense, and 
businesses that have a stake in ensuring the public health of the population for security, political, 
and economic reasons. 
Addressing health inequalities early in the life-course – An additional policy implication 
of the study findings is that overall, childhood and early adulthood strategies to reduce social 
inequalities implemented before a diagnosis of diabetes stand the best chance of reducing 
disparities in physical disability over the course of diabetes. Education was the only modifiable 
determinant with a continuous effect before and after diabetes diagnosis and it further influenced 
the link between other social determinants of health—a finding that accords with the observation 
that socioeconomic status is a fundamental cause of health inequalities (Link & Phelan, 1995). 
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According to a recent comprehensive report on health inequalities in the U.S., racial differences 
in health are not observed within neighborhoods with people of similar education and income, 
which suggests that social conditions, not individual characteristics, may be the most important 
drivers of health disparities (Bleich, Jarlenski, Bell, & LaVeist, 2012, 2013). Therefore policies 
to address health inequalities in the general population, and consequently among older adults 
with diabetes should focus on mutable factors such as income inequalities and residential 
segregation, which jointly affect educational opportunities and thereby determine life prospects 
(LaVeist, Gaskin, & Richard, 2009).  
 
Research implications 
Several new observations are highlighted by the study. First, research is needed to 
confirm and explain how and why lower education and income result in greater Hispanic 
disadvantage with longer diabetes duration. Moreover, the heterogeneity among older people 
with diabetes poses one of the most difficult challenges for diabetes prevention, management, 
and care (Kirkman et al., 2012). The study’s finding of significant variation in the random 
component variances requires further investigation to identify individual trajectories of people 
with successful or pathological aging (Rowe & Kahn, 1997) and to link these trajectories to 
individual characteristics, including behavioral, psychological and socioeconomic predictors and 
outcomes, as well as to the availability and use of health services. 
 
CONCLUSION 
The event-based approach to the study of diabetes and health change adopted in the 
current study provides a new way to look at patients’ experience of diabetes. While disability 
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trajectories accelerate after diagnosis for all, people’s experience of diabetes varies significantly 
by age at diagnosis, by cohort, and by social group. Therefore efforts to limit functional decline 
in late-onset diabetes should be undertaken in conjunction with broader policies for early 
detection of diabetes and early prevention of functional decline. These policies also need to 
address the Hispanic disadvantage with longer diabetes duration, and also address the respective 
roles of race, ethnicity, and gender in functional status before the onset of diabetes. Further 
research is needed to explain how and why age at diagnosis and education affect disability 
trajectories with longer diabetes duration. A broader research agenda challenges gerontologists to 
incorporate the natural history of chronic illnesses into studies of aging.
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Table 2: Descriptive Statistics for the sample 
 Mean or % SD 
Measures of time and main outcomes   
Average diabetes duration (years) 3.561 2.315 
ADL/IADL disability (0-11) 1.229 1.665 
Mobility disability (0-5) 1.745 3.484 
   
Level 1: Time varying covariates at baseline (n=10,883)   
Married (%) 61.551 - 
Self-rated health 3.353 1.050 
Comorbidities (excluding diabetes) 1.412 0.611 
CESD  1.903 2.156 
Treatment burden 1.939 0.602 
BMI 29.880 5.871 
Proxy (%) 9.749 - 
   
Level 2: Time constant variables (n=3307)   
Age at diabetes diagnosis 68.960 9.166 
Birth cohort (age in 1995) 60.667 9.647 
Non-Hispanic white men (%) 34.624 - 
Non-Hispanic black men (%) 6.955 - 
Hispanic men (%) 4.929 - 
Men of other race (%)   1.331 - 
Non-Hispanic white women (%) 33.353 - 
Non-Hispanic black women (%) 10.463 - 
Hispanic women (%) 6.774 - 
Women of other race (%)  1.572 - 
Education (%)   
Less than high school (%) 32.156 - 
High school graduate (%) 34.333 - 
Graduate school (%) 33.511 - 
Death at any point in time (%) 27.155 - 
Attrition at any point in time (%) 16.208 - 
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Table 3: Trajectory of ADL/IADL Disability with longer diabetes duration 
 M1  M2  M3  M4  M5  
  Est. Sig Est. Sig Est. Sig Est. Sig Est. Sig 
Fixed effects           
For intercept           
Intercept 0.824 *** 0.652 *** -0.054  0.426 *** 0.458 *** 
Age at diagnosis   0.064 *** 0.110 *** 0.114 *** 0.102 *** 
Birth cohort (age in 1995)     -0.052 *** -0.060 *** -0.052 *** 
Female     0.565 *** 0.533 *** 0.345 *** 
Non-Hispanic black     0.536 *** 0.407 *** 0.372 *** 
Hispanic     0.445 *** 0.161  0.033  
Other race     0.177  0.143  0.099  
High school graduate       -0.608 *** -0.339 *** 
College graduate       -0.595 *** -0.178 * 
           
For linear slope           
Intercept 0.110 *** 0.097 *** 0.081 *** 0.113 *** 0.075 *** 
Age at diagnosis   0.008 *** 0.008 ** 0.008 ** 0.008 *** 
Birth cohort (age in 1995)     0.001  0.000  -0.002  
Female     0.009  0.005  0.013  
Non-Hispanic black     0.031  + 0.022  0.027  
Hispanic     0.058 ** 0.039  + 0.037  +  
Other race     -0.028  -0.031  0.001  
High school graduate       -0.041 * -0.046 ** 
College graduate       -0.041 * -0.048 ** 
           
For quadratic slope           
Intercept 0.006 *** 0.008 *** 0.009 *** 0.009 *** 0.008 *** 
Age at diagnosis   0.0001 * 0.0001  0.0001  -0.001  
Birth cohort (age in 1995)     0.001  + 0.001  + 0.001  + 
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Time variant variables           
Married         0.004  
Self-rated health         0.279 *** 
Comorbidities         0.223 *** 
CESD         0.209 *** 
Treatment burden         0.143 *** 
           
Survey status           
Death  1.335 *** 1.053 *** 1.300 *** 1.252 *** 0.862 *** 
Attrition  -0.192 * -0.125  -0.124  -0.140  -0.158 * 
Proxy (time variant) 2.585 *** 2.473 *** 2.505 *** 2.486 *** 2.205 *** 
           
Random effect           
Variance           
Intercept 1.906 *** 1.884 *** 1.834 *** 1.822 *** 1.571 *** 
Linear slope 0.237 *** 0.223 *** 0.221 *** 0.221 *** 0.202 *** 
Quadratic slope 0.028 *** 0.027 *** 0.028 *** 0.028 *** 0.025 *** 
Covariance           
Intercept x linear slope 0.341 *** 0.371 *** 0.346 *** 0.344 *** 0.336 *** 
Intercept x quadratic slope -0.455 *** -0.437 *** -0.478 *** -0.498 *** -0.594 *** 
Linear x quadratic slope -0.310 *** -0.359 *** -0.352 *** -0.366 *** -0.414 *** 
Level 1 residual 1.157 *** 1.155 *** 1.156 *** 1.155 *** 1.141 *** 
           
Model statistics            
Observations 10883  10883  10883  10883  10883  
Groups 3307  3307  3307  3307  3307  
AIC 139649  139427  139316  139288  136725  
BIC 139764  139569  139556   139564   137045   
Log likelihood  -69811  -69697  -69631  -69613   -68326   
 -2ΔLog Likelihood statistic -  227 *** 132.7 *** 36.3 *** 2573.2 *** 
	   89	  
Degrees of freedom -  3  11  4  5  
***p<0.001; **p<0.01; *p<0.05; +p<0.10; AIC: Akaike Information Criteria; BIC: Bayesian Information Criteria; Log Likelihood 
Ratio Test tests nested models 2 vs 1, 3 vs 2, 4 vs 3, and 5 vs 4, respectively.
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Table 4: Trajectory of mobility disability with longer diabetes duration 
 M1  M2  M3  M4  M5  
  Est. Sig Est. Sig Est. Sig Est. Sig Est. Sig 
Fixed effects           
For intercept           
Intercept 1.482 *** 1.389 *** 0.862 *** 1.260 *** 1.304 *** 
Age at diagnosis   0.035 *** 0.058 *** 0.061 *** 0.053 *** 
Birth cohort (age in 1995)     -0.028 *** -0.035 *** -0.021 ** 
Female     0.678 *** 0.634 *** 0.450 *** 
Non-Hispanic black     0.020  -0.064  -0.076  
Hispanic     0.076  -0.147  + -0.242 *** 
Other race     0.118  0.004  -0.028  
High school graduate       -0.381 *** -0.143 ** 
College graduate       -0.584 *** -0.188 ** 
           
For linear slope           
Linear slope 0.081 *** 0.078 *** 0.087 *** 0.077 *** 0.043 *** 
Age at diagnosis   0.003 *** 0.001  0.001  0.001  
Birth cohort (age in 1995)     0.003  + 0.003  + 0.002  
Female     -0.001  -0.002  0.006  
Non-Hispanic black     0.002  0.001  0.007  
Hispanic     -0.002  0.030 * 0.026 * 
Other race     -0.005  -0.058 * -0.028  
High school graduate       0.010  0.002  
College graduate       0.014  0.004  
           
For quadratic slope           
Quadratic slope 0.003 ** 0.004 *** 0.003 * 0.003 ** 0.002 * 
Age at diagnosis   -0.00003  0.00002  -0.00002  -0.0001  
Birth cohort (age in 1995)   0.0002  0.0002  0.0002  0.0002  
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Time variant variables           
Married         -0.032  
Self-rated health         0.364 *** 
Comorbidities         0.217 *** 
CESD         0.123 *** 
Treatment burden         0.083 *** 
BMI         0.037 *** 
           
Survey status           
Death  1.052 *** 0.876 *** 1.058 *** 1.000 *** 0.619 *** 
Attrition  0.004  0.048  0.070  0.047  0.023  
Proxy (time variant) 0.882 *** 0.810 *** 0.846 *** 0.822 *** 0.614 *** 
           
Random effect           
Variance           
Intercept 1.247 *** 1.230 *** 1.174 *** 1.153 *** 0.836 *** 
Linear slope 0.111 *** 0.103 *** 0.103 *** 0.102 *** 0.078 *** 
Quadratic slope 0.000  0.000  0.000  0.000  0.000  
Level 1 residual 0.945 *** 0.944 *** 0.945 *** 0.945 *** 0.931 *** 
           
Model statistics            
Observations 10883  10883  10883  10883  10883  
Groups 3307  3307  3307  3307  3307  
AIC 130331  130168  130005  129934  124700  
BIC 130420  130283  130219   130183   125002  
Log likelihood  -65156  -65071  -64979  -64939   -62316   
 -2ΔLog Likelihood statistic -  169 *** 184 *** 79 *** 5246 *** 
Degrees of freedom -  3  15  4  6  
***p<0.001; **p<0.01; *p<0.05; +p<0.10; AIC: Akaike Information Criteria; BIC: Bayesian Information Criteria; Log Likelihood 
Ratio Test tests nested models 2 vs 1, 3 vs 2, 4 vs 3, and 5 vs 4, respectively.
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Figure 3: Average trajectory of ADL/IADL disability with longer diabetes duration at different age at diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† Model controls for death (=0), attrition (=0), and proxy interview (=0 in each wave); outcome is truncated to improve visualization. 
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Figure 4: Average trajectory of mobility disability with longer diabetes duration at different age at diagnosis†  
 
 
†  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model controls for death (=0), attrition (=0), and proxy interview (=0 in each wave) 
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Figure 5: Average trajectory of ADL/IADL disability with longer diabetes duration by race/ethnicity and gender† 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†Model controls for death (=0), attrition (=0), proxy interview (=0 at each wave), diabetes timing (mean age at diagnosis) and birth 
cohort (mean age in 1995); outcome is truncated to improve visualization. 
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Figure 6: Average trajectory of mobility disability with longer diabetes duration by race/ethnicity and gender† 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† Model controls for death (=0), attrition (=0), proxy interview (=0), diabetes timing (mean age at diagnosis) and birth cohort (mean 
age in 1995). 
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CHAPTER 3 
Depressive Symptoms Trajectory After Diabetes Diagnosis in Middle-Age and 
Older Adulthood: Age and Social Variations 
 
INTRODUCTION 
Studies of diabetes and depressive symptoms 
The prevalence of diabetes is expected to rise in the general population and at faster rates 
in older adults compared with younger adults (Centers for Disease Control and Prevention, 
2014). Depressive symptoms, which co-vary with diabetes, also increase after middle adulthood 
(Clarke, Marshall, House, & Lantz, 2011; Mirowsky & Ross, 1992; Wu, Schimmele, & Chapell, 
2012; Xu, Liang, Bennett, Quinones, & Ye, 2010), especially in more recent cohorts (Clarke, et 
al., 2011; Yang, 2007). 
Among diabetics, depression and its symptoms have both policy and clinical relevance. 
Depressive symptoms exacerbate the negative effects of diabetes on health through biological 
mechanisms, and by inhibiting self-management behaviors (Chiu, Wray, Beverly, & Dominic, 
2010). They also have societal implications, due to their association with increased use of health 
services, lost productivity, reduced functioning, and diminished quality of life (Egede, Zheng, & 
Simpson, 2002; Markowitz, Gonzalez, Wilkinson, & Safren, 2011).  
Cross-sectional studies of people with and without diabetes find higher levels of 
depressive symptoms and depression among people with diabetes compared to diabetes-free 
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adults (Anderson, Freedland, Clouse, & Lustman, 2001; Egede, et al., 2002; Engum, Mykletun, 
Midthjell, Holen, & Dahl, 2005). A recent meta-analysis reported a 24% increased risk of 
incident depression among people with type 2 diabetes compared to people without diabetes 
(Nouwen et al., 2010).  
The literature further provides evidence for significant stratification in the link between 
diabetes and health. Some studies have found no link between depressive symptoms and race or 
ethnicity (Egede & Zheng, 2003), but others have found higher initial and transient depression 
among blacks (Peyrot & Rubin, 1999). Sex differences in initial levels of depressive symptoms 
have also been described (Peyrot & Rubin, 1999). Lower education is linked to both higher 
initial levels of depression and persistent depressive symptoms (Peyrot & Rubin, 1997, 1999) in 
patients with type 1 and type 2 diabetes (Engum, et al., 2005). Lack of employment is also 
associated with major depression (Egede & Zheng, 2003).  
Overall, the existing literature is effective in describing the association between diabetes 
and mental health. It is, however, limited by small, clinical, and ethnically homogeneous 
samples, and by the use of only one to three observation periods. Longitudinal studies of the 
effect of diabetes and mental health are lacking, and the few published reports largely focus on 
exploring the directionality of the relationship between diabetes and depression (Engum, et al., 
2005; Golden et al., 2008; Palinkas, Lee, & Barrett-Connor, 2004; Pan et al., 2010).  
Furthermore, conceptually these studies use diabetes as a time-invariant personal 
attribute, meaning that patients are classified as “having diabetes” or “not having diabetes.” This 
approach can be problematic because the biomedical literature reports that the natural history of 
diabetes is characterized by biological, physiological, and health change over time (Ramlo-
Halsted & Edelman, 2000). Therefore at any point in time “people with diabetes” of the same 
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age comprise individuals at different stages of their disease. As a consequence, the estimated link 
between diabetes and mental health is confounded by the natural history of diabetes.  
 
Theoretical framework 
We argue that a person’s location on his or her disease career at any point in time, and the 
social context in which this career is formed and maintained, are important markers of mental 
health status. Therefore the timing of diabetes, the patterns of health change after diagnosis, and 
the social context in which these health changes occur are all important research questions. Yet 
because medical sociologists, health services researchers, and epidemiologists are often 
interested in the impact of diabetes on mental health, diabetes is consistently conceptualized as a 
time-invariant and individual attribute. What happens to mental health after diabetes has been 
diagnosed is therefore unknown, and the experiences may well be unique to this population. If 
they are, this knowledge can inform clinical decisions and policy. The goal of this study is to fill 
this void in research.  
We propose that health changes with time, not only because of the effects of aging, but 
also because of disease progression and the social environment in which this progression occurs. 
The current study bridges the gap between the medical and the sociological research by 
incorporating elements of both clinical medicine and medical sociology in assessing people’s 
experience of diabetes. In addition to taking into account the natural history of diabetes, in which 
the illness is manifested as a dynamic phenomenon, the current study utilizes the Illness Career 
Model and the theory of social stratification to describe and estimate health change after a 
diagnosis of diabetes.   
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Natural history of diabetes – The natural history of diabetes allows us to conceptualize the 
disease as a dynamic phenomenon. Accordingly we hypothesize that health change occurs 
simultaneously with disease progression; therefore time should be measured from the perspective 
of both the disease and the patient. Age, age at diagnosis, and birth cohort allow us to locate 
people on their life trajectory, while diabetes onset and diabetes duration provide keys to 
describe the disease. 
 
Illness Career Model – The Illness Career Model (Aneshensel, 1999, 2013) and its clinical 
variant the Illness Trajectory Model (Corbin, 1998; Corbin & Strauss, 1991; Strauss & Glaser, 
1975) is a sociological model of chronic illness which provides a conceptual framework for 
understanding people’s experience of diabetes. The model allows the conceptualization of mental 
health change with diabetes as a common experience shared by individuals affected by the 
condition, starting with its diagnosis. The mental health of people with diabetes can therefore be 
modeled as a trajectory which links the individual, the illness, and the social environment in 
which these interact. Since we treat diabetes as a career, the trajectory of depressive symptoms 
with diabetes begins with the year in which a patient was diagnosed with the disease, and 
continues along the disease career.  
 
Social stratification and depressive symptoms – According to the theory of social stratification, 
ascribed characteristics such as race and ethnicity (Williams & Jackson, 2005), age (Riley, 
1987), and gender (Bird & Rieker, 1999; Rieker & Bird, 2000), all partially mediated by 
socioeconomic status  (Robert & House, 2000), form the foundation of a system of dominance 
and subordination, which results in several dualistic social structures. Such structures create 
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systemically unequal allocation of resources and risks, which in turn leads to poorer health in 
disadvantaged groups (House, Lantz, & Herd, 2005; House et al., 1994; Lantz et al., 2001; Link 
& Phelan, 1995).  
Barriers to self-management, to access to healthcare, poor quality of healthcare, obstacles 
to diabetes control, less family support, worse psychological outcomes, distress, and 
comorbidities are consistently found in the research on blacks, individuals of lower 
socioeconomic status, women, and Hispanics (Brown et al., 2000; Glasgow, McCaul, & Schafer, 
1986; Gucciardi, Wang, DeMelo, Amaral, & Stewart, 2008; Heisler et al., 2007; Jezewski & 
Poss, 2002; Lanting, Joung, Mackenbach, Lamberts, & Bootsma, 2005; Ponzo et al., 2006; 
Quandt et al., 2005; Sentell & Halpin, 2006; Szalat & Raz, 2007; Walker et al., 2006). Therefore 
we except that with longer diabetes duration, people in socially disadvantaged groups will have 
poorer mental health trajectories at diagnosis and with longer diabetes duration, due to these 
inequalities.   
 
EVENT-BASED APPROACH TO THE STUDY OF DIABETES AND HEALTH 
The main hypothesis in the current study is that beyond the effects of age and time, 
physical, mental, and cognitive health changes associated with a chronic illness vary with 
progression of the disease. Therefore to quantify the course of diabetes in terms of physical, 
mental, and cognitive changes after a diagnosis of diabetes, we adopted the event-based 
approach to the study of diabetes and health, which postulates that health trajectories 1) begin 
with the onset of diabetes; 2) are defined by duration of the disease, which is the measure of 
time; and 3) are modeled as a function of time-variant and time-constant social determinants of 
health change. 
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In this framework, the role of four measures of time relevant to the disease (diabetes 
duration) and the person (age, age at diagnosis, cohort) are necessary to capture health change 
with longer diabetes duration. The distinction between these measures of time is necessary in 
order to ascertain the social causes of health change with diabetes and to facilitate medical and 
policy intervention; for programs must be tailored to the needs of people who are at different 
points on their disease trajectory and in their life course. 
 
Chronological age 
Time-variant chronological age captures changes stemming only from the process of 
aging (Riley, 1987). An event-based perspective allows for a more accurate estimate of the 
health of people with diabetes at every age by using a combination of diabetes duration and age 
at diagnosis. For instance, the mental health of a patient diagnosed at age 50 can be predicted 
when they reach 60 or 70 years of age. Likewise, that of a person diagnosed at 70 can be 
predicted 5 or 10 years later. Since our interest is not in describing the effect of diabetes with 
age, but rather health changes over the clinical course of diabetes, we have not designated a 
specific measure of the aging process. The current study is therefore unable to distinguish the 
effect of diabetes from that of aging at any given time after diabetes has been diagnosed.  
 
Diabetes duration 
Rather than age or time, in an event-based approach, diabetes duration is conceptualized 
as a time-variant measure, which describes health trajectories after a diagnosis of diabetes.  
Diabetes duration makes it possible to capture health change as the disease progresses, and as 
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people age along with the disease.  Estimates of health status for a particular patient at any point 
in the progression of the disease, and dependent on the age at diagnosis, accurately measures 
health at every stage of the natural history of diabetes.  
A few studies of transition in and out of mental health states feature diabetes duration as a 
covariate or a predictor, and find that depression regularly recurs. These studies report a link 
between diabetes duration and increased risk of diabetes-related depressive symptoms one year 
after diagnosis (Skinner et al., 2010) and increasing risk of incident depression (Egede & Zheng, 
2003; Nefs, Pouwer, Denollet, & Pop, 2012; Thoolen, de Ridder, Bensing, Gorter, & Rutten, 
2006). However, the studies have several limitations. First, using diabetes duration as a time-
constant predictor does not capture changes in the different areas of life that can influence mental 
health as the disease unfolds. On the other hand, conceptualized as a time-variant predictor, 
diabetes duration merely provides a qualitative measure of the stage of diabetes without 
indicating the nature of health change over the course of diabetes, which exists on a time 
continuum. Second, these studies are limited by their cross-sectional design, which cannot 
distinguish between intrapersonal and interpersonal differences in health outcomes. Therefore we 
do not know how much of the estimated effect of diabetes duration is based on personal 
differences in health over time or on the true effects of diabetes duration. Finally, studies using 
two or three time points provide little information about the underlying growth curve of health 
change with diabetes duration. Multiple underlying trajectories exist as people’s mental health 
varies at diagnosis and with longer diabetes duration, and these interpersonal variations at 
baseline and with diabetes duration are not captured in the studies cited, which use conventional 
methods of analysis.  
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Diabetes timing (age at diagnosis) 
Diabetes timing conceptualizes people’s location on their life course at the time of 
diabetes diagnosis. Bury’s concept of chronic illness as ”biographical disruption” suggests that 
the event of a chronic illness can define new health trajectories, making it a key measure of the 
experience of illness (Bury, 1982). 
Some studies suggest that patients with earlier onset experience a greater clinical burden 
of diabetes (Hatunic, Burns, Finucane, Mannion, & Nolan, 2005; Hillier & Pedula, 2001; Hillier 
& Pedula, 2003; Selvin, Coresh, & Brancati, 2006; Wong, Moluneaux, Constantino, Twigg, & 
Yue, 2008), but they do not include diabetes duration, which is a strong confounder of the link 
between age at diagnosis and health. One study, which incorporated diabetes duration, found that 
the risk of complications—including cataract, diabetes foot, and microvascular complications—
increased with every year added to the average age at onset. The risk did not differ for 
macrovascular or neuropathic complications (Chuang et al., 2006). However, the study used a 
clinical sample of patients aged 18 and older, and a cross-sectional design. Therefore this 
research does not provide useful information on the role of age at diagnosis on health change in 
middle age compared to older adulthood. To the author’s knowledge, only one population study 
tested the link between age at diagnosis and health in middle age compared to older age (Selvin, 
et al., 2006). But here too, diabetes duration was not adjusted for. As a consequence, the role of 
diabetes timing on health change with longer diabetes duration remains unclear.  
 
Birth cohort 
Cohort effects reflect the impact of exogenous social factors on the health of people of 
similar age group with shared experiences (Ryder, 1965). Studies investigating cohort effects on 
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depressive symptoms generally found a reduction in depressive symptoms with successive 
cohorts, in part attributed to higher education (Clarke, et al., 2011) and to improvement in 
socioeconomic and marital status (Yang, 2007). For diabetes, educational and behavioral 
improvement (Schoeni, Freedman, & Martin, 2008) between cohorts, changes in the diagnostic 
criteria (Koopman, Mainous, Diaz, & Geesey, 2005) and in treatment modalities such as the 
relaxation in management modalities for older adults (American Diabetes Association, 2014) can 
exert a positive influence on people’s experience of diabetes; but these factors have not been 
investigated. However, it is reasonable to expect that the mental health of older adults with 
incident diabetes also improves with successive cohorts. 
 
HYPOTHESES 
Hypothesis 1: Studies of loss-related stressors, including bereavement, divorce, and 
retirement, show that people psychologically adapt within a few years of the event (Aneshensel, 
Botticello, & Yamamoto-Mitani, 2004; Lucas, Georgellis , Clark, & Diener, 2003; Lynch & 
George, 2002). But because of the pernicious nature of diabetes, its psychological impact and the 
burden of its management, the negative effects of diabetes on mental health are likely to intensify 
over the course of the illness. They are also likely to proliferate into several areas of individuals’ 
lives, including their behaviors, their social relationships, and their health. We hypothesize that 
people do not adapt to diabetes, because its complications and the burden of treating it result in 
increasingly poorer mental health with longer diabetes duration, and these changes can be 
modeled as a trajectory.  
This view agrees with the “psychological burden hypothesis,” according to which the 
burden of knowing that one has diabetes, having to manage it, and coping with its complications 
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and treatment can contribute to higher levels of depression over time (Talbot & Nouwen 2000). 
It is also in agreement with Harris’s conceptualization of a psychological pathway linking 
continuous exposure to stressors over the course of illness to psychological distress among 
diabetics (Harris, 2003).  
Hypothesis 2: In anticipation that the mental health burden of diabetes and its 
management are exacerbated by increasing complications (Chuang, et al., 2006) and involuntary 
role exits, which have adverse effects on mental health and diabetes self-care (Blazer, Bruce, 
Service, & George, 1991; Mirowsky & Ross, 1992; Nicklett & Liang, 2010), we expect that 
among middle-aged and older adults with incident diabetes, older age at diagnosis will result in 
poorer mental health at diagnosis and will be associated with a faster mental health decline with 
longer duration of diabetes.  
Hypothesis 3: In middle-aged and older adults with incident diabetes, people in older 
cohorts will have higher levels of depressive symptoms at diagnosis and faster increase with 
longer diabetes duration. This hypothesis stems from evidence of improvement in educational, 
behavioral and medical improvements in recent cohorts. 
Hypothesis 4: Based on the literature, barriers to self-management and to access to 
healthcare, and poor quality of healthcare, along with obstacles to diabetes control, less family 
support, worse psychological outcomes, and comorbidities should raise the vulnerability of 
blacks, women, and individuals of lower socioeconomic status over the course of diabetes, and 
reduce the Hispanic advantage in the years following diagnosis. Therefore we hypothesize that 
blacks, Hispanics, women, and individuals of lower socioeconomic status will have higher levels 
of depressive symptoms at diagnosis compared to their counterparts, and faster increase in the 
number of depressive symptoms with longer diabetes duration. 
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METHODS 
Data and sample 
The Health and Retirement Study (HRS) is a biennial multi-sample nationally 
representative panel survey of uninstitutionalized U.S. adults aged 50 and older (Juster & 
Suzman, 1995). Respondents interviewed between 1995 AHEAD/1996 HRS and 2010 HRS3 
were included in the study if they reported being diagnosed with diabetes for the first time while 
in the study, and were aged 50 or older. It is assumed that most respondents had type 2 diabetes 
because of the late age at onset (Kenny, Aubert, & Geiss, 1995), and because only 5% of 
diabetes cases in adulthood are attributed to type 1 diabetes (Centers for Disease Control and 
Prevention, 2014).  
Self-reported diabetes status was assessed by consecutive negative and positive response 
to the HRS diabetes question, which asked whether a doctor had told the respondent he or she 
had a series of conditions, including diabetes (1=yes, 0=no). Cases with conflicting responses 
(total of 88) were recoded to “diabetic”’ if respondents reported taking insulin or oral medication 
for diabetes in any given year (Liang, Quinones, Bennett, & Ye, 2011).  
The data were stacked beginning from the year diabetes was reported for the first time 
(year of diagnosis=0). Time since diabetes diagnosis was recorded for every wave thereafter 
between 1995/1996 and 2010, for a total of 7 waves (14 years). 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  Baseline years are 1996 for HRS and 1995 for AHEAD because the functional limitation 
questions for HRS did not include difficulties using a toilet in the prior waves (1992 and 1994). 
The wording, structure and coding of the questions were also different. Starting in 1996, 
however, the question measuring functional limitations was consistent in both wording and 
coding. In addition, responses to the diabetes question in the years 1994 HRS and 1993 AHEAD 
were used to confirm that respondents reported being diabetes-free before the initial assessment 
in 1996 HRS and 1995 AHEAD.	  
	  	   107	  
Measures 
Depressive symptoms – An abbreviated version of the Center for Epidemiologic Studies 
Depression rating scale (CES-D) was used. It rates the following: feeling depressed, feeling 
everything was an effort, restless sleep, feeling lonely, sad, happy, enjoying life, could not get 
going, and having a lot of energy much of the time in the previous week (Radloff, 1977). 
Depressive symptoms were measured every other year. The summary score obtained from the 
items ranged between 0 and 9, and higher scores reflected more negative affect. The scale has 
acceptable validity and internal consistency with standardized Cronbach’s alpha of 0.80 
(Davidson, Feldman, & Crawford, 1994; Radloff, 1977). 
Time measure (diabetes duration) – In the event-based approach to diabetes and health 
change, time is conceptualized as diabetes duration, and is operationalized as the year since 
diabetes was diagnosed. It ranges from 0 to 14 years after diabetes diagnosis, and is assessed 
after stacking the data, so that the baseline year for all respondents is the year diabetes was 
reported the first time. 
Other measures of time – Age at diagnosis measures interpersonal age differences in the 
experience of diabetes. Birth cohort operationalized as respondents’ age in 1995, measured 
cohort or inter-generational age differences. They are both centered on their grand means, and 
birth cohort was included as a continuous measure because of its monotonous relationship with 
the outcome. 
Measures of social stratification – Race and ethnicity (1=non-Hispanic white, 2=non-
Hispanic black, 3=Hispanic, 4=other), sex (1=female, 0=male), and educational attainment 
(1=less than high school, 2=high school graduate, 3=college graduate) were included as time-
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constant covariates.  Median household income quartile (highest income is in the highest 
quartile) was also included as a time-variant covariate. 
Time-variant covariates – The accumulation of comorbid conditions and diabetes-
specific complications over the course of illness is a risk factor for psychological disturbances 
(de Groot, Anderson, Freedland, Clouse, & Lustman, 2001; Katon et al., 2004; Peyrot & Rubin, 
1999; Talbot & Nouwen 2000; Wu, et al., 2012). Health status, including a person’s self-rated 
health, functional limitations, and comorbid condititions, can further influence depressive 
symptoms in diabetics (Benoit, Fleming, Philis-Tsimikas, & Ming, 2005; Pan, et al., 2010). Self-
rated health assessed on a 5-point Likert scale (1=very good health, 5=very poor health) and 
mean number of comorbidities (range 0-11), including diabetes-related complications and five 
major conditions4 were included. The functional status index (range 0-11) combined the Katz’s 
Activities of Daily Living index (ADL) and Lawton & Brody’s Instrumental Activities of Daily 
Living index (Katz, Ford, Moskowitz, Jackson, & Jaffe, 1963; Lawton & Brody, 1969; Spector 
& Fleischman, 1998).  
Social and spousal support among diabetics is also tied to psychological health because 
such support facilitates improved self-care (Murphy, Williamson, & Nease, 1994; Rad, Bakht, 
Feizi, & Mohebi, 2013), improved access to information, and emotional and instrumental support 
(Van Dam et al., 2005). A dichotomous variable for being married (1= yes, 0=no) was included. 
Finally, the complexity of the treatment regimen reflects the severity of the condition 
(Benoit, et al., 2005) and the burden of treatment, which can predict psychological impairment 
(Thoolen, et al., 2006). Treatment burden (1=no treatment; 2=oral; 3=insulin injection; 4=oral 
and insulin injection) controlled for its potentially confounding effect.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  Kidney problems or proteins in urine, trouble with eyesight, trouble with hearing, incontinence, 
psychiatric problems, lung problems, hypertension, stroke, cancer, arthritis, and heart disease.	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Mortality selection and attrition were addressed by including two time-constant indicators 
in the models (death: 1=yes, 0=no; attrition: 1=yes, 0=no). A time-variant indicator of proxy 
interview status was also included to account for the responses obtained from proxy individuals.  
Diabetes duration and continuous time-variant covariates were centered on their 
respective means.  
 
Data analyses 
Hierarchical Linear Modeling (HLM) allows quantification and depiction of the average 
trajectory of depressive symptoms from the time of diabetes diagnosis onward (Raudenbush & 
Bryk, 2002) by modeling intrapersonal (level 1) and interpersonal (level 2) differences in the 
outcome.  
The level 1 model estimates intrapersonal differences in depressive symptoms for each 
person and for each year after diabetes diagnosis. For every respondent, the model provides 
estimates of the outcome at baseline (intercept) and the linear and non-linear slopes for each year 
following diagnosis. Time-variant covariates can be included at this level. 
Linear, quadratic, and cubic models were compared using the log likelihood ratio test in 
order to select the curvature that best described the data. In addition, penalty-driven criteria, 
including Akaike Information Criteria (AIC) and the Bayesian Information Criteria (BIC), which 
address the rising number of parameters with each model, were used in selecting the model. The 
level of significance for the intercept, linear, and quadratic fixed effects were also taken into 
account and the most parsimonious model was selected. Results from these preliminary analyses 
show that the data fit the linear model best. Neither the quadratic nor cubic estimates were 
significant, and compared to the linear model, changes in AIC and BIC were marginal.  
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The level 2 model estimates intrapersonal or interpersonal differences in depressive 
symptoms at baseline and over time. It is at this level that the effect of time-constant covariates 
on the intercept and the linear slope from the level 1 model are estimated.  
First, a baseline linear model was estimated accounting for death, attrition, and proxy 
interview (Model 1). Subsequent models included age at diagnosis (Model 2), birth cohort and 
socio-demographic characteristics (Model 3), socioeconomic characteristics, including education 
and income (Model 4), and time-variant covariates, including marital status and health status 
measures (Model 5). The level 1 and level 2 models are described below: 
CESDti = π0i + π1i*(diabetes duration) + Σπki*Xkti + eti 
CESDti is the level of depressive symptoms for each individual i at time t; π0i is the level 
of depressive symptoms for each individual at time of diagnosis; π1i is the linear rate of change 
in depressive symptoms for each individual; diabetes duration is the year since diabetes 
diagnosis and is the time variable; πki is the effect of the kth time-variant covariates Xk for 
individual i on the trajectory; Xkti are the kth time-variant covariates in the model; and eti is the 
measurement error in the outcome. 
π0i = β00 + Σβ01q*Xqi + r0i 
π1i = β10 + Σβ11q*Xqi + r1i 
          πki = βk0 
π0i, π1i, and π2i are the same as above; β00, β10, and βk0 are the fixed effects or expected 
depressive symptoms at mean diabetes duration, and expected linear growth; β01q, and β11q are 
the effects of the qth time-constant covariates X for each individual i on the intercept and linear 
slope; Xqi is the qth time-constant covariate for each individual i; r0i and r1i, are random outcome 
variations at the intercept and linear slope. 
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To address missing items, the data were imputed using the multiple imputation procedure 
in Stata® (Little & Rubin, 2002; Rabe-Hesketh & Skrondal, 2008; Schafer, 1997). Five imputed 
data sets were generated. The risk of selection and response bias due to attrition, mortality, and 
the use of proxy interviews was addressed with the inclusion of time-constant indicators for 
mortality and attrition (death or attrition at any point in the study; 1=yes, 0=no), and a time-
variant indicator for proxy interview. All analyses were conducted using Stata® software 
(version 12). 
 
RESULTS 
From the 3,307 respondents that met the selection criteria, most were female (52.16%) 
and white (67.97%), 17.41% black and 11.70% Hispanic. Two-thirds of the respondents had at 
least a high school degree (67.84%). The mean age at diagnosis was 68.96 years, with a mortality 
and attrition rate of 27.16% and 16.21%, respectively. Overall, the levels of depressive 
symptoms were relatively low at baseline, with a mean score of 1.903 (sd=2.156; range 0-20). At 
baseline, 62% of the respondents had at least one depressive symptom, and by year 14, this 
number rose to 98%. Table 5 presents additional statistics that describe the sample.  
 
Trajectory of depressive symptoms with longer diabetes duration 
In agreement with our first hypothesis, on average, while depressive symptoms were 
relatively low at the time of diagnosis, there is a modest linear increase in the number of 
depressive symptoms over the course of illness (intercept=1.621, p<0.001; linear slope=0.023; 
p<0.001; M1 in Table 6).  Figure 7 offers a visualization of the depressive symptoms’ trajectory.  
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Adjusting for time-constant socio-demographic characteristics reduced the levels of 
depressive symptoms to 1.155 (p<0.001, M3, Table 6), a 28.75% change. It further reduced the 
fixed parameter associated with the linear slope. Adjusting for education and income fully 
mediated the effect of time on depressive symptoms and flattened the trajectory (0.023, p<0.001 
to -0.015, p>0.050; M3, Table 6). The direction of the trajectory was reversed after the inclusion 
of health variables and marital status (linear slope=-0.074, p<0.010). 
We found a significant unexplained variance in the intercept (1.488, p<0.001) and linear 
slope (0.110, p<0.001), which remained significant after controlling for time-constant and time-
variant covariates. Model fit improved with each model: Values increased for the model BICs 
and AICs with each subsequent model.  
 
Diabetes timing (age at diagnosis) 
In agreement with our second hypothesis, older age at diagnosis was associated with 
depressive symptoms at baseline (Figure 7). However, the gap did not increase over time 
(intercept=-0.269; p<0.001; linear slope=-0.006; p>0.5; M2, Table 6). The estimates were not 
noticeably modified by the inclusion of time-constant or time-variant covariates. We observed, 
however, that controlling for age in 1995 by itself increased the negative effect of age at 
diagnosis on the cognitive levels by 25%, from -0.269 to -0.337, p<0.001 (results not shown). 
 
Birth cohort 
 Contrary to our third hypothesis, younger cohorts did not experience a better depressive 
symptom trajectory compared to their older counterparts. In fact, after controlling for age 
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differences at diagnosis, cohort differences at baseline and in the linear slope were very small 
and non-significant (intercept=0.002, p<0.005; linear slope=0.002, p>0.05; Table 6, Model 3). 
 
Social stratification 
In agreement with our third hypothesis, the study found support for racial, ethnic and 
gender inequality at the time of diabetes diagnosis. Hispanics showed the highest levels of 
depressive symptoms, followed by women and blacks. Yet contrary to our expectation of a 
widening gap over the course of illness, these differences remained constant over time. 
Model 3 in Table 6 shows that higher education and higher median household income 
protect against depessive symptoms at diagnosis. But there was no accumulated advantage for 
those with higher socioeconomic status over the course of diabetes. In fact, depressive symptoms 
increased faster among individuals in the top two income quartiles. This is clearly shown in 
Figure 8, where the levels of depressive symptoms for individuals in the top two quartiles 
reached those of individuals in the third highest quartile by year 6, and those in the top quartile 
by year 10. The negative effect of higher income over the course of diabetes was partially 
mediated by health status (M5, Table 6), but a significant number (about 40%) remained 
unexplained by the covariates in the models.  
Low socioeconomic status accounted for all of the racial differences in depressive 
symptoms and for about one-third of the Hispanic disadvantage. While lower socioeconomic 
status reduced the gender gap in depressive symptoms, health and marital status were the 
strongest predictors of the gender gap over the course of the illness. 
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DISCUSSION 
The key contribution of the study is its conceptualization of diabetes as a dynamic career, 
which allows the linkage of its 14-year natural history to dynamic changes in depressive 
symptoms from the time of diagnosis onward. Therefore compared to conventional approaches, 
which conceptualize diabetes as a time-constant predictor or use an arbitrary baseline year and 
measure of time, the current study provides a more accurate description of mental health change 
after diabetes diagnosis in mid to late life.  
 
Trajectory of depressive symptoms with longer diabetes duration 
The results corroborate earlier findings of modest levels of depressive symptoms in old 
age (Wu, et al., 2012; Yang, 2007) and rising incidence over longer duration (Skinner, et al., 
2010). But contrary to trajectories of depressive symptoms after bereavement, which show only a 
transient increase after the event (Aneshensel, et al., 2004; Lucas, et al., 2003; Lynch & George, 
2002), and studies of major depression, which show higher risk of depression before 5 years and 
after 10 years of diabetes duration (Egede & Zheng, 2003), we found that middle-aged and old-
aged adults with diabetes do not emotionally adapt to their condition over time. Rather, the 
progression of diabetes is characterized by modest but persistent depressive symptoms over 14 
years after diagnosis, as demonstrated by a linear increase in the trajectory. On average, and after 
adjusting for age at diagnosis and cohort effects, there is a 1.35% increase in depressive 
symptoms per year from initial levels of 1.620 at diagnosis. The results also support both the 
“psychological burden hypothesis” (Talbot & Nouwen 2000) and Harris’s conceptualization of a 
psychological pathway which links continuous exposure to stressors over the course of illness to 
psychological distress among diabetics (Harris, 2003).  
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Adjustment for socioeconomic status and health status reversed the direction of the CES-
D growth rate for the overall sample, which changed from an ascending to a descending 
trajectory. These results mirror earlier reports showing that social status reverses the negative 
effects of aging on depressive symptoms (Clarke, et al., 2011; Lynch & George, 2002; Mendes 
de Leon, Barnes, Bienias, Skarupski, & Evans, 2005; Taylor & Lynch, 2011; Xu, et al., 2010; 
Yang, 2007). They also highlight the need to detect and adequately address the growing 
psychological needs of middle-aged and older adults with late-onset diabetes all along their 
disease career. They further substantiate the view that change in depressive symptoms with time 
is not inherently tied to the stage of diabetes. Rather, education and income synergistically 
determine the mental health outlook of middle-aged and older adults with diabetes. Therefore 
future research should elucidate the components of education and socioeconomic status that 
might be most relevant to diabetes management and outcomes. In addition, given the modest 
increase in depressive symptoms over time, research is needed to determine the level of 
depressive symptoms at which self-management behaviors and clinical outcomes begin to be 
affected in the course of diabetes. 
 
Diabetes timing (age at diagnosis) 
Our second hypothesis that older age at diagnosis would result in worse mental health 
after diabetes diagnosis was substantiated by the findings. The study provides evidence that old 
age at diagnosis is a key determinant of poor mental health over the course of diabetes, with an 
increasingly negative influence with longer diabetes duration. Therefore ignoring the timing of 
diabetes –measured as people’s age at diagnosis– as a risk factor in clinical practice and medical 
guidelines for diabetes management can contribute to greater disparities in mental health among 
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older adults with diabetes. The study findings are particularly salient to policy, because the 
literature reports worse clinical profiles among people with diabetes diagnosed during middle-
age compared to those with later-onset diabetes (Hatunic, et al., 2005; Hillier & Pedula, 2001; 
Hillier & Pedula, 2003; Selvin, et al., 2006). Yet according to our study, these findings are 
confounded by the natural history of diabetes.  
Several features of our study strengthen the validity of its findings and support the quality 
of the results. First, it used a national representative sample of older adults with self-reported 
diabetes, which improves its generalizability. Second, it conceptualized time variables important 
to both the person and the disease and is therefore able to tease out the relative contribution of 
each. Finally, it employed statistical methods, which took into account the structure in the data, 
thereby provide more accurate estimates for both interpersonal and intrapersonal differences in 
health.  
The results of the study support Bury’s concept of the timing of illness as a biographical 
disruption (Bury, 1982) in the sense that late age at diagnosis sets older adults with incident 
diabetes on a trajectory of worse depressive symptoms, with longer diabetes duration. Older age 
is also tied to a series of social events which can negatively impact mental health and the 
experience of diabetes. For instance, involuntary role exits, including retirement and widowhood, 
and declining social support, physical functioning, sense of control, and income in old age are 
well documented, and these can negatively affect mental health (Blazer, et al., 1991; Mirowsky 
& Ross, 1992) and diabetes self-care (Nicklett & Liang, 2010). It is therefore not surprising that 
diabetes diagnosis results in greater disparities in mental health by age at diagnosis. 
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Birth cohort 
Our expectation that socio-economic, behavioral, and medical improvements would 
result in improved mental health trajectories in younger cohorts of diabetics was not 
substantiated by our findings (Hypothesis 3). There was no evidence that within 14 years after a 
diagnosis of diabetes, people in younger cohorts might be better off compared to older cohorts. 
Therefore among middle-aged and old-aged adults with incident diabetes, social and economic 
gains observed in the general population do not translate into better mental health with younger 
cohort. In light of these results, earlier findings that younger cohorts have better mental health in 
the general population may not accurately depict the link between cohort and health with late-
onset diabetes (Clarke, et al., 2011; Yang, 2007).  
Economic and social gains in younger cohorts may be offset by increases in risk factors 
tied to diabetes outcomes in our sample. For instance, physiological changes, including higher 
obesity rates in more recent cohorts (Reynolds & Himes, 2007), coupled with worse functional 
health in younger cohorts of peri-retirement age (Seeman, Merkin, Crimmins, & Karmalanga, 
2010) are documented. Although functional limitations were included in the current study and 
did contribute to the overall trends (along with other measures of health status), obesity was not; 
therefore future studies may need to investigate its impact on cohort differences with late-onset 
diabetes.   
 
Social stratification 
One additional contribution of the study is its depiction of mental health change in 
various social groups after diabetes diagnosis. Depressive symptoms after a diagnosis of diabetes 
are characterized by persistent inequality over the course of diabetes, with more depressive 
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symptoms in Hispanics, blacks, and women compared to their counterparts. This finding was 
somewhat unexpected, for we hypothesized widening gaps as diabetes progressed, due to the 
abundant literature that described a greater burden of diabetes among Hispanics, blacks, and 
women; and a greater burden of depressive symptoms among Hispanics and blacks (George & 
Lynch, 2003; Glasgow, et al., 1986; Klein, Shankman, & Rose, 2008; Legato et al., 2006; Szalat 
& Raz, 2007; Walker, et al., 2006; Walsemann, Gee, & Geronimus, 2009; Xu, et al., 2010; Yang, 
2007). Yet our study did not show evidence of these findings.    
Our study also revealed the negative effect of higher income on the trajectory of 
depressive symptoms, in that individuals in the top two quartiles begin with lower levels of 
depressive symptoms, but converge within the first 6 to 10 years after diagnosis. These results 
have both clinical and policy implications, because although a few studies have reported a 
reduction in the advantageous effect of income on mental health with old age (Kim & Durden, 
2007; Mirowsky & Ross, 2001), most studies have found that lower social status is tied to faster 
growth of depressive symptoms (Aneshensel, et al., 2004; Liang, et al., 2011; Lynch & George, 
2002; Yang, 2007) and higher levels of major depression (Anderson, et al., 2001; Egede, et al., 
2002; Katon, et al., 2004). This counter-intuitive finding may be related to a ceiling effect of the 
measure of depressive symptoms among people who have less education. Alternatively, people 
with higher income and more demanding jobs may be more reluctant to consult professionals 
about their psychological problems, resulting in increased mental health morbidity and poor 
diabetes outcome. For instance, in a study of several Asia Countries, adults with higher income 
who have lower rates of depressive symptoms, are also less likely to seek treatment for these 
symptoms (Fukuda & Hiyoshi, 2012). If similar trends exist among older U.S. adults with 
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diabetes, these trends may explain the fact that mental health worsens among with higher income 
over the course of their diabetes.  
 
Limitations 
Because of sample selection and the measures we used, the study has several imitations.  
First, self-reported diabetes could introduce self-selection bias due to differential access to care 
among social groups; but a recent study found limited cases of false-positive self-reported 
diabetes (Jackson et al., 2013). Second, the CDC found that about 28% of diabetes cases are 
undetected; therefore our estimates may be larger than the true estimates due to the exclusion of 
undiagnosed diabetics. Third, clinical and biological changes in diabetes can start up to 7 years 
before diagnosis (Ramlo-Halsted & Edelman, 2000). As a consequence, initial levels of 
depressive symptoms could be inflated at diagnosis. In addition, information during the first two 
years after diagnosis is not available; at least one study found that increases in psychological 
distress could start as early as the first year after diagnosis (Skinner, et al., 2010). Therefore 
subtle changes in mental health might have been overlooked in our study. Nevertheless, the 
overall message of the study remains unchanged, for we found a steady increase in depressive 
symptoms over 14 years. Fourth, the effect of income on mental health may be influenced by 
reverse causation. This issue was addressed with the inclusion of income as time-variant, which 
also captures change in income over the course of illness. Finally, the effect of aging itself 
cannot be isolated in the study. But again, comparing people with diabetes to those without 
diabetes was not the goal of the current study, which was to describe mental health change with 
diabetes duration.  
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POLICY IMPLICATIONS 
Overall, we found that on average, people do not adapt to their condition after they have 
been diagnosed with diabetes in middle-age and old age; there is a linear increase in depressive 
symptoms with longer diabetes duration. But although the decline in mental health is relatively 
small, even modest changes can result in poor health, an increase in the use of health services, 
institutionalization, and increased demands on the health system; for these changes can lead to a 
worsened biological profile, worse diabetes outcomes, and poor diabetes self-management 
(Bruce, 2000; Chiu, et al., 2010; Chodosh, Miller-Martinez, Aneshensel, Wight, & Karlamangla, 
2010).  
The study has several major implications for policy. First, it is clear from the results that 
comprehensive diabetes management should incorporate measures of mental health as an integral 
part of diabetes monitoring in old age. Several guidelines already recommend mental health 
assessment in the U.S. (American Diabetes Association, 2014; American Geriatrics Society 
Expert Panel on the Care of Older Adults with Diabetes Mellitus, 2013) and internationally 
(International Diabetes Federation, 2010; Sinclair et al., 2011). However, all of these guidelines 
limit their recommendations to the point of clinical care, in the doctor’s office. Yet monitoring 
mental health at home and in the community is just as important; for subtle changes in mental 
health between visits can interfere with diet, exercise, diabetes care, and diabetes monitoring 
(Ciechanowski, Katon, & Russo, 2000; Rosen et al., 2003). The screening and monitoring of 
changes in mental health should also involve not only the patient but also family caregivers and 
case managers. This more comprehensive personal involvement could be achieved by developing 
and incorporating screening tools into electronic devices such as smart phones, tablets, and the 
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internet with built-in reminders; and in addition, creating efficient systems of referral to mental 
health services. 
A second implication for policy is that the study identified diabetes duration and age at 
diagnosis as key elements in diabetes management and treatment. Determining age at diagnosis 
can help predict mental health change in people with late-onset diabetes, reduce the effects of 
population heterogeneity in health outcomes during clinical care, and achieve better 
individualized diabetes management. For instance, a 70-year-old recently diagnosed with 
diabetes is at greater risk of mental health decline after diagnosis than a 70-year-old with longer 
diabetes duration, who was diagnosed 5 or 10 years earlier. Yet based on current 
recommendations, which only focus on diabetes duration and age, the level of care and attention 
might be higher for the 70-year-old whose diabetes was of longer duration.  
Regarding social stratification, findings of persistent inequality indicate that childhood 
and early adulthood may be the best times to intervene in order to reduce mental health 
disparities with late-onset diabetes. Given the anticipated rise in the size of the Hispanic 
population, greater diversity in the U.S. population, faster increase in diabetes incidence among 
socially disadvantaged people, and the increasing longevity among people with diabetes, we can 
expect an increase in the number of older diabetic adults who suffer from poor mental health. 
Consequently we can also anticipate a greater need for mental health treatment and diabetes care, 
as well as for hospitals and nursing homes, and thus a greater strain on caregivers, mainly 
women, and on younger cohorts of Americans. For the country as a whole, the U.S. may face an 
increasing financial burden due to loss of productivity and a greater burden on existing social 
programs, including Medicare, Medicaid, and Supplemental Security Income. 
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It is important to acknowledge that although these recommendations can reduce the 
impact of mental health decline on diabetes outcomes, primary interventions remain the first line 
of intervention. To this effect, existing programs that are effective at reducing risk factors or 
diabetes onset (Diabetes Prevention Program Research Group, 2009), including poor diet and 
lack of physical exercise, should be further supported financially in conjunction with a general 
culture of healthy living. 
 
CONCLUSION 
When a social condition is time-variant, its occurrence can explain long-term changes in 
health, over and beyond the effect of age. This perspective has been recently applied in studies of 
life events, which model health as a function of time after the event. However, the time-variant 
nature of diabetes is often overlooked in studies on diabetes. The current study adopted the view 
that diabetes is dynamic, and found that after diagnosis, middle-aged and older-aged adults 
experience a moderate but steady increase in depressive symptoms. Our results further highlight 
that the rise in depressive symptoms after late-onset diabetes is socially patterned, and as such 
can be addressed through policy. Old age at diagnosis along with socioeconomic status are 
important factors that should be taken into account, to ensure healthy and equitable mental health 
with late-onset diabetes. Accordingly, policies that address depressive symptoms with incident 
diabetes in late adulthood should incorporate broad interventions before diagnosis, in order to 
reduce economic and health disparities which set women, blacks, Hispanics, and people of lower 
socioeconomic status on a trajectory of worse depressive symptoms over their illness career. 
Such policies would have to implement strategies for the early detection of diabetes and 
depressive symptoms in the oldest population.  
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Table 5: Descriptive statistics for the sample 
 
  Mean or % SD 
Measure of time and main outcome   
Diabetes duration (years) 3.561 2.315 
CESD (0-9) 1.903 2.156 
   
Level 1: Time varying covariates (n=10,883)   
Married (%) 61.551 - 
ADL/IADL disability 1.229 1.665 
Self-rated health 3.353 1.050 
Comorbidities (excluding diabetes) 1.412 0.611 
Treatment burden 1.939 0.602 
Proxy (%) 9.749 - 
   
Level 2: Time constant variables (n=3307)   
Age at diagnosis 68.960 9.166 
Birth cohort (age in 1995) 60.667 9.647 
Female (%) 52.162 - 
White (%) 67.978 - 
Black (%) 17.418 - 
Hispanic (%) 11.702 - 
Other race (%) 2.902 - 
Education   
Less than high school (%) 32.156 - 
High school graduate (%) 34.333 - 
Graduate school (%) 33.511 - 
Median household income (USD)   
  Quartile 1 8,620 3,582 
  Quartile 2 20,868 4,191 
  Quartile 3 38,993 6,870 
  Quartile 4 107,487 101,140 
Death at any point in time (%) 27.155 - 
Attrition at any point in time (%) 16.208 - 
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Table 6: Average trajectory of depressive symptoms with longer diabetes duration 
  M1   M2  M3   M4   M5   
  Est. sig. Est. sig. Est. sig. Est. sig. Est. sig. 
Fixed effects           
For intercept           
Intercept 1.621 *** 1.632 *** 1.155 *** 2.201 *** 2.151 *** 
Age at diagnosis   -0.0004  -0.002  0.001  -0.048 *** 
Birth cohort (age in 1995)     0.002  -0.011  0.020 * 
Female     0.586 *** 0.414 *** 0.089 + 
Black     0.289 ** 0.019  -0.039  
Hispanic     0.784 *** 0.271 ** 0.324 *** 
Other race     0.191  0.113  0.097  
High school graduate       -0.514 *** -0.261 *** 
College graduate       -0.756 *** -0.454 *** 
Income quartile 2        -0.273 *** -0.058  
Income quartile 3       -0.554 *** -0.211 ** 
Income quartile 4        -0.668 *** -0.204 ** 
           
For linear slope           
Linear slope 0.023 *** 0.025 *** 0.029 ** -0.015  -0.074 ** 
Age at diagnosis   0.002 * -0.0001  -0.001  -0.0004  
Birth cohort (age in 1995)     0.002  0.003  0.001  
Female     -0.014  -0.005  -0.008  
Black     0.013  0.025  0.034 * 
Hispanic     -0.015  0.005  -0.007  
Other race     -0.050  -0.041  -0.011  
High school graduate       -0.002  0.006  
College graduate       -0.002  0.007  
Income quartile 2       0.024  0.016  
Income quartile 3       0.055 ** 0.034 * 
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Income quartile 4       0.056 ** 0.036 * 
           
Time variant variables           
Married         -0.448 *** 
ADL/IADL disability         0.225 *** 
Self-rated health         0.327 *** 
Comorbidities         0.612 *** 
Treatment burden         0.004  
           
Survey status           
Death 0.770 *** 0.788 *** 0.824 *** 0.665 *** 0.028  
Attrition 0.071  0.069  0.026  -0.028  -0.024  
Proxy 1.060 *** 1.052 *** 1.071 *** 1.023 *** 0.166 * 
           
Random effect           
Variance           
Intercept 1.488 *** 1.490 *** 1.431 *** 1.346 *** 1.020 *** 
Linear slope 0.110 *** 0.108 *** 0.107 *** 0.107 *** 0.091 *** 
Intercept x linear slope -0.115 * -0.112  -0.107  -0.059  -0.163 * 
Level 1 residual 1.435 *** 1.435 *** 1.435 *** 1.437 *** 1.394 *** 
           
Model statistics            
Observations 10883  10883  10883  10883  10883  
Groups 3307  3307  3307  3307  3307  
AIC 183470  183466  183301  182987  179203  
BIC 183550  183564  183488  183263  179524  
Log likelihood -91726  -91722  -91629   -91462  -89566  
-2∆log likelihood statistic -  8 * 185 *** 334 *** 3794 *** 
Degrees of freedom -  2  10  10  5  
***p<0.001; **p<0.01; *p<0.05; +p<0.10; AIC: Akaike Information Criteria; BIC: Bayesian Information Criteria; Log Likelihood 
Ratio Test tests nested models 2 vs 1, 3 vs 2, 4 vs 3, and 5 vs 4, respectively
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Figure 7: Average depressive symptoms trajectory with longer diabetes duration* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† Model controls for death (=0), attrition (=0), proxy interview (=0 in each wave); outcome is truncated to improve visualization 
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Figure 8: Average depressive symptoms trajectory with longer diabetes duration by income quartile† 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*† Model controls for death (=0), attrition (=0), interview (=0), age at diagnosis (mean age at diagnosis), birth cohort (mean age in 
1995), race/ethnicity (non-Hispanic white), gender (female), education (graduate school); outcome is truncated to improve 
visualization 
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CHAPTER 4 
Trajectory of Cognitive Functioning After Diabetes Diagnosis in 
Middle-age and Later Adulthood 
 
INTRODUCTION 
Background 
Cognitive impairments increase the risk of dementia (Plassman et al., 2008). They are 
further linked to reduced functional independence (Dodges, Du, Saxton, & Ganguli, 2006) and to 
increased healthcare and societal costs (Albert et al., 2011; Chodosh et al., 2004; Lin & 
Neumann, 2013). In 2002, 22% of adults aged 71 and older had non-dementia related cognitive 
impairments (Plassman, et al., 2008). A recent empirical study estimated that 4.8 million U.S. 
adults aged 72 and older developed non-dementia-related cognitive impairments within a period 
of 5.9 person-years (Plassman et al., 2011).  
Cognitive impairments and type 2 diabetes are both degenerative conditions, which 
increase in prevalence with age. Type 2 diabetes exacerbates poor cognition through mechanisms 
involving dysglycemia, hypertension, micro- and macro-vascular complications, and depression 
(Cukierman-Yaffe, 2010; Reijmer, van den Berg, Ruis, Kappelle, & Biessels, 2010). Cross-
sectional studies found an effect size of diabetes of 0.2 to 0.8, and a positive association with 
cognitive decline (Stewart & Liolitsa, 1999). Reviews of longitudinal studies also report a 
consistent negative change in cognitive function associated with diabetes (Allen, Frier, & 
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Strachan, 2004; Awad, Gagnon, & Messier, 2007; Cukierman, Gerstein, & Williamson, 2005; 
Reijmer, et al., 2010; Tilvis et al., 2004). Some studies report a cognitive gap between diabetics 
and non-diabetics in old age, which although modest (Reijmer, et al., 2010), has significant 
clinical and economic implications (Lin & Neumann, 2013). Yet the impact of diabetes on 
health, including cognitive health, has been based on conceptualizing diabetes as a time-constant 
individual attribute. In other words, individuals under study are classified into two categories: 
individuals with diabetes and individuals without diabetes.  
 
Theoretical framework 
Conceptually, the view of illness as a time-constant attribute directly contradicts the 
biomedical perspective of the natural history of disease and sociological theories of the 
experience of illness.  
Natural history of diabetes – According to the natural history concept, type 2 diabetes is 
characterized by a series of phases, which are themselves defined by biomedical, physiological, 
and clinical characteristics and norms (Ramlo-Halsted & Edelman, 2000). On the basis of these 
characteristics and norms, identification of the phase within which each patient with diabetes 
falls determines the type and course of care, as well as the prognosis. We therefore adopt the 
view that diabetes is a dynamic phenomenon. Therefore, estimates of the link between diabetes 
and cognitive health in earlier longitudinal studies, which used age and arbitrary time (usually 
study wave) are confounded by the natural history of diabetes; that is, the cumulative damages to 
a diabetic patient’s biological, psychological, and social health, and the social, behavioral, and 
medical interventions that are implemented to bend the health curve among diabetics. At any 
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point on the age or time continuum, people with diabetes represent a heterogeneous group in 
which the natural history of diabetes manifests itself uniquely in each diabetic person. 
The Illness Career Model – The Illness Career Model (Aneshensel, 1999; Goffman, 
1961) and its clinical version, the Illness Trajectory Model (Corbin, 1998), is a sociological 
theory of people’s experience of illness. It conceptualizes the experience of illness as dynamic, 
and views illness (its onset or diagnosis) as the starting point of a new life trajectory 
characterized by health, behavioral, and social changes. The Illness Career Model portrays health 
change with diabetes as a common experience, which is influenced by interactions between the 
ill person and their disease, as well as individual, family, community, medical, and other social 
factors that impact health. Health change with a chronic illness is therefore more accurately 
represented as a trajectory or an “illness career,” the shape of which is a function of dynamic 
factors specific to the disease, the person, and the social environment. While these two theories 
focus more on psychosocial and behavioral changes due to illness, this concept can apply to any 
health change following a life event. 
Social Stratification Theory – Social Stratification Theory also informs the study. It 
stipulates that age, race, gender, and ethnicity establish differentiations in social systems which 
determine one’s life chances. Stratification manifests in unequal distribution of resources and 
benefits that can mitigate the negative effects of disease, resulting in worse health in socially 
disadvantaged groups; and socioeconomic status mediates the link between agents of 
stratification and health outcomes (Bird & Rieker, 1999; House, Lantz, & Herd, 2005; House et 
al., 1994; Lantz et al., 2001; Link & Phelan, 1995; Rieker & Bird, 2000; Riley, 1987; Robert & 
House, 2000; Williams & Jackson, 2005).  
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Cross-sectional studies of people with diabetes found that blacks experience lower 
cognitive performance and faster cognitive decline in more complex tasks (Obidi et al., 2008); 
and these differences are attributed to greater susceptibility to diabetes and its complications 
(Wessels et al., 2011). Older Mexican Americans have lower cognition at baseline, but decline at 
rates similar to those of whites of similar age (Karlamangla et al., 2009). To the author’s 
knowledge, this relationship has not been tested among diabetics. Lower socioeconomic status, 
as assessed by wealth, income (Karlamangla, et al., 2009), or education (Lievre, Alley, & 
Crimmins, 2008) is an additional risk factor for lower cognition and faster decline in older 
adults. Gender, on the other hand, is usually not tied to cognition among diabetics (Bruce et al., 
2008; Reijmer, et al., 2010). In addition to social inequalities in cognitive functioning, social 
stratification can potentially influence the progression of diabetes and its impact on cognitive 
change after diagnosis. Lower socioeconomic status can limit access to healthcare, obstruct 
compliance with diabetes treatment (Obidi, et al., 2008; Reijmer, et al., 2010; Wessels, et al., 
2011), and can induce stress, which in turn has neuro-degenerative consequences (McEwen, 
1998; O'Brien, Ames, & Schweitzer, 1993).  
Although this research viewed both disease and the experience of disease as dynamic, 
cognitive health change has not been investigated in the context of dynamic diabetes. As a 
consequence, several questions remain unanswered. 1) What is the pattern of cognitive change 
with longer diabetes duration? 2) How does diabetes timing affect cognitive health with longer 
diabetes duration? 3) Does birth cohort influence cognitive change with longer diabetes 
duration? 4) Finally, does the experience of diabetes vary among people of different social 
backgrounds or is it the same? These questions form the basis for the current study. 
	  	   	  140	  
The study is grounded in the belief that the severity of cognitive decline associated with 
diabetes varies not only with age and time, but also with progression of the disease.  Ascribed 
characteristics (age, race, ethnicity, cohort, gender) directly, but also indirectly through their 
impact on attained social status (education, income, marital status), diabetes timing, medical, 
behavioral, psychosocial, and health status can further influence health change over the course of 
diabetes.  
 
EVENT-BASED APPROACH TO THE STUDY OF DIABETES AND HEALTH 
In agreement with this framework, and to investigate health change as it co-occurs with 
disease progression, diabetes duration is the measure of time that will permit the accurate 
characterization of cognitive change with diabetes. We further focus on middle-aged and older 
adults with incident diabetes for several reasons. First, the prevalence of cognitive impairments 
and diabetes is increasing in the oldest age groups. Second, the U.S. population is aging at 
unprecedented rates. Finally, obesity, which is one of the most important risk factors for 
diabetes, is also rising in both prevalence and incidence in older adults. Therefore the prospect of 
reduced functional independence due to poor cognitive health, higher healthcare costs, and 
heightened morbidity in late life, all highlight the need for a better understanding of the link 
between diabetes and cognitive health in old age. The study focuses on middle-aged and older 
adults newly diagnosed with diabetes, and assesses the extent to which diabetes duration—the 
progression of diabetes—establishes trajectories of cognitive health beginning with the year 
diabetes is diagnosed.  
The aim of an event-based approach is not to describe health differences over time or 
with age between people with diabetes and people without diabetes. Rather, it focuses solely on 
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people with diabetes, and describes how their health changes as their disease progresses. With 
this approach, measures of time, which describe people’s location on their life course (age, 
cohort, age at diagnosis) and disease progression (diabetes duration), are used to accurately 
capture health change with the progression of diabetes. 
 
Diabetes duration 
Rather than age or time, which were used in earlier studies, diabetes duration (year since 
diabetes diagnosis), conceptualized as a time-variant predictor, is the measure used in the study 
to describe health trajectories after diabetes has been diagnosed.   
Earlier age-based and time-based studies provided some support for cognitive decline 
with longer diabetes duration. Longer duration is linked to poor cognitive performance, 
specifically to lower verbal memory (Elias et al., 1997), and to reduced processing speed and 
executive functioning (Cosway, Strachan, Dougall, Frier, & Deary, 2001; Saczynski et al., 2008). 
There is additional circumstantial evidence that the detrimental effects of diabetes on cognition 
may become stronger as the disease progresses. Longer diabetes duration is linked to increased 
risk of diabetes complications (Selvin, Coresh, & Brancati, 2006), to poorer diabetes control 
(Benoit, Fleming, Philis-Tsimikas, & Ming, 2005), to increased risk of diabetes complications, 
such as vasculopathy, depression (Cosway, et al., 2001; Elias, et al., 1997), and dysglycemia 
(Reijmer, et al., 2010). Finally, chronic hyperglycemia results in greater cognitive impairments 
and faster decline over time (Reijmer, et al., 2010). Nevertheless, no research has described 
health change with longer diabetes duration. 
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Diabetes timing (age at diagnosis) 
The timing of diabetes, measured as age at diagnosis, is an important aspect of the 
experience of the disease. According to the sociological concept of illness as a “biographical 
disruption,” the onset of an illness can establish new life trajectories for the people affected 
(Bury, 1982); and the impact of the disruptive event varies by type of illness, people’s location 
on their life course, and the medical and social environment in which the illness occurs 
(Faircloth, Boylstein, Rittman, Young, & Gubrium, 2004). Recent research further suggests that 
the negative influence of an illness is maintained over time (Faircloth, et al., 2004). We therefore 
propose that among people with diabetes, older age at diagnosis can be an important risk factor 
for cognitive impairments for two reasons: 1) Old age is the single most important risk factor for 
dementia, cognitive impairments (Kloppenborg, van den Berg, Kappelle, & Biessels, 2008), and 
cognitive decline (Bruce et al., 2003; Tilvis, et al., 2004). 2) People with late-onset diabetes are 
at greater risk of several diabetes complications, including worsened cognitive function and 
microvascular complications (Chuang et al., 2006).  
 
Birth cohort 
Cohort effects on health change reflect the impact on health and health change of social 
experiences common to individuals born at the same time (Ryder, 1965). Research shows that 
cognitive health improves significantly with each cohort (Dodge, Zhu, Lee, Chang, & Ganguli, 
2013; Karlamangla, et al., 2009; Salthouse, 2013), and there is slower decline in younger 
cohorts, partly due to higher education (Dodge, et al., 2013). Although similar studies among 
diabetics are lacking, gains in education in the last decades, relaxation in the diagnostic criteria, 
improvement in diabetes treatment, and modifications of the treatment recommendations to 
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facilitate diabetes management for older adults (American Diabetes Association, 2014) can all 
exert a positive influence on patients’ experience of diabetes, and possibly on their cognitive 
health also. We can expect improvement in cognitive health with younger cohorts of middle-
aged and older adults with diabetes. 
 
Chronological age 
Old age is the single most important risk factor for dementia and cognitive impairments 
(Kloppenborg, et al., 2008) and cognitive decline (Bruce, et al., 2003; Tilvis, et al., 2004); and 
the effect of diabetes on cognition is stronger with time or age (Bruce, et al., 2003; Gregg et al., 
2000; Kanaya, Barrett-Connor, Gildengorin, & Yaffe, 2004; Nooyen, Baan, Spijkerman, & 
Verschuren, 2010; Okereke et al., 2008; Stewart, Prince, & Mann, 2003; Wu et al., 2003). 
Review articles corroborate the findings of the negative effect of age on cognitive health 
(Biessels, Kerssen, de Haan, & Kappelle, 2007). 
However, while time-variant chronological age captures developmental changes related 
to aging (Riley, 1987), it cannot accurately describe the experience of illness, since at any point 
in time, people with diabetes with the same age can be at varying stages of their illness. No 
designated indicator of the aging process was included in the current study; therefore we are 
unable to distinguish how much of the estimated cognitive health levels and cognitive health 
change are attributable to diabetes itself, and how much is attributable to aging. However, the 
event-based approach allows us to accurately predict the cognitive health of a given patient 
diagnosed at age 50, when he or she reaches 60 or 70 years of age. Similarly, health for a person 
diagnosed at 70 can be predicted in later years.  
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HYPOTHESES 
Hypothesis 1: Given the circumstantial evidence suggesting that longer diabetes duration 
is tied to poor cognitive health at any age, and that microvascular complications, which are 
linked to poor cognition, increase with time, we expect that longer diabetes duration will be 
associated with a decline in the cognitive health trajectory in middle-aged and older adults with 
incident diabetes. 
Hypothesis 2: Viewed within the context of “biographical disruption,” the limited 
evidence that older age at diagnosis is tied to microvascular complications allows us to speculate 
that people diagnosed at an older age will experience a greater cognitive burden, as well as 
higher and faster levels of cognitive decline with longer diabetes duration. 
Hypothesis 3: We further expect that improvement in education in recent years along 
with looser diagnostic criteria for diabetes, and improvement in diabetes treatment for older 
adults will result in better health trajectories both at diagnosis and with longer diabetes duration 
among middle-aged and older-aged adults with incident diabetes.  
Hypothesis 4: In agreement with the Social Stratification Theory, we expect that 
exposure to risks before and after diabetes diagnosis among blacks, Hispanics, women, and 
individuals of lower socioeconomic status will result in worse health trajectories at baseline and 
with widening gaps with longer diabetes duration. 
 
METHODS 
Data and sample 
The Health and Retirement Study (HRS) is a biennial representative panel survey of 
Americans aged 50 and older (Juster & Suzman, 1995). Respondents interviewed between 
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1995/1996 and 2008 HRS and aged 65 years and older were included if they self-reported that 
they had been diagnosed with diabetes by their doctor for the first time during the observation 
period. Age 65 and older was selected due to higher rates of cognitive impairments in later 
adulthood compared to middle age (Schaie, 1996). 
Incident diabetes was documented by consecutive negative and positive responses to the 
diabetes question. Conflicting answers to the diabetes question (88 total) were addressed using a 
method previously reported, which involves recoding diabetes status from negative to positive if 
respondents reported taking diabetes medication or insulin in any given year (Liang, Quinones, 
Bennett, & Ye, 2011). The selection criteria were met by 2,139 respondents at baseline. Due to 
the late age at onset, it is assumed that most respondents had type 2 diabetes (Kenny, Aubert, & 
Geiss, 1995).  
 The data were stacked starting with the year diabetes was reported for the first time (year 
of diagnosis) for each respondent. Time since diabetes diagnosis was recorded every wave 
thereafter, for a total of 7 waves (range: 0-14 years).   
 
Measures 
Cognitive functioning – The Total Cognition Score assesses different domains of 
cognition, including short-term and long-term memory, knowledge of current events, language 
skills, mathematical skills, and general orientation. The score is a combination of the Total 
Recall Index (TICS) –which measures episodic memory for immediate and delayed word recall 
tasks, and items from the Telephone Interview of Cognitive Status – which includes the serial’s 7 
subtraction from 100 test, backward counting, or naming test (date, objects, presidents and vice 
president), and a vocabulary test (Ofstedal, Fisher, & Herzop, 2006). It ranges from 0 to 35, with 
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higher scores representing greater cognitive functioning. Earlier assessments demonstrate its 
strong construct and internal validity (Herzog & Wallace, 1997).  
Time measure (diabetes duration) – Diabetes duration is operationalized as the number of 
years since diabetes was reported the first time. Six data waves were generated every two years 
thereafter (0-12). The data were aligned so that the baseline data for every respondent were 
obtained from the wave diabetes diagnosis was reported for the first time.  
Other time measures – Diabetes timing operationalized as age at diagnosis, measured 
interpersonal age differences in the experience of diabetes. Birth cohort, on the other hand, was 
operationalized as respondents’ age in 1995 and measured inter-generational differences. Both 
were included as continuous variables due to their monotonous relationship with the Total 
Cognitive Score. 
Measures of social stratification – Three measures of social stratification were included 
as time-constant predictors: race and ethnicity (1=non-Hispanic white, 2=non-Hispanic black, 
3=Hispanic, 4=other); gender (1=female, 0=male); education (1=less than high school, 2=high 
school graduate, 3=college graduate); and median household income (highest income quartile 
means highest income). 
Time-variant covariates – Treatment burden (Ott, Stolk, & van Harskamp, 1999), several 
diabetes-related macrovascular and microvascular complications (Reijmer, et al., 2010), 
cardiovascular diseases (Ott, et al., 1999), hypertension (Elias, et al., 1997), loss of functional 
independence (Njegovan, Man-Son-Hing, Mitchell, & Molnar, 2001) and depressive symptoms 
(Chodosh, Miller-Martinez, Aneshensel, Wight, & Karlamangla, 2010) negatively influence 
cognition. Being married can positively influence both diabetes management (Van Dam et al., 
2005) and cognitive outcomes (Hakansson et al., 2009). A person’s self-rated health (Montiahuc 
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et al., 2011), and overweight and obesity status (Raji et al., 2010; Smith, Hay, Campbell, & 
Trollor, 2011) are also powerful correlates of cognitive functioning in old age.  
We therefore used self-rated health (1=very good health, 5=very poor health); mean 
number of comorbidities (range 0-11) including diabetes-related complications and non-diabetes 
related conditions; marital status (1= yes, 0=no); treatment burden (1=no treatment; 2=oral; 
3=insulin injection; 4=oral and insulin injection); the Center for Epidemiologic Studies 
Depression Scale (CES-D, range 0-9) (Radloff, 1977); body mass index; and a functional status 
index (range 0-11), which combined Katz’s Activities of Daily Living (ADL) and Lawton & 
Brody’s Instrumental Activities of Daily Living (Katz, Ford, Moskowitz, Jackson, & Jaffe, 1963; 
Lawton & Brody, 1969; Spector & Fleischman, 1998).   
Selection and response bias due to attrition, mortality, and the use of proxy interviews 
were addressed by the inclusion of indicators for each variable. All analyses were conducted 
using Stata® (version 12). 
 
Data analyses 
Hierarchical Linear Modeling (HLM) was used to describe the average functional 
trajectory after diabetes diagnosis (Raudenbush & Bryk, 2002). Preliminary analyses relying on 
the log likelihood ratio test, the Bayesian Information Criteria (BIC) and the Akaike Information 
Criteria (AIC) showed that compared to models with second and third order polynomials of age, 
the data best fit the model with a first order polynomial. Results from these models are presented 
in the results sections.  
The level 1 model estimates intrapersonal differences within repeated observations every 
year after diabetes was diagnosed. For each respondent, the model provides estimates of 
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cognitive levels at baseline (intercept), and the linear change in cognitive functioning with every 
added year after diagnosis. Time-variant covariates can be included at this level to assess the 
expected outcome at any given point in time for every change in value of the time-variant 
covariate. 
The level 2 models estimate interpersonal differences in the intercept and slope between 
respondents. These models also estimate the effects of time-constant covariates on the estimates 
obtained in level 1. 
Time since diabetes diagnosis is centered on its grand mean; so were the continuous time-
variant covariates. A baseline model was first estimated with time, accounting for mortality, 
attrition, and proxy interview (Model 1). Subsequent models estimated the effect of time-
constant and time-variant covariates, in the following order: age in 1995 (Model 2), socio-
demographic characteristics (Model 3), socioeconomic characteristics (Model 4), and health and 
marital status (Model 4). These nested models were compared using the Likelihood Ratio Test, 
and the model fit was confirmed with penalty-driven criteria, including the AIC and BIC. The 
models are described below: 
COGTOTti = π0i + π1i*(diabetes duration) + Σπki*Xkti + eti 
COGTOTti is the total cognition score for each individual i at time t; π0i is the level of 
depressive symptoms for each individual at the time of diagnosis; π1i is the linear rate of change 
in cognitive score for each individual; diabetes duration is the year since diabetes diagnosis; πki 
is the effects of the kth time-variant covariates Xk for individual i on the trajectory; Xkit are the 
kth time-variant covariates in the model; and eit is the measurement error in the outcome. 
π0i = β00 + Σβ01q*Xqi + r0i 
π1i = β10 + Σβ11q*Xqi + r1i 
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          πki = βk0 
π0i, π1i, and π2i are the same as above; β00, β10, and βk0 are the fixed effects or expected 
cognitive score at mean diabetes duration, and expected linear growth for every year of diabetes 
duration; β0q, and β1q are the effects of the qth time-constant covariates Xq for each i on the 
intercept and linear slope; Xqi is the qth time-variant covariate for each i; r0i and r1i, are random 
outcome variations at the intercept and linear slope. 
The data were imputed using the multiple imputation procedure in Stata® (Rabe-Hesketh 
& Skrondal, 2008), assuming the data were missing at random (Little & Rubin, 2002). Five 
imputed data sets were generated.  
Two time-constant indicators were also included to address mortality selection and 
attrition (death while in the study: 1=yes, 0=no; and attrition while in the study 1=yes, 0=no). A 
time-variant indicator of proxy interview was included as well. All analyses were conducted 
using Stata® (Version 12).  
 
RESULTS 
The sample had 52.9% female (n=2,139), 71.1% white, 16.2% black, and 10.2% 
Hispanics (results not shown). About two-thirds had completed high school (65.8%). At baseline, 
cognitive levels were at 20.50 (sd=5.54; range 0-35), and diminished to 15.63 by year 12. On 
average, respondents reported 1.11 comorbid conditions, excluding diabetes. The mean number 
of depressive symptoms and ADL/IADL limitations was 1.80 (sd=2.07; range 0-11) and 1.33 
(sd=2.69; range 0-11), respectively. During follow-up, 32.82% of the sample died, while 14.82% 
missed at least one interview. Table 7 provides additional sample descriptive statistics.  
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Trajectory of cognitive functioning with longer diabetes duration 
After adjusting for death, attrition and proxy interview, it was found that cognitive 
functioning declines linearly at a rate of approximately one-third of a unit per year from a rate of 
21.051 at diagnosis (intercept; p<0.001; linear slope=0.364; p<0.001; M1, Table 8). Adjusting 
for demographic characteristics and health covariates reduced the level of cognitive functioning 
by 14%, most of which was due to socioeconomic variations (adjusted intercept=17.990; 
p<0.001; M5, Table 8). It further reduced the fixed parameter associated with the linear slope by 
31%, and this change was mostly attributable to increasing disability and being married (adjusted 
linear slope=-0.251; p<0.001; M5, Table 8).  
The model fit improved with each subsequent model, as demonstrated by significant log 
likelihood statistics and increasing AIC and BIC statistics. The random effects also show a 
significant unexplained variability in the intercept (0.392; p<0.001) and linear coefficient (3.917; 
p<0.001), which was reduced by 9% and 41%, by the inclusion of social and health variables in 
Model 5.  
 
Diabetes timing (age at diagnosis) 
In agreement with our second hypothesis, older age at diagnosis was associated with 
lower cognitive levels at baseline (Figure 9). However, the gap did not increase over time 
(intercept=-0.269; p<0.001; linear slope=-0.006; p>0.5; M2, Table 8). The estimates were not 
noticeably modified by the inclusion of time-constant or time-variant covariates. We observed, 
however, that controlling for cohort by itself increased the negative effect of age at diagnosis on 
the cognitive levels by 25%, from -0.269 to -0.413, p<0.001 (results not shown). 
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Birth cohort 
Adjusting for age at diagnosis, cohort differences were significant both at diagnosis 
(intercept=0.122, p<0.001), and with longer diabetes duration (linear slope=0.021, p<0.005; 
results not shown). However, similar to age at diagnosis, cohort differences in cognitive 
functioning were significantly reduced by the inclusion of race, ethnicity, and gender indicators 
(Model 3, Table 8), suggesting that the demographic composition of the cohorts mediate the link 
between cohort and cognitive functioning in middle-aged and older adults with incident diabetes. 
 
Social stratification 
Model 3 in Table 8 shows great vulnerability among disadvantaged groups compared to 
their counterparts, with lower cognitive levels at baseline (interceptrace=-4.693, p<0.001; 
interceptethnicity= -3.545, p<0.001; interceptgender=0.606; p<0.005; range of intercepteducation=2.674-
4.141; range of interceptincome quartile=0.816-1.307; p<0.005). Yet the race, ethnic, gender, and 
economic gaps observed at baseline do not increase over time (Model 4). In addition, socio-
demographic characteristics account for very little of the cognitive scores and cognitive change 
with diabetes. 
Several additional findings are noteworthy. For instance, compared to men we observed a 
cognitive advantage among women at baseline in model 4 (intercept=-0.606; p<0.001; Table 8). 
However, this advantage was non-significant in Model 3 due to women’s lower socioeconomic 
status and poor health. Furthermore, health and socioeconomic status reduced the racial and 
ethnic gap in cognitive health, but did not fully explain either (Model 4 & 5, Table 8). Finally, 
both physical disability and being married were the only time-variant covariates significantly 
linked to worse cognitive trajectory (Model 5, Table 8).  
	  	   	  152	  
DISCUSSION 
The current study conceptualizes illness as a trajectory beginning with a diagnosis of 
diabetes. To our knowledge, this is the first study to assess cognitive change after diabetes 
diagnosis in middle-aged and older adults. The study results provide useful tools for patients and 
clinicians alike, to anticipate the clinical course of diabetes in terms of changes in cognitive 
functioning after diagnosis in middle-aged and older-aged adults. The study ultimately allows 
providers and policymakers to better predict the healthcare and social needs of people with 
diabetes along the illness career.  
 
Trajectory of cognitive functioning with longer diabetes duration 
Research shows that having diabetes modestly promotes accelerated aging of the brain 
(Reijmer, et al., 2010). The current study extends this research, and in agreement with our first 
hypothesis, shows that this cross-sectional effect moderately and linearly intensifies with longer 
diabetes duration. This finding is salient because even mild cognitive deficits can result in 
difficulties concentrating and in forgetfulness (Reisberg, Ferris, de Leon, & Crook, 1982), which 
can adversely affect adherence to medical treatment (Hayes, Larimer, Adami, & Kaye, 2009), as 
well as self-care and independent living (Njegovan, et al., 2001). Our findings therefore support 
the view that cognitive impairments will continue to be a major clinical and policy concern, as 
people live longer, and the prevalence of diabetes is expected to increase.  
The study supports the need for interventions implemented before and during the illness 
career to reduce cognitive impairments and cognitive decline. Socioeconomic status, marital 
status, and physical functioning were the most important modifiable determinants that appeared 
to bend the cognitive curve after diabetes diagnosis by as much as 31% (from -0.364 to -0.251 in 
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Table 8, M1 and M5). Contrary to previous findings of a declining effect of socioeconomic 
status on cognitive health with older age (Karlamangla, et al., 2009), our study found that 
education and income reduced both levels and rate of cognitive decline. Furthermore, previous 
studies showed that being married improves diabetes management and prevents cognitive decline 
(Hakansson, et al., 2009; Van Dam, et al., 2005). Yet among diabetics, married individuals 
experience a worse cognitive trajectory compared to their unmarried counterparts. This finding 
agrees with reports that some forms of support can be detrimental to health. For instance, spousal 
over-protective behaviors (Johnson et al., 2014), tempting (Henry, Rook, Stephens, & Franks, 
2013), and obstructive behaviors (Mayberry & Osborn, 2014) can undermine adherence to 
diabetes management, and thus be harmful to both self-care and diabetes control. While it is 
impossible to speculate about the mechanism through which being married affects the cognitive 
trajectory of newly diagnosed diabetics, the current study raises important questions regarding 
the role and importance of spousal involvement in diabetes care.  
 
Diabetes timing (age at diagnosis) 
As stated in our second hypothesis, the study results suggest that age at diagnosis is a 
significant agent of stratification for cognitive health (Bruce, et al., 2003; Kloppenborg, et al., 
2008; Tilvis, et al., 2004). This finding contradicts previous studies, which reported a stronger 
effect of diabetes on cognition in people aged 60 to 80 compared to those 85 and older (Biessels, 
et al., 2007; Biessels, Staekenborg, Brunner, Brayne, & Scheltens, 2006), and a worse clinical 
profile in younger adults compared to older adults (Hatunic, Burns, Finucane, Mannion, & 
Nolan, 2005; Hillier & Pedula, 2001; Hillier & Pedula, 2003; Selvin, et al., 2006). These 
contradictions could reflect methodological differences (analytic differences, and differences in 
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how age at diagnosis was measured), or differences in the samples under study. Given the 
important role of diabetes duration in defining cognitive trajectories as highlighted by the current 
study, its omission can conflate its impact on cognitive health with that of age at diagnosis. Our 
study can disentagle these effects: It showed that although longer diabetes duration results in 
incrementally worse cognitive functioning, older age at diagnosis is independently tied to worse 
cognitive functioning at any point in the disease trajectory. 
To the author’s knowledge, only one other study included diabetes duration as a covariate 
in multivariate analysis, and the results were more in line with those of the current study. In this 
earlier study, the link between diabetes complications and age at diagnosis varied by outcome, 
with greater risks of cataract, diabetes foot, and microvascular complications among people with 
every added year of age at diabetes onset (Chuang, et al., 2006). Chuang’s study included a 
sample from several Asian countries and people from a wide age-range (18 years and older), 
which limit its comparability to our own study. Nevertheless, our findings are in line with his 
results. This can be explained by the strong link between microvascular complications and poor 
cognitive health (Biessels, et al., 2007), which Chuang and collegues found to be more frequent 
with older age at diagnosis. It is therefore reasonable to conclude that older age at diagnosis 
establishes new trajectories characterized by greater vulnerability to diabetes with longer 
duration.  
Our conclusions are further strengthened by indications that older age may represent a 
critical period for cognitive impairments during which even diabetes may have greater effects. 
Compared to middle-aged adults, older adults have a greater mental health burden due to the 
association between involuntary role exits (retirement and widowhood) and declining social 
support, physical functioning, sense of control, and lower socioeconomic status, and the link 
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between these factors and poor mental health (Blazer, Bruce, Service, & George, 1991; 
Mirowsky & Ross, 1992) and poor diabetes self-management. A few authors have suggested that 
the pathogenesis of diabetes may further vary by age group (Stewart & Liolitsa, 1999). Others 
have shown that severe forms of cognitive impairments and dementia exist in higher frequency 
with older age, and milder forms of cognitive impairments in younger age (Biessels, Deary, & 
Ryan, 2008; Reijmer, et al., 2010). While no empirical proof is available for these claims, our 
study supports previous results by confirming that cognitive trajectories differ significantly by 
age at diagnosis: Older-aged adults exhibited worse trajectories than their middle-aged 
counterparts, with a dose-effect on cognitive functioning of age at diagnosis.  
Finally, delayed diagnosis among the oldest adults could explain the wider gaps in the 
cognitive trajectory by age at diagnosis. It is acknowledged, for instance, that over one-third 
(26.9%) of older adults with diabetes go undetected (Centers for Disease Control and Prevention, 
2011). If delayed diagnosis explains our results, the study shows clearly that the consequences of 
delayed diagnosis can lead to faster decline in cognitive trajectories after diabetes diagnosis 
among older adults. These findings strongly support the necessity for policies aimed at early 
detection of diabetes.  
  
Birth cohort  
The study results do not support our hypothesis that younger cohorts of older adults with 
diabetes will have a better cognitive trajectory compared to their older counterparts. The results 
also contradict previous age-based studies of the general population, which suggest that 
educational gains in general have resulted in improved cognitive health with each cohort coupled 
with a slower decline (Dodge, et al., 2013; Karlamangla, et al., 2009; Salthouse, 2013). After 
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adjusting for age differences, those in older cohorts experience better cognitive trajectories with 
higher cognitive functioning at baseline and slower decline with longer diabetes duration. In 
addition, the rate of change with longer diabetes duration was reduced to non-significance by 
socio-demographic variations in the sample (race, ethnicity, and gender). Therefore the social 
composition of younger cohorts increases the impact of diabetes duration on physical and 
cognitive health.  
For policy makers and clinicians, these results call for a new approach in dealing with 
diabetes, an approach which would take into account not only diabetes duration and age at 
diagnosis but also cohort differences in the experience of diabetes. As baby boomers have now 
reached retirement age and are reaching old age in large numbers, and the racial and ethnic 
diversity of the population is expected to rise, the healthcare needs of younger cohorts of people 
with diabetes in old age might increase in the near future, as the number of older adults with poor 
cognitive functioning increases. 
 
Social stratification  
The study contributes to the research on social stratification by showing that socio-
demographic predictors explain about 14% of cognitive impairments at diagnosis, but have a 
limited influence on the rate of change (only 5%). The study also showed persistent gender, 
racial, ethnic, and economic disparities in cognitive functioning after diabetes diagnosis, with 
worse trajectories among women, blacks, Hispanics and people of lower socioeconomic status. 
The finding of a constant risk of poor cognitive functioning for blacks and Hispanics over the 
course of diabetes (about 20% higher), when compared to whites, is consistent with the 
hypothesis that the risk of cognitive decline in late life among minorities may be more affected 
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by higher levels of cognitive functioning achieved early in life (Karlamangla, et al., 2009). We 
conclude that inequalities in cognitive functioning remain stable with longer diabetes duration 
after late-onset diabetes in middle-aged and older adults, because cognitive damages may have 
taken place earlier for socially disadavantaged groups before diagnosis. Nevertheless, although 
this possibility may explain higher cognitive levels at baseline, it cannot completely explain why 
cognitive functioning remains unchanged over the course of diabetes—especially because 
compared with whites, faster cognitive decline with time among blacks, particularly in complex 
cognitive tasks, is documented (Obidi, et al., 2008). Similarly, a cognitive advantage among 
women, which declined with age, has also been reported (Karlamangla, et al., 2009). These 
findings underscore the difficulties in linking mediators of social inequalities such as social 
support, access to care, and diabetes management to health outcomes. For instance, while 
diabetes support, which is socially distributed, is tied to health-promoting activities consistent 
with good diabetes management, there was no significant link between diabetes support and 
health decline (Nicklett & Liang, 2010). Future studies need to clarify the possible connection 
between elements of social stratification, behavioral, psychological, and medical mediators, on 
the one hand, and health outcomes over the course of diabetes, on the other. 
Overall, the event-based approach cautions clinicians and policy makers not to 
extrapolate evidence of social inequalities in the general population to older adults with incident 
diabetes. The current study shows that circumstances existing before diagnosis are the most 
relevant determinants of inequalities in cognitive functioning with diabetes. Blacks, women, 
Hispanics and people of low socioeconomic status are at risk of poor cognition at diagnosis, and 
this risk is not mitigated over the course of diabetes. Because of the effects of even slight 
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changes in cognitive heath on diabetes management, self-care and mental health, monitoring 
cognitive healh is necessary to reduce health inequities among social groups.    
 
Limitations 
The study results should be interpreted in the light of several limitations.  First, about 
one-third of the general population who meet the biological criteria for diabetes are not clinically 
diagnosed (Centers for Disease Control and Prevention, 2014). Therefore we can infer from this 
fact that a similar proportion of undiagnosed eligible diabetics were not included in the study. If 
these individuals are healthier than their diagnosed counterparts included in the sample, our 
estimates may be larger than the “true” population estimates. Second, differential access to care 
among social groups can lead to under-representation of individuals in disadvantaged groups, 
who also tend to have poorer health status. As a result, social differences may be underestimated 
in our study. Despite these limitations, self-reported diabetes has proved to be an acceptable 
measure and has been successfully used in longitudinal population studies in which objective 
measures are not readily available (Bruce, et al., 2003; Bruce, et al., 2008). Furthermore, tests of 
reliability have shown self-reports to be robust measures of diabetes status (Jackson et al., 2013). 
However, the use of diagnosis as the starting point of the cognitive trajectory can be problematic 
because microvascular complications, which are strongly associated with cognitive impairments 
can start as early as 7 years before a diagnosis of diabetes (Ramlo-Halsted & Edelman, 2000). 
Cognitive changes due to diabetes may therefore have begun before the diagnosis of diabetes. 
This limitation could partly explain the levels of cognitive functioning at baseline. Future studies 
of cognitive change with diabetes should begin the cognitive trajectory years before diagnosis, if 
studies are to capture these earlier cognitive changes. 
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Policy implications 
Diabetes presents a challenge to the entire healthcare system and its stakeholders due to 
its high economic and social costs, along with the complexity and burden of its treatment. The 
current study is the first to describe the clinical course of diabetes in terms of cognitive health 
after diagnosis in middle and old age. As such, it can provide patients with a graphic illustration 
of the general trend in cognitive functioning as their disease progresses. The study can also be 
useful to clinicians as a tool to illustate the course of diabetes in terms of correlates of functional 
independence, which are patients’ greatest concern (Huang, Brown, Ewigman, Foley, & Meltzer, 
2007).  
Overall, the study articulates four general recommendations for intervention; these are 
primary intervention, a shift in diabetes management, planning for upcoming cohorts with lower 
cognitive functioning, and finally addressing health inequalities early on in the life course.  
Primary prevention at the onset of diabetes should be the first line of intervention. 
Evidence-based programs such as the Diabetes Prevention Program, have proved effective in 
motivating diabetic adults to change their diet and to exercise; and these behaviors have proved 
effective up to 10 years after the intervention (Diabetes Prevention Program Research Group, 
2009). Therefore efforts to expand and fund such programs should become policy priorities for 
diabetic patients in general, and for older diabetic adults in particular, in order to support their 
cognitive health. As the role of diabetes in the future of the nation is being recognized, several 
initiatives have emerged and are moving a policy agenda in the right direction. These include the 
American Medical Association’s 2013 Improving Health Outcomes Initiative in collaboration 
with the YMCA, and the 2015 Prevent Diabetes STAT (Screen, Test, Act—Todaytm)4 campaign 
by the American Medical Association and the Centers for Disease Control and Prevention, a 
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screening campaign which reaches out to, and educates stakeholders in the treatment of diabetes, 
including patients, clinicians, medical associations, insurers, employers, community 
organizations, and the general public.  
Secondary prevention, on the other hand, aims to reduce health decline after the onset of 
diabetes. The results of this study highlight the importance of continuous monitoring of cognitive 
health to minimize the effects of cognitive health decline on diabetes and its management. The 
incorporation of measures of cognitive health as an integral part of diabetes monitoring in old 
age is necessary. Although this monitoring is already implemented in physicians’ offices, in 
European guidelines (International Diabetes Federation, 2010; Sinclair et al., 2011), and U.S. 
guidelines (American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes 
Mellitus, 2013), monitoring cognitive functioning at home is also important, because small 
changes in cognitive functioning between visits to the doctor can interfere with diet, exercise, 
diabetes care, and diabetes monitoring (Ciechanowski, Katon, & Russo, 2000; Feil et al., 2009; 
Feil, Zhu, & Sultzer, 2012; Okura, Heisler, & Langa, 2009; Rosen et al., 2003). Continuous 
monitoring should involve family members and case managers in order to prevent delays in 
addressing health decline. Measures of cognitive functioning are relatively easy to self-
administer, and studies have shown that validated screening instruments can improve the 
detection of depression and dementia (Ott, et al., 1999). Incorporating these measures into 
electronic devices such as apps for IPad®, tablets, smart phones, Fit-bits®, and online 
assessments, can further promote access to care and allow instant detection of changes in 
cognitive functioning over the course of diabetes.  
The finding that younger cohorts are at increased risk of a poor cognitive trajectory over 
the course of diabetes, due to demographic variations between cohorts, carries significant policy 
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implications. The current senior population entering old age may face poor cognitive functioning 
in greater numbers relative to their elders, and the increase in numbers can place a serious burden 
on families caring for older adults, on the healthcare system, and on the economy. The study 
therefore highlights the need for more research, and for policies that address the economic and 
social impact of reduced cognition in younger cohorts of older adults with diabetes.  
Finally, given the importance of cognition on diabetes management, self-care, physical 
functioning and overall well-being (Sinclair, Conroy, & Bayer, 2008; Sinclair, Girling, & Bayer, 
2000), middle-aged and older-aged blacks, Hispanics, women, and people of lower 
socioeconomic status with incident diabetes will continue to be at a cognitive disadvantage over 
the course of diabetes. At every stage of their disease, they may require more financial and social 
resources to deal with their condition. According to the study findings, it is clear that social and 
other conditions that existed before a diagnosis of diabetes are the most important causes of 
social variations in the cognitive trajectory of middle-aged and older-aged adults with incident 
diabetes; and socioeconomic status lies at the center of these variations. And although the 
protective effect of higher socioeconomic status does not increase over the course of diabetes, it 
also does not diminish. This fact most likely stems from the positive influence of higher 
education and better income on access to, and use of health services, to fewer diabetes 
complications, and to less stress (McEwen, 1998; Obidi, et al., 2008; Reijmer, et al., 2010; 
Wessels, et al., 2011). Therefore acting on economic conditions in older age to improve the 
cognitive trajectory of middle-aged and older-aged adults with incident diabetes is a reasonable 
policy option. A recent comprehensive report on health inequalities in the U.S. makes the strong 
case that social conditions, specifically education, income and neighborhood, rather than 
individual characteristics, may be the main drivers of racial inequalities (Bleich, Jarlenski, Bell, 
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& LaVeist, 2012, 2013). Therefore although the Patient Protection and Affordable Care Act 
improves access to care by expanding health insurance to almost the entire U.S. population, 
especially to socially disadvantaged people (Roberts & Rhoades, 2010), any serious policy 
should address the real sources of inequality, which are income inequalities and residential 
segregation, which are both influenced by how the school system is financed.  
  
CONCLUSION 
The illness career approach to diabetes and cognitive health shows that in middle-age and 
older adulthood, cognition declines modestly but steadily as diabetes progresses, and the risk of 
cognitive impairment varies by social group. Older age at diagnosis, younger cohorts, black race, 
Hispanic ethnicity, low education, and low income increase the risk of cognitive impairments at 
diagnosis, which remains unabated over the course of diabetes. Women also lose their cognitive 
advantage over men due to their lower socioeconomic status and poor health. As a consequence, 
efforts to address cognitive impairments among older adults with late-onset diabetes should 
focus on prevention and early detection, expand monitoring of cognitive functioning to patients’ 
homes, prepare for greater needs for care and social services with younger cohorts, and address 
educational and residential inequalities to reduce the socioeconomic gap in cognitive 
functioning.  
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Table 7: Descriptive statistics for the sample 
 Mean or % SD 
Measure of time and main outcome   
Diabetes duration (years) 3.011 3.956 
Total Cognition Score (0-35) 20.503 5.537 
   
Level 1: Time varying covariates (n=6,234)   
Married (%) 58.200 - 
ADL/IADL disability 1.326 2.691 
Self-rated health 3.311 1.057 
Comorbidities (excluding diabetes) 1.111 0.615 
CES-D 1.799 2.072 
Treatment burden 1.752 0.647 
Proxy (%) 0.118 - 
   
Level 2: Time constant variables (n=2,139)   
Age at diabetes diagnosis 74.139 6.417 
Age in 1995 65.284 7.516 
Female (%) 52.922 - 
White (%) 71.161 - 
Black (%) 16.176 - 
Hispanic (%) 10.192 - 
Other race (%) 2.571 - 
Education    
Less than high school (%) 34.222 - 
High school graduate (%) 35.512 - 
Graduate school (%) 30.266 - 
Median household income (USD)   
Quartile 1 8657 - 
Quartile 2 18367 - 
Quartile 3 33025 - 
Quartile 4 91363 - 
Death at any point in time (%) 32.819 - 
Attrition at any point in time (%) 14.820 - 
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Table 8: Average trajectory of cognitive functioning with longer diabetes duration 
 M1  M2  M3  M4  M5  
  Est. Sig Est. Sig Est. Sig Est. Sig Est. Sig 
Fixed effects           
For intercept           
Intercept 21.051 *** 20.822 *** 21.926 *** 18.081 *** 17.990 *** 
Age at diagnosis   -0.269 *** -0.336 *** -0.354 *** -0.292 *** 
Birth cohort (age in 1995)     0.055  0.100 * 0.071 * 
Female     0.110  0.606 ** 0.739 *** 
Black     -4.693 *** -3.552 *** -3.383 *** 
Hispanic     -3.545 *** -1.510 *** -1.462 *** 
Other race     -1.096 + -1.111 * -1.023 * 
High school graduate       2.674 *** 2.385 *** 
College graduate       4.141 *** 3.838 *** 
Income quartile 2       0.816 *** 0.754 ** 
Income quartile 3       0.965 *** 0.962 *** 
Income quartile 4       1.307 *** 1.210 *** 
           
For linear slope           
Linear slope -0.364 *** -0.401 *** -0.443 *** -0.346 *** -0.251 *** 
Birth cohort (age in 1995)   -0.006  -0.007  -0.008  -0.008  
Age in 1995     0.002  0.000  0.003  
Female     0.011  0.014  0.012  
Black     0.018  -0.007  -0.002  
Hispanic     0.118  0.058  0.069  
Other race     0.263  0.254  0.217  
High school graduate       -0.031  -0.034  
College graduate       -0.059  -0.061  
Income quartile 2       -0.076  -0.091  
Income quartile 3       -0.096  -0.094  
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Income quartile 4 (highest)       -0.043  -0.052  
           
Time variant variables           
Married         -0.524 * 
ADL/IADL disability         -0.539 *** 
Self-rated health         -0.050  
Comorbidities         0.162  
CES-D         -0.082  + 
Treatment burden         -0.281  + 
           
Survey status           
Death -3.358 *** -2.211 *** -2.298 *** -1.638 *** -0.907 *** 
Attrition -1.098 ** -1.357 *** -0.916 ** -0.680 * -0.713 * 
Proxy -2.123 *** -1.798 *** -1.794 *** -1.698 *** -0.020  
           
Random effects           
Variance           
Intercept 0.392 *** 0.384 *** 0.379 *** 0.375 *** 0.355 *** 
Linear slope 3.917 *** 3.634 *** 3.118 *** 2.570 *** 2.309 *** 
Intercept x linear slope -0.131  -0.116  -0.103  -0.066  -0.211  
Level 1 residual 3.618 *** 3.598 *** 3.596 *** 3.601 *** 3.530 *** 
           
Model statistics            
Observations 6234  6234  6234  6234  6234  
Groups 2139  2139  2139  2139  2139  
AIC 168828  168462  167976  167437  166527  
BIC 168903  168554  168151  167696  166836  
Log likelihood -84405  -84220  -83966  -83687  -83226  
-2ΔLog Likelihood statistic -  370 *** 485 *** 559 *** 922 *** 
Degrees of freedom -  2  10  10  6  
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***p<0.001; **p<0.01; *p<0.05; +p<0.10;  AIC: Akaike Information Criteria;  BIC: Bayesian Information Criteria;  Log Likelihood 
Ratio Test tests nested models 2 vs 1, 3 vs 2, 4 vs 3, and 5 vs 4, respectively
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Figure 9: Trajectory of cognitive functioning with longer diabetes duration at age 65 and 70† 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† Model controls for survey status and birth cohort (age in 1995) 
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CHAPTER 5 
Conclusions 
 
The goal of this chapter is to provide an overview of the study by 1) summarizing the 
results of the three studies and drawing conclusions in the context of the current literature on 
diabetes and health; 2) laying out the policy implications of the findings; and 3) discussing future 
investigations that can clarify and expand the current research. 
 
SUMMARY OF FINDINGS WITHIN THE CURRENT RESEARCH ON DIABETES AND 
HEALTH 
Health change with longer diabetes duration 
Previous studies have effectively shown that having diabetes results in greater 
impairments at any point in time and at any age, and that impairments increase with age. In their 
estimates, however, these studies conflate the effect of diabetes duration and diabetes timing 
with that of age. The current study addresses these limitations, and takes the concept further in 
three ways.  
First, rather than adopting an age-based or time-base approach, which compares people 
with diabetes to those without diabetes, it adopts an event-based approach to diabetes and health 
change, which aligns the natural history of diabetes with patients’ experience of the disease. 
Therefore it bridges the gap between the biomedical (natural history of a disease) and the 
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sociological (patients’ experience of illness as outlined in the Illness Career Model and the 
Disablement Process Model) literatures.  
Second, contrary to previous studies, which included both incident and prevalent cases, 
the current study focused exclusively on people with incident diabetes in middle-age and old-
age. As a result, it describes, for the first time, the true experience of diabetic patients, and 
quantifies the shape of physical, mental, and cognitive health change with longer diabetes 
duration. Rather than focusing on age or arbitrary time, this approach also mirrors the clinical 
course of diabetes by delineating health trajectories that begin with the diagnosis of diabetes, and 
by using diabetes duration as the measure of time for a common experience. Therefore it is more 
useful to clinicians and patients, but also to policy makers who want to understand the course of 
diabetes after diagnosis and to plan for the healthcare needs of diabetic patients.   
Finally, it incorporates several measures of time relevant to both the disease (diabetes 
duration) and the patient (age at diagnosis and cohort); and isolates the respective roles of 
intrapersonal and interpersonal differences on physical, mental, and cognitive health change with 
diabetes.  
Overall, the study corroborates cross-sectional findings that link diabetes duration with 
poor health (Park et al., 2006; Skinner et al., 2010; Spauwen, Kohler, Verhey, Stehouwer, & Van 
Boxtel, 2013). It further provides a longitudinal description of how health changes with longer 
diabetes duration and supports the assumption that illness is a dynamic event that can be depicted 
as beginning a trajectory, and that it is shaped by social factors, some of which also change with 
time. After diabetes is diagnosed in middle age and older adulthood, physical, mental, and 
cognitive health is characterized by relatively modest decline in health trajectories within the 
first 14 years. However, a proportionally faster decline in health is observed for physical health 
	  	   178	  
compared to mental and cognitive health. The first chapter demonstrated that functional health 
among older adults, measured as ADL/IADL, and mobility disability declined according to a 
quadratic function. The second and third chapters demonstrated a linear increase in depressive 
symptoms and a decrease in cognitive functioning with longer diabetes duration.  
On average, and after adjusting for age at diagnosis and cohort effects, there is a 25% loss 
in people’s ability to function physically every year following a diagnosis of diabetes, and a 
2.17% quadratic increase with every additional year from an initial level of 0.415 limitations. 
These changes correlate with a 2.28% decline in cognitive functioning per year from an average 
of 20.736, and a decline in mental health of 1.35% per year from initial levels of 1.620 
depressive symptoms (Appendix E).  
Socio-demographic and health status differences over the course of diabetes, including 
the differential burden of diabetes care, explained some of the differences and the rate of change 
in the health trajectories. Socioeconomic status (education and income) completely explained the 
linear increase in mental health with longer diabetes duration, but the trends reversed after 
adjustment for differences in health status.  
It is important to emphasize that these trends varied from person to person, as 
demonstrated by significant variations in the random components at baseline and in the slopes 
for all three outcomes, even after the inclusion of socio-demographic and health-related factors. 
Future studies should investigate the respective roles of social and medical factors most relevant 
to the management of diabetes and to the progression of the disease; the latter would include 
complications, obesity, smoking, physical activity, and alcohol use. 
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Diabetes timing (age at diagnosis)  
Results presented in the three Chapters provide strong evidence that old age at diagnosis 
is a key determinant of poor health across all outcomes. When middle-aged and older-aged 
adults are diagnosed at later ages, they begin their diabetes career with higher levels of 
ADL/IADL disability and lower cognitive functioning. Over the course of the illness, age-related 
health gaps remain constant for cognitive functioning, meaning that longer diabetes duration 
does not seem to significantly influence age differences in cognitive health. However, the gaps in 
the trajectories for ADL/IADL disability and depressive symptoms widen at a constant rate with 
longer diabetes duration.  
An important contribution of the study, therefore, is the strong evidence it provides that 
during the course of diabetes in middle age and old age, age at diagnosis is an important risk 
factor for all three precursors of loss of independence. We find persistent inequality in cognitive 
health trajectories and in the trajectories for ADL/IADL and depressive symptoms by age at 
diagnosis with longer diabetes duration. Therefore identical clinical treatment of patients who 
were at different ages when diabetes was diagnosed may contribute to greater functional and 
mental health disparities among older people with the disease. In addition, adjusting for cohort 
differences exacerbates these disparities. Thus studies of health change that do not incorporate 
cohort effects underestimate the negative effect on health of older age at diagnosis and longer 
duration of diabetes.  
The findings are particularly salient to policy, because the literature reports more severe 
clinical profiles among people with diabetes diagnosed during middle age compared to those 
with later-onset diabetes (Hatunic, Burns, Finucane, Mannion, & Nolan, 2005; Hillier & Pedula, 
2001; Hillier & Pedula, 2003; Selvin, Coresh, & Brancati, 2006). Furthermore, age-based studies 
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suggest that older cohorts are at risk of faster functional decline over time (Chiu & Wray, 2010). 
But several methodological and conceptual limitations of these earlier studies, discussed in 
Chapter 1, can explain the differences between their findings and our own. The consistency of 
the effects of older age at diagnosis across outcomes, coupled with our nationally representative 
sample of older adults with self-reported diabetes, our conceptualization of time variables 
important to both the person and the disease, and our statistical methods, which take into account 
the structure of the data, all strengthen the validity of our findings and the quality of our results. 
We can confidently conclude that efforts to ensure successful and equitable aging with diabetes 
will require addressing the disproportionate risk of poor health both before diagnosis and over 
the course of illness among older people compared to their younger counterparts. 
From a sociological point of view, Bury’s conceptualization of the timing of chronic 
diseases as a biographical disruption and Larsson’s finding of a continuous disruption of this 
biography over the course of chronic illnesses both support our own findings of differential 
trajectories by age at diagnosis (Bury, 1982; Larsson & Grassman, 2012). Older age at diagnosis 
delimits new physical and cognitive trajectories characterized by worsening health with longer 
diabetes duration.  
Health gaps by age at diagnosis at baseline may be attributed to age differences in 
health—a reasonable possibility given the negative effects of old age on health. However, the 
faster decline in physical and mental health among people diagnosed at older age can be due to 
differences in clinical vulnerability, psychosocial vulnerability, or to delays in diabetes diagnosis 
in people of older age at diagnosis.  
Several studies on cognitive health suggest that the pathogenesis of diabetes may vary by 
age (Stewart & Liolitsa, 1999), while others propose that for people with diabetes, older age may 
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represent a critical period that increases their vulnerability (Biessels, Deary, & Ryan, 2008). The 
validity of these conclusions would have to be confirmed through empirical studies. 
Nevertheless, our study deepens our understanding of the relationship between diabetes and 
aging by showing that the age at diagnosis plays a crucial role in a patient’s experience of the 
illness.  
The concept of diabetes as a ”biographical disruption” in old age is further supported by 
studies, which show that old age can exacerbate risk factors of poor health via psychosocial 
pathways. Old age is linked to social isolation and involuntary role exits (retirement and 
widowhood). It is further linked to declining social support, physical functioning, sense of 
control, and income, which are in turn associated with poor mental health and lower ability to 
manage diabetes (Blazer, Bruce, Service, & George, 1991; Mirowsky & Ross, 1992). In addition, 
reduced social support is tied to poor diabetes management (Nicklett & Liang, 2010). Therefore 
social isolation and weak social support may explain why old age at diagnosis results in worse 
health trajectories with longer diabetes duration. These observations were explored in Chapter 2, 
which reported similar depressive symptoms at diagnosis, and a faster increase of these 
symptoms over the course of diabetes, among people diagnosed in older age.  
Finally, delayed diagnosis among the oldest adults could explain the wider health gaps at 
diagnosis as discussed in Chapters 1 and 3. It is acknowledged, for instance, that over one-third 
(26.9%) of older adults with diabetes go undetected (Centers for Disease Control and Prevention, 
2011). If delays in diagnosis explain our findings, the study might have compared respondents 
who were at different locations in the natural history of their illness. One way to eliminate this 
limitation would be to use biomarkers to accurately identify the time at which patients moved 
from the pre-diabetic to the diabetic phase. From a policy perspective, however, the results of the 
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study clearly support the probability that if delayed diagnosis in older adults explains our results, 
the consequences of delayed diagnosis would lead to faster physical and cognitive functional 
decline with longer diabetes duration, for every year of delay. These findings would be similar to 
Chuang’s results, which showed an increasing risk of complications with every added year of 
age at diagnosis (Chuang et al., 2006). Therefore, the study results strongly support policies 
geared towards early prevention and early diabetes detection until the effect of age at diagnosis 
on precursors of functional loss is better understood. 
 
Birth cohort  
The study’s contribution extends beyond the effects of age at diagnosis and diabetes 
duration on the experience of diabetes. It explains the ways in which differences in historical 
time may influence health change with incident diabetes in middle age and old age. We 
hypothesized that generational improvements in diabetes care and in the reduction of risky 
behaviors should translate into better health trajectories among people in younger cohorts. Our 
findings, however, did not support this hypothesis. Among middle-aged and old-aged adults with 
incident diabetes, those in older cohorts experience better cognitive trajectories with higher 
cognitive functioning at baseline and slower decline with longer diabetes duration—evidence of 
divergent cognitive trajectories (Appendix E). Physical health trajectories showed evidence of 
persistent inequality with longer duration, with fewer ADL/IADL limitations at baseline in 
people from older cohorts. No cohort differences were found for depressive symptoms. None of 
the outcomes studied supported the view that within 14 years after a diagnosis of diabetes, 
people in younger cohorts might be better off. We conclude that younger cohorts of middle-aged 
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and older-aged diabetics are at similar risk of poor mental health, but experience persistent and 
increasingly divergent physical and cognitive health trajectories with longer diabetes duration.   
In light of these findings, earlier assumptions, reported by time-based studies, that 
younger cohorts of diabetics are healthier do not accurately depict the link between cohort and 
health with late-onset diabetes (Chiu & Wray, 2010). Using an event-based approach, we found 
that people in younger cohorts have worse physical and cognitive trajectories beginning at 
diagnosis, and differences in cognitive health among cohorts widen over the course of diabetes.  
The worsening cognitive trajectories can be explained by socio-demographic variations in the 
sample (race, ethnicity, gender, and socioeconomic status), but remained significant at baseline. 
Therefore the social composition of younger cohorts increases the impact of diabetes duration on 
cognitive trajectories over the course of diabetes.  
Several factors may be at play. First, functional health improves in all age groups except 
the middle-aged (Seeman, Merkin, Crimmins, & Karmalanga, 2010). Our findings may therefore 
reflect general trends in the U.S. population, at least regarding physical health. Second, 
increasing sedentary lifestyle, lack of physical activity, and obesity in younger cohorts, with 
greater frequencies in socially disadvantaged groups, can explain our results. For instance, higher 
obesity rates in more recent cohorts is well documented (Reynolds & Himes, 2007) along with 
significant social stratification in BMI trajectories (Botoseneanu & Liang, 201). In the mobility 
disability, however, the inclusion of BMI along with other measures of health status and of 
comorbidities of diabetes did not fully explain the physical, mental, and cognitive health gap by 
cohort, with longer diabetes duration. Therefore although BMI may partially explain why 
younger cohorts are at risk of poor physical and cognitive trajectories with diabetes, its 
contribution may be marginal. 
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Regardless of the explanation, for policy makers and clinicians, dealing with diabetes will 
necessitate taking into account not only diabetes duration and age at diagnosis, but also cohort 
differences in the experience of diabetes. Since baby boomers have reached retirement age and 
are reaching old age in greater numbers, it can be expected that the healthcare needs of people 
with diabetes in old age will increase in the near future, especially with regard to physical and 
cognitive health. 
 
Social stratification  
The three Chapters also contribute to the research on health disparities. They showed that 
overall (a few exceptions apply and are discussed below), racial, ethnic, gender, and 
socioeconomic differences in patients’ experience of diabetes are manifested mainly in persistent 
inequalities the longer the duration of diabetes. These results confirm that social stratification in 
childhood and adulthood before diagnosis ranks among the most important determinants of 
physical, mental, and cognitive health among middle-aged and older adults newly diagnosed 
with diabetes. The important role of early childhood and adulthood life chances on health in old 
age health is widely acknowledged in developmental and life-course research, which describes 
how life-course circumstances and events, including social stratification, influence disease 
susceptibility, illness behaviors, and disease outcomes (Ben-Shlomo & Kuh, 2002; Kuh & Ben-
Shlomo, 1997). The research also shows that prenatal and childhood exposure to risks, such as 
low socioeconomic status and birth weight, along with adulthood factors such as lower 
socioeconomic status; behavioral factors such as alcohol, smoking, diet, and physical exercise; 
and psychosocial factors increase the risk of poor health in old age (Lynch & Davey Smith, 
2005). These risk factors are unequally distributed in the population. For instance, researchers 
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have shown a link between chronic disease outcomes and social stratification, including race and 
ethnicity (Ferraro, Farmer, & Wybraniec, 1997), socioeconomic status (House et al., 1994; 
Strohschein, 2005), and gender (Zhang & Hayward, 2006). 
However, the stability of these social gaps over the course of illness was an unexpected 
finding, for reports of social differences in diabetes management and outcomes between socially 
advantaged groups and their disadvantaged counterparts are common in the diabetes literature. 
Blacks, Hispanics, and women experience more barriers to self-management, less access to and 
lower quality of healthcare, obstacles to diabetes control, worse psychological outcomes, less 
family support, and worse diabetes-specific self-efficacy and distress, and more comorbidities 
(Brown et al., 2000; Glasgow, McCaul, & Schafer, 1986; Gucciardi, Wang, DeMelo, Amaral, & 
Stewart, 2008; Heisler et al., 2007; Jezewski & Poss, 2002; Lanting, Joung, Mackenbach, 
Lamberts, & Bootsma, 2005; Ponzo et al., 2006; Quandt et al., 2005; Sentell & Halpin, 2006; 
Szalat & Raz, 2007; Walker et al., 2006). Similarly, lower socioeconomic status, especially 
lower educational attainment, hinders important diabetes self-management behaviors (Anderson 
et al., 1995), and creates barriers to healthcare access (Baker, Watkins, Wilson, Bazargan, & 
Flowers, 1998; Beckles et al., 1998) and to the process of care (Brown et al., 2004). Given this 
list of indicators of problematic diabetes management, one key question remains to be answered: 
Why do socially disadvantaged people not have worse outcomes after a diagnosis of diabetes?  
A few exceptions apply to this general observation. As expected, and in agreement with 
studies reporting significant disadvantage in diabetes management among Hispanics (Hertz, 
Unger, & Ferrario, 2006; Saha, Arbelaez, & Cooper, 2003), the physical disability trajectory 
accelerates faster compared to that of whites, especially in Hispanic men (Chapter 1). This 
finding is significant for two reasons. First, the literature supports either similar physical health 
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trajectories between Hispanics and whites with time and in the general population (Carrasquillo, 
Lantigua, & Shea, 2000; Liang et al., 2008), or a Hispanic advantage among diabetics (Chiu & 
Wray, 2010). It seems, however, from our study that Hispanics are adversely affected by diabetes 
duration as it relates to physical functioning. Therefore current clinical practice may 
underestimate the high risk of physical disability among Hispanics with diabetes. Second, our 
research highlights the urgent need to understand the factors that put Hispanics at high risk of 
functional decline with longer diabetes duration. Given the demographic transitions occurring in 
the U.S., with rising numbers of people of Hispanic descent expected in the near future 
especially in states such as California and Texas (Passel, Cohn, & Lopez, 2011), diabetes can 
adversely affect healthcare, social, and familial institutions. We also found that the gap in 
functional trajectory by ethnicity was completely explained by educational differences between 
Hispanics and whites. General interventions to improve education in minority groups are 
therefore important for policy. Research is also necessary to identify the specific components of 
education that can explain the Hispanic disadvantage.  
The finding that social gaps do not widen in the trajectories of depressive symptoms 
(Chapter 2) and cognitive functioning (Chapter 3) is most likely due to small variations in the 
CES-D and the Total Cognition Score within the study period. Longer-term observations and 
more culturally sensitive measures may better detect racial and ethnic differences, if any, in the 
experience of diabetes.  
In addition to the Hispanic disadvantage in functional health, the study found that lower 
socioeconomic status reduced to non-significance the cognitive advantage of women observed in 
the general population (Karlamangla et al., 2009) (Chapter 3). This result is consistent with 
studies of diabetic patients which report either no gender differences in cognitive functioning 
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(Bruce et al., 2008; Okereke et al., 2008), or a larger negative effect of diabetes in men compared 
to women (Maggi et al., 2009). We further found that lower socioeconomic status reduces 
women’s cognitive advantage to non-significance. Cognitive health being one of the few health 
outcomes where women do not suffer greater morbidity in general (Bruce, et al., 2008; Reijmer, 
van den Berg, Ruis, Kappelle, & Biessels, 2010), the numbers of women needing support to live 
independently in the future may rise with the increase of incident diabetes in old age. 
Finally, the study confirmed research that among middle-aged and older adults with 
newly diagnosed diabetes, lower socioeconomic status (education and income) is a fundamental 
cause of health inequalities (Link & Phelan, 1995). Socioeconomic status has a negative 
influence on health trajectories and a mediating effect in the relationship between components of 
social stratification (race, ethnicity, and gender) and physical, mental, and cognitive health 
trajectories (Chapters 1, 2, and 3). Two findings in particular are noteworthy.  
First, as reported in Chapter 2, lower socioeconomic status completely explains the 
increase in depressive symptoms, suggesting that improvement in socioeconomic status among 
adults with diabetes may result in late-life improvement in mental health. Similar findings have 
emerged in the general population, in which persistent evidence has shown a reversal of the 
negative effects of aging on depressive symptoms (Clarke, Marshall, House, & Lantz, 2011; 
Mendes de Leon, Barnes, Bienias, Skarupski, & Evans, 2005; Taylor & Lynch, 2011; Xu, Liang, 
Bennett, Quinones, & Ye, 2010; Yang, 2007). Therefore the current study supports the view that 
depressive symptoms over the course of diabetes is not inherent in the illness; rather, it is lower 
socioeconomic status that results in poor mental health.  
Second, and unexpectedly, the study showed that higher-income individuals as a group 
are more vulnerable to a faster decline in mental health with longer diabetes duration compared 
	  	   188	  
to lower-income individuals. Although benefiting from lower depressive symptoms at diagnosis, 
this advantage was reversed as diabetes progressed. Therefore the general expectation of a 
positive link between socioeconomic status and health may result in unmet health needs among 
diabetics in the higher socioeconomic class. This counter-intuitive finding may be related to a 
ceiling effect of the measure of depressive symptoms among people with lower education. 
Alternatively, people with higher income and more demanding jobs may be more reluctant to 
consult professionals about their psychological problems, reluctance that may lead to increased 
mental health morbidity and poor diabetes outcome. Findings from a Japanese study support this 
observation. Although experiencing lower rates of depressive symptoms, people with higher 
income also showed lower levels of treatment for depression (Fukuda & Hiyoshi, 2012). If a 
similar trend exists among older U.S. adults with diabetes, it may explain why mental health 
worsens among people with higher income.  
It is important to note that despite increasing levels of depressive symptoms among older 
adults in the higher income quartiles, average differences in depressive symptoms between the 
groups in the top two versus the bottom two income quartiles remained mostly in favor of higher 
income; and this finding agrees with cross-sectional studies that report a protective effect of 
higher income among diabetic patients. The current study strengthens this research by showing 
that the gap in depressive symptoms between individuals in higher income and their counterparts 
gradually diminishes with a longer duration of diabetes.   
 
Summary  
In sum, this study allows an accurate prediction of the clinical course of late-onset 
diabetes in terms of physical, mental, and cognitive health. It further identifies social factors that 
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are relevant to diabetes management and policy—factors which, if taken into account, can 
positively influence health trajectories and ensure equitable and successful aging with diabetes. It 
finds that overall, health declines after late-onset diabetes, at different rates, and with different 
outcomes. And although diabetes duration and age have been extensively used to determine the 
goals of diabetes management, age at diagnosis as well as birth cohort are equally important 
determinants of health change after late-onset diabetes. In addition, the experience of diabetes is 
socioeconomically differentiated; differentiation begins in childhood, continues into adulthood, 
and is carried over to the time of diabetes diagnosis, with little indication that it diminishes over 
the course of illness. 
 
POLICY IMPLICATIONS 
Older adults with type 2 diabetes are a rapidly growing population and account for a great 
share of healthcare costs in the U.S. They present unique clinical and policy challenges due to 
their significant socio-demographic diversity, and variations in age at diagnosis, diabetes 
duration, and clinical presentation (American Diabetes Association, 2014; Kirkman et al., 2012). 
As a result, physicians must struggle with the incongruence between their own treatment goals 
and that of their patients (Huang, Brown, Ewigman, Foley, & Meltzer, 2007). Previous studies 
comparing people with diabetes to people without diabetes have been unable to provide practical 
tools to clinicians to deal with these issues. In this study we focused solely on people with 
diabetes and set out to describe physical, mental, and cognitive health changes after a diagnosis 
of diabetes in middle-aged and older adultshood in ways that are useful to clinical care, to 
patients, and to policy. The implications of our findings are outlined below.  
 
	  	   190	  
Health change with longer diabetes duration 
Overall, health changes over the course of diabetes are relatively small. However, even 
modestly incremental changes in physical, mental, and cognitive health can result in poor health, 
increased use of health services, institutionalization, and increasing demands on the health 
system as a whole. Every added unit of functional limitation can mean the difference between 
living independently or needing to live in assisted-living facilities, or in a nursing home. Our 
results show that for someone diagnosed at age 50 with already 6 functional limitations, it would 
take only 4 years for the person to need nursing home care; and at 4 functional limitations at 
diagnosis, by the time the person reaches age 62, the patient is likely to require 
institutionalization in a nursing home. With these sobering numbers in mind, several strategies 
can be adopted to reduce the impact of diabetes on physical, mental, and cognitive health in 
middle age and older adulthood. 
Primary intervention – Primary intervention to prevent the onset of diabetes is the first 
and most effective policy action. Empirical studies have found that it is possible to delay and 
even prevent type 2 diabetes with lifestyle interventions. For instance, clinical trials of the 
Diabetes Prevention Program found that the 12-month program increased exercise and reduced 
weight among adult diabetics, and its effects can last up to 10 years (Diabetes Prevention 
Program Research Group, 2009). To date, about 500 such programs have already been 
implemented throughout the U.S. A few other initiatives have also emerged to tackle the diabetes 
epidemic. The American Medical Association’s 2013 Improving Health Outcomes Initiative, in 
collaboration with the YMCA, aims to increase diabetes screening and referral to community 
organizations for interventions to effect changes in lifestyle. In March 2015, the American 
Medical Association with the Centers for Disease Control and Prevention initiated the Prevent 
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Diabetes STAT: Screen, Test, Act—Todaytm 5 campaign to reach out to, and educate 
stakeholders, including clinicians, medical associations, insurers, employers, community 
organizations, and the general public, about diabetes. It also gives an opportunity for the general 
public to assess their individual risk factors for diabetes online.  
While evidence for the effectiveness of the last two initiatives is not yet available, 
funding and expansion of Diabetes Prevention Programs to promote physical activity, weight 
control, and a general culture of healthy eating and exercise in the community at large, seems to 
be adequate policy options to prevent and delay diabetes and its clinical, and functional 
complications (American Diabetes Association, 2014). For instance, expanding these programs 
to local gyms, yoga clubs, or lifestyle programs such as Curves®, which targets middle-aged and 
older women can link this population to diabetes screening and prevention. Funding could be a 
public-private sector endeavor, involving insurers, Medicare and Medicaid, the Department of 
Defense, and businesses that have a stake in ensuring the public health of the population for 
health, security, political, and economic reasons. 
In addition, intervention might also focus on widening the diagnostic criteria for diabetes 
to identify individuals in the prediagnostic phase. For instance, the ADA guidelines propose 
screening annually for type 2 diabetes starting at age 45. Adoption of this recommendation, its 
universal implementation in clinical practice, and reimbursement by third-party payers can 
reduce delayed diagnosis in old age. Such an initiative would require support from the American 
Medical Association and other professional medical organizations, and funding from private and 
public insurance organizations.    
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  http://www.ama-assn.org/sub/prevent-diabetes-stat/	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Primary intervention should also focus on creating a general culture of physical activity 
and healthy diet to improve health in the upcoming cohorts. Such an effort, preferably 
originating in appropriate U.S. government agencies, should include patient-advocacy 
organizations, public health experts, clinicians, policy makers, third-party payers, and more 
importantly, community organizations, the food industry, the media, and urban planners. These 
key stakeholders in the health of the nation should brainstorm ways to create an environment 
conducive to healthy living. Financing such an effort would pose a challenge, and resistance 
from the food industry might also be a roadblock. Earmarked taxation for public health on the 
processed-food industry might be the equivalent of the taxation on tobacco, which has worked 
successfully in the past (Chaloupka, Yuekli, & Fong, 2012). Monies raised from these taxes 
could be used to fund such efforts. Consumer groups could also be encouraged and educated in 
order to counteract the resistance expected from the processed-food industry. 
Secondary prevention – Secondary prevention, on the other hand, aims to reduce health 
decline after the onset of diabetes. It is clear from our study that for comprehensive diabetes 
management, it is necessary to incorporate measures of physical, mental, and cognitive health as 
an integral part of diabetes monitoring in old age. Monitoring of functional health outcomes over 
the course of the illness (annual check-ups) is not new, as it is included in at least two 
international guidelines, including the European Diabetes Working Party for Older People6 
(Sinclair et al., 2011) and the International Diabetes Federation (International Diabetes 
Federation, 2010). Yet regular assessment of functional status still lags behind in U.S. guidelines, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  1) Each older patient with type 2 diabetes should have an assessment of their functional status 
by a multidisciplinary team skilled in evaluation using well-validated assessment tools. This 
should be at the time of diagnosis and annually thereafter. 2) Each functional assessment must 
include a measure of the three major domains of function: global/physical, cognitive and 
affective.  
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with the exception of mental status assessment7 (American Diabetes Association, 2014) and 
recent recommendations from the American Geriatrics Society Expert Panel (American 
Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus, 2013).8  
Nevertheless, recommendations, which incorporate the assessment of physical, mental, 
and cognitive health focus only on monitoring functional status at the point of clinical care. But 
monitoring functional status at home is just as important because subtle changes in physical, 
mental, and cognitive status between visits to the doctor can interfere with diet, exercise, 
diabetes care, and diabetes monitoring (Ciechanowski, Katon, & Russo, 2000; Feil et al., 2009; 
Feil, Zhu, & Sultzer, 2012; Okura, Heisler, & Langa, 2009; Rosen et al., 2003). Continuous 
monitoring is therefore necessary, and should involve not only the patient, but also family 
members and case managers in order to prevent delays in addressing critical health decline, 
linked to diabetes management. Measures of physical, mental, and cognitive health are relatively 
easy to self-administer, and studies have shown that validated screening instruments can improve 
the detection of depression and dementia (Ott, Stolk, & van Harskamp, 1999). The American 
Geriatrics Society provides a short list of such tests, which could be adapted to the home, the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7 1) It is reasonable to include assessment of the patient’s psychological and social situation as an 
ongoing part of the medical management of diabetes. 2) Psychosocial screening and follow-up 
may include, but are not limited to, attitudes about the illness, expectations for medical 
management and outcomes, affect/ mood, general and diabetes-related quality of life, resources 
(financial, social, and emotional), and psychiatric history. 3) Routinely screen for psychosocial 
problems such as depression and diabetes-related distress, anxiety, eating disorders, and 
cognitive impairment.  
 8	  Specific geriatric syndromes that have been included and emphasized in the updated 2013 
guidelines are depression, polypharmacy, cognitive impairment, urinary incontinence, injurious 
falls, and persistent pain. Clinical and functional heterogeneities in older adults with DM that 
were also addressed in the 2013 guidelines are differences in general health status, age and 
duration of disease at diagnosis, number of years of treatment, comorbidities and underlying 
chronic conditions, range of complications, degree of frailty, limits in physical or cognitive 
function, and differences in life expectancy (time horizon for benefit).	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nursing home, and community settings (American Geriatrics Society Expert Panel on the Care of 
Older Adults with Diabetes Mellitus, 2013).  
Incorporating these measures into electronic devices such as apps for IPad®, tablets, and 
smart phones; but also Fit-bits® or even online assessments, can further increase access and 
allow instant detection of health change over the course of diabetes. These devices often have 
built-in reminder systems, but emails or postal mail can also be used to remind patients, family 
members, or case managers to monitor physical, mental, and cognitive health change. Adoption 
of technology is not significantly hindered by old age. For instance, a 2012 Pew Research Center 
survey found that more than half of older adults (65 or older) are Internet users. About 59% go 
online; 86% use email – 48% of them on a daily basis; 47% report having a high-speed 
broadband connection at home; and 77% have a cell phone. Similar trends are found with tablets 
and iPads among those who adopt electronic devices as they become an integral part of their life. 
The feasibility, cost, and effectiveness of this strategy in preventing adverse diabetes outcomes 
should be investigated, and if the results are conclusive, the measures outlined above could be 
incorporated into future diabetes guidelines. However, caution is essential, so that unequal access 
to electronic devices does not result in widening inequalities in health in this population. 
An additional contribution of the study is that it provides a tool that could improve 
patient-physician agreement on the goals of diabetes treatment (Huang, Gorawara-Bhat, & Chin, 
2005). Estimates from the models of health change with diabetes duration can be used to develop 
visual graphs of the course of diabetes in terms of physical, mental, and cognitive trajectories 
parallel to the metabolic and clinical course of diabetes, including hemoglobin A1c, insulin, and 
glucose levels. These graphs could be incorporated as promotional tools and supporting materials 
during diabetes assessment and follow-up visits, to discuss the implications of life-style changes, 
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medical treatment, and functional and metabolic outcomes on functional independence. 
Additionally, they could be used to predict the timing of institutionalization given their 
functional levels at assessment. Future studies can assess the effectiveness of such materials in 
ensuring patient-physician agreement on the goals of diabetes management and encouraging 
adherence to diabetes treatment.  
Finally, the study highlights the need to develop an effective and efficient referral system 
to physical, mental, and cognitive health services. 
 
Diabetes timing (age at diagnosis) and birth cohort 
Our results regarding age at diagnosis and cohort differences in the experience of 
diabetes has several policy implications. 1) Both measures of time are important factors to 
consider during diabetes management. 2) Interventions to address age-related and cohort-related 
gaps in health trajectories will require both primary and secondary prevention. 3) The burden on 
society may increase with younger generations of older adults with incident diabetes.  
Although the key role of diabetes duration is recognized in several U.S. guidelines for 
clinical care, age at diagnosis is identified by the current study as a major risk factor for poor 
health. For instance, the U.S. Department of Veterans Affairs and the U.S. Department of 
Defense9 mention diabetes duration as a criterion for glycemic control and aspirin therapy in the 
2010 update of their guidelines. Similarly, the American Diabetes Association’s 2014 Standards 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 The patient with longer duration diabetes (more than 10 years) or with comorbid conditions and 
who requires a combination medication regimen including insulin should have an A1C target of 
<8%; Consider individual evaluation for aspirin therapy for patients age 30 to 40 with type 2 
DM, with other cardiovascular risk factors, or with type 1 DM for duration of disease longer than 
2 years. 
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of Medical Care in Diabetes uses diabetes duration as a criterion for diabetes care in old age.10 
Our study highlights the fact that ascertaining cohort and age at diagnosis are just as important in 
predicting functional change in patients with late-onset diabetes. In fact, they are necessary to 
account for population heterogeneity in diabetes outcomes. According to our results, a 70-year-
old person recently diagnosed with diabetes is at much greater risk of physical and mental health 
decline after diagnosis than a 70-year-old with longer diabetes duration, diagnosed 5 or 10 years 
earlier. The focus of care should therefore probably shift to the 70-year-old who has been 
recently diagnosed, so that an opportunity is not missed for administering equitable and 
appropriate care.  
Finally, the finding that younger cohorts are at increased risk of poor physical and 
cognitive health trajectories over the course of diabetes has significant policy implications, for 
the senior population currently entering old age may face functional and cognitive limitations in 
greater numbers relative to their elders. The increasing burden of disability in middle adulthood 
and early old age will place a serious strain on the healthcare system, the economy and social 
institutions, including Social Security, Medicare, and Medicaid. In particular, middle-aged adults 
will be less likely to participate in the labor market despite their inflated ranks, resulting in lower 
tax contributions and greater demands on the health system. Greater prevalence of physical and 
cognitive disability can result in a greater burden on families left to care for diabetic family 
members, and the burden will be even greater for women, who are more likely to be caregivers 
(Bird & Rieker, 1999). The study therefore highlights the need for more research, and policy 
makers should pay attention to the risk of poor cognition and physical health in the upcoming 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 Perform an annual test to quantitative urine albumin excretion in type 1 diabetic 
patients with diabetes duration of ≥5 years and in all type 2 diabetic patients starting at 
diagnosis.  
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cohorts of older diabetics. Here too, aggressive primary interventions (change in culture, early 
detection, Diabetes Prevention Programs) and secondary interventions (monitoring, behavior 
change, referrral) can reduce the risk of poor health in younger cohorts. 
 
Social stratification 
The most important implication of the findings regarding race, ethnicity, gender, and 
economic disparities is that policies to address physical, mental, and cognitive health inequalities 
in the general population early in the life course may be the best approach to address physical, 
mental, and cognitive inequalities with diabetes in middle-aged and older adults. By the time 
socially disadvantaged older adults are diagnosed, little can be done to bend the health gap 
compared to their socially advantaged counterparts. Given the anticipated rise in the size of the 
Hispanic population, along with faster increase in the incidence of diabetes among socially 
disadvantaged people, and the increasing longevity among people with diabetes, the lack of 
political action to seriously tackle health inequalities will likely result in increased numbers of 
older adults with diabetes in socially disadvantaged groups suffering from physical, mental, and 
cognitive impairments. We can therefore expect greater need for diabetes care, but also for 
hospital and nursing home care, and an added burden on caregivers, mainly women, and on 
younger cohorts of Americans. Moreover, an increasing financial burden will be placed upon 
existing social programs, including Medicare, Medicaid, and Supplemental Security Income.  
Health inequalities are unjust and costly. Between 2003 and 2006, about $1.24 in health 
costs were attributed to health (LaVeist, Gaskin, & Richard, 2009). Measures to reduce health 
inequalities have been called for by the public health community for a long time, starting in the 
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1980s with the Black Report, the Whitehall Report, and the Acheson Report in the UK and 
Canada.   
Empirical studies have found a consistent link between socioeconomic status and poor 
functional and self-rated health (Lantz et al., 2001) across time, place, and populations (Link & 
Phelan, 1995), and over the life course (House, et al., 1994). This link occurs through multiple 
pathways as identified by the fundamental-cause hypothesis (Link & Phelan, 1995), and includes 
race (Williams & Collins, 1995), gender (Adler & Newman, 2002; Verbrugge, 1985), and 
ethnicity (Markides & Black, 1996; Markides & Eschbach, 2005). Research has consistently 
shown that systemically unequal distribution of determinants of good health lead to risk-bearing 
behaviors, stress, poor neighborhoods, and poor healthcare among socially disadvantaged 
groups. The unequal burden of obesity (Botoseneanu & Liang, 201), lack of physical exercise, 
poor nutrition and diet (Coggins, Swanston, & Crombie, 1999; Davey Smith & Brunner, 1997), 
poor neighborhoods along with residential segregation and their related stressors (Williams & 
Collins, 2001; Sampson, Morenoff, Gannon-Rowley, 2002; Morenoff, 2003; Diez-Roux, 2007), 
greater exposure to stress (Pearlin, 1989), and unequal access to adequate and quality care 
(Smedley, Stith, & Nelson, 2003) in socially disadvantaged populations are all widely 
documented. In a comprehensive study of population-based data sets in the U.S. and England, 
Bleich and colleagues confirmed that race, ethnicity, gender, and socioeconomic disparities in 
life expectancy, risk behaviors, and metabolic indicators have persisted over the past three 
decades (Bleich, Jarlenski, Bell, & LaVeist, 2012). The same authors further demonstrated that 
social conditions rather than individual characteristics may be the main drivers of these 
inequalities (Bleich, et al., 2012; Bleich, Jarlenski, Bell, & LaVeist, 2013). They found no 
evidence of health disparities in a black and white sample of adults with similar income levels, 
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and living in the same neighborhoods. Therefore policies to address health inequalities in the 
general population and consequently among older adults with diabetes could be more efficiently 
focused on factors such as socioeconomic status and neighorbhood conditions.  
To date, most policies are geared toward gathering information about health inequalities, 
developing recommendations, setting priorities to address health or economic disparities, and 
creating research institutions to document these inequalities.11 However, little action has been 
taken to address health inequalities. The recent enactment of the Patient Protection and 
Affordable Care Act attempts to address access to care by expanding health insurance to almost 
the entire population. It can by the same token improve access to healthcare among socially 
disadvantaged people, who are more likely to be uninsured (Roberts & Rhoades, 2010). So far, 
the results of the Act are promising. There has been a 4% to 7% reduction in the number of 
uninsured, and the largest changes are occurring in socially disadvantaged groups, including 
Hispanics and blacks, but also in adults 18 to 34 years of age (Sommers et al., 2014). Regardless 
of political will, however, income inequalities and residential segregation, which are linked by 
the ways in which school systems are financed, will continute to determine life chances and 
maintain existing health disparities, which begin before birth and continue into old age. 
A recent analysis of U.S. school finance data over three years reveals that property taxes 
play a disproportionate role in inequality in per-student revenues because taxable property wealth 
is inversely related to poverty rate (Baker & Corcoran, 2012). Therefore districts with higher 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  Social policies including the Supplemental Security Income, Temporary Assistance for Needy 
Families, the Earned Income Tax Credit, the Supplemental Nutrition Assistance Program 
(formerly food stamps) attempt to reduce economic inequalities; Agencies and programs created 
to study health inequalities include the Office of Minority Health, The Indian Health Care 
Improvement Act, the Special Diabetes Program for Indians, The National Center on Minority 
Health and Health Disparities. An example of goal setting includes Healthy People 2020 (Bleich 
et al 2012).	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poverty rates receive less from property taxes than districts with lower poverty, despite similar 
levels of tax effort. While state aid is designed to offset these inequalities, it is often insufficient 
to compensate for disparities in local resources. Revisiting the school financing system seems to 
be a viable policy option in efforts to reduce health inequalities in general, and among people 
with diabetes in particular. 
 
Summary 
Improving physical, mental, and cognitive health with late-onset diabetes and related 
social inequalities will require a paradigm shift, in which both primary and secondary 
preventions play important roles. Primary prevention entails efforts to improve the health of 
upcoming cohorts and early diabetes detection. Secondary prevention would incorporate means 
to closely monitor physical, mental, and cognitive change using innovative technology and an 
effective and efficient system of referrals to service providers that can prevent or reduce 
physical, mental, and cognitive health decline with diabetes. Disparities in the experience of 
illness are best addressed through general social and economic policies that aim to reduce 
gender, racial, ethnic, and economic gaps in health in the general population. These efforts will 
require using all the research that is currently available. And while the ACA is a step in the right 
direction, other policies addressing social factors such as income inequality, neighborhood 
segregation, and the education system need to be developed. 
 
RESEARCH PRIORITIES AND FUTURE DIRECTIONS 
Five major directions can be taken from here. The first direction would improve study 
methodologies, while the second would address questions unanswered by the current study. The 
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third direction would identify steps for assessing heterogeneity in health trajectories and its link 
to health outcomes. The fourth direction would investigate the trajectories of physical, mental, 
and cognitive health with longer diabetes duration. The final direction would extend the disease-
career perspective to other chronic and acute conditions. 
 
Methodological improvements 
Self-reported diabetes – Self-reported diagnosis is a reliable proxy of diabetes status 
(Jackson et al., 2013), but diagnosis itself is problematic, for about one-third of people with 
diabetes remain undiagnosed (Centers for Disease Control and Prevention, 2014). Selection bias 
due to differential access to care could be reduced by the use of biomarkers such as Hemoglobin 
A1c (HbA1c) in several ways. Biomarkers provide accurate estimates of the timing of diabetes 
onset and health changes in the pre-diabetic stage (Haianza et al., 2012; Ramlo-Halsted & 
Edelman, 2000); they also address issues raised by differences in the timing of diabetes diagnosis 
by social group (Koopman, Mainous, Diaz, & Geesey, 2005). Finally, they can be used as time-
variant predictors in the form of a trajectory (Haianza, et al., 2012), which can then be linked to 
health trajectories. Unfortunately, the HRS has only two measures of HbA1c from the same 
respondents. Blood samples were collected every four years for the first half of the sample in 
2006 and 2010; and in 2008 and 2012 for the second half. These data could not be used for the 
purpose of the current study, but the results highlight the need for such data. 
 The type of diabetes (type 1 or type 2) was not assessed at baseline. Yet a differential link 
between diabetes type and mental health progression (Engum, Mykletun, Midthjell, Holen, & 
Dahl, 2005; Peyrot & Rubin, 1999; Talbot & Nouwen 2000) and cognitive dysfunction (Biessels, 
Kerssen, de Haan, & Kappelle, 2007; Kodl & Seaquist, 2008; Reijmer, et al., 2010) has been 
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reported, thus has the potential to introduce a bias in our estimates. However, only about 5% of 
diabetes cases in adulthood are attributed to type 1 diabetes (Centers for Disease Control and 
Prevention, 2014), suggesting that most of the study sample falls under the diagnosis of type 2 
diabetes. Therefore if there is a case definition bias, it should be negligiable given our large 
sample size.  
Censoring – Left censoring, which occurs when people die before having a chance to 
enter in the study is a threat to the validity of longitudinal studies, for it can influence the 
representativeness of the sample and generalizability of the results. However, since we included 
only incident cases, death before study participation was not a major problem over the course of 
diabetes. On the other hand, right censoring due to mortality or attrition when the respondent is 
in the study, can be a problem as sicker people are more likely to die or drop out. This problem 
was handled by incorporating two indicators of mortality and attrition in the statistical models. 
As expected, both were significant; therefore their inclusion in the analyses was justified.  
Study time frame – Another methodological improvement would entail expanding the 
study time-frame to the time before diabetes was diagnosed. This change in the study time-frame 
would allow longitudinal assessment of the acute and long-term effects of diabetes on post-event 
functional, cognitive, and mental health, while controlling for functional change before the 
diagnosis of diabetes. This approach has been already applied to studies of health changes before 
and after myocardial infarction (Dhamoon, Moon, Paik, Sacco, & Elkind, 2012) and stroke 
(Levine et al., 2014). 
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Address unanswered questions  
A significant amount of outcome variance in the slopes remains unexplained in Chapters 
1 and 3. There is also a large amount of unexplained variance for the random effects presented in 
all three Chapters. The explanatory power of the study could therefore be strengthened by the 
inclusion of variables known to influence diabetes outcomes and tied to the dynamic changes of 
diabetes. These include behavioral (diet, physical exercise, smoking, treatment adherence), 
psychological (coping, social support) and physiological factors (HbA1c, lipid profile) (Chiu & 
Wray, 2011).  
Additional questions involve 1) explaining why Hispanics are at risk of greater functional 
decline (Chapter 1); 2) explaining how socioeconomic status reverses the trajectory of depressive 
symptoms over the course of illness; 3) identifying the measures of social status most relevant to 
diabetes management at every stage of diabetes (Chapter 2); 4) explaining why the beneficial 
effect of income is reversed for those in the top two income quartiles; and 5) explaining why age 
at diagnosis is a persistent risk factor for poor health, whether it is a consequence of age-related 
vulnerabilities, delayed diagnosis, or a completely different pathogenesis by age group. 
 
Heterogeneity in the experience of diabetes 
Heterogeneity in older people with diabetes is one of the most difficult challenges for 
diabetes prevention, management, and care (Kirkman, et al., 2012). The findings of significant 
variation in the random component variances in the current study reflect a high degree of 
heterogeneity in health trajectories with longer diabetes duration. As spelled out in the career 
model (Aneshensel, 2013), it is reasonable to expect significant heterogeneity in how people 
experience diabetes, with some individuals having a relatively stable progression, others 
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experiencing remission, and still others experiencing a rapid decline in health. This person-
centered approach (as opposed to the variable-centered approach adopted in the current study) 
allows the identification of qualitatively distinct trajectories within the study group (Jones & 
Nagin, 2007; Jones, Nagin, & Roeder, 2001; Nagin, 2005), and the classification of people with 
diabetes into those able to achieve successful aging, those with normal aging, and those with 
pathological aging in the course of diabetes (Rowe & Kahn, 1997). The clinical significance of 
each of these groups is useful for research and policy as they can be linked to characteristics of 
the health system, characteristics of the diabetic, including behavioral, psychological, and 
socioeconomic predictors, and outcomes. In addition, the linkage of each trajectory to death or 
survival, or to the use of health services and to behaviors such as treatment adherence can be 
estimated. Ultimately, the effectiveness of medical and policy interventions to ensure successful 
aging with diabetes can be developed and evaluated using the trajectories identified (Nagin, 
2005).  
 
Joint trajectories of physical, mental, and cognitive health with longer diabetes duration 
The study found strong evidence that among middle-aged and older adults with incident 
diabetes, physical, mental, and cognitive health trajectories change over time, and the changes 
can vary by outcome. Therefore there are co-occurring changes in multiple functional domains, 
which are not well understood. Xu and colleagues have demonstrated that underlying 
multisystem processes of health change with age can increase our understanding of overall health 
change over time (Xu, Liang, Bennett, Botoseneanu, & Allore, 2014). Our fourth direction is 
therefore to estimate multi-trajectories of physical, mental, and cognitive health and their link to 
socio-demographic and behavioral characteristics and to the quality of health systems. This type 
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of research is supported by evidence showing the interconnectedness of physical, mental, and 
cognitive health. For instance, prevalent and incident depressive symptoms, stroke, and ADL 
disabilities contribute independently to poorer cognitive functioning in older Americans, 
although they do not appear to influence rates of cognitive decline (Chodosh, Miller-Martinez, 
Aneshensel, Wight, & Karlamangla, 2010). A recent longitudinal population study further found 
that diminished cognitive function was linked to early onset and faster rate of progression of 
disability after onset (Rajan et al., 2012). Finally, while the directionality of the link between 
depressive symptoms and disability is complicated by the variety and appropriateness of 
measures, methods, and samples, available cross-sectional and longitudinal studies generally 
agree that there is a strong link between depression and disability (Bruce, 2000).  
This type of research can help elucidate population heterogeneity in older adults with late 
onset diabetes. Investigating the simultaneous effect of diabetes duration on physical, mental, 
and cognitive health can provide a more complete picture of patients’ experience of diabetes, and 
its relationship to the health services that diabetic patients would need. Ultimately a multi-
trajectory approach can help fine-tune interventions tailored to older adults with incident diabetes 
based on a set of morbidities relevant to diabetes progression and diabetes care.  
 
Extend the career perspective to other chronic and acute conditions 
 Studies of life events have used a variety of technical approaches to investigate health 
change, before and after a social or medical event. Examples include studies of mental health 
change among caregivers after bereavement (Aneshensel, Botticello, & Yamamoto-Mitani, 
2004), physical and cognitive health change after a stroke (Dhamoon, et al., 2012; Levine, et al., 
2014), changes in body mass index before the development of type 2 diabetes (Heianza et al., 
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2014), in physical health after a traumatic brain injury (Andelic et al., 2014), in self-rated health 
with retirement (Curl & Townsend, 2014), and in health before hospice care (Stabenau et al., 
2015). These studies confirm that the dynamic effect of life events on health can be documented 
and is relevant for medical care and policy. Therefore the last future direction involves 
expanding the career perspective on health change to other chronic and acute conditions, 
including obesity, stroke, cancer and the identification of behavioral, social, economic, and 
medical determinants of health trajectories before and after these events. 
 
CONCLUSIONS 
It is widely recognized that diabetes increases the risk of poor health at every age and at 
any point in time. The current study is less interested in the magnitude of the effect of diabetes 
on health than on describing the pattern of health change after a diagnosis of diabetes, and 
quantifying patients’ experience of the illness. The three Chapters, which comprise this study 
covered different domains of health, complement each other, and provide a dynamic view of 
health experiences of diabetes in middle-aged and older adults. They show that health change 
with diabetes is characterized by a quadratic acceleration in physical disability and a linear 
decline in mental and cognitive health. People who are older at the time of diagnosis, younger 
cohorts, women (due to lower socioeconomic status), blacks and Hispanics (partly due to 
socioeconomic disadvantage and health disparities before diagnosis) are at increased risk of a 
poor health trajectory over the diabetes career, when compared to their counterparts. Cumulative 
or persistent socioeconomic disadvantages were found for all outcomes, with worse health 
trajectories among older adults whose socioeconomic status was lower, with the exception of 
those in the top two income quartiles, who experienced a faster decline in mental health despite 
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better scores at diagnosis. The study concludes that diabetes cannot be viewed as a time-constant 
individual characteristic. Rather, the dynamic nature of chronic illnesses needs to be better 
understood so that effective healthcare and policy interventions can be devised to ensure 
successful and equitable aging after a diagnosis of diabetes in middle age and old age.  
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APPENDICES 
 
 
Appendix A: Average ADL/IADL disability trajectory using HLM® negative binomial 
multilevel poisson regression 
 
   M1   M2   M3   M4   M5   
 ERR Sig ERR Sig ERR Sig ERR Sig ERR Sig 
Fixed Effect           
For intercept           
Intercept 0.244 *** 0.210 *** 0.113 *** 0.096 *** 0.141 *** 
Age at diagnosis   1.056 *** 1.120 *** 1.123 *** 1.105 *** 
Birth cohort (age in 1995)     0.936 *** 0.930 *** 0.943 *** 
Female     1.429 *** 1.381 *** 1.223 ** 
Non-Hispanic black     1.529 *** 1.339 ** 1.352 *** 
Hispanic     1.805 *** 1.367 ** 1.205  + 
Other race     1.049  1.030  1.036  
Less than high school       1.889 *** 1.390 *** 
High school graduate       1.107  0.992  
           
For linear slope           
Intercept 1.128 *** 1.123 *** 1.135 *** 1.162 *** 1.097 *** 
Age at diagnosis   1.003 *** 1.006 * 1.005 * 1.006 * 
Birth cohort (age in 1995)     0.997  0.998  0.997  
Female     0.990  0.991  0.998  
Non-Hispanic black     1.004  1.012  1.019  
Hispanic     1.035 + 1.051 * 1.040  + 
Other race     0.914 * 0.910 * 0.942  
Less than high school       0.956 * 0.968  + 
High school graduate       0.973  0.980  
           
For quadratic slope           
Intercept 0.997  + 0.998  0.999  0.995  0.999  
Age at diagnosis   1.000  1.000  1.000  1.000  
Birth cohort (age in 1995)     1.000  1.000  1.000  
Female     1.004  1.003  1.001  
Non-Hispanic black     0.998  0.996  0.995  
Hispanic     0.989 * 0.987 * 0.991  + 
Other race     1.009  1.010  1.005  
Less than high school       1.008 * 1.006  + 
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High school graduate       1.005  1.004  
           
Time variant variables           
Married         1.016  
Self-rated health         1.294 *** 
Comorbidities         1.265 *** 
CESD         1.117 *** 
Treatment burden         1.089 ** 
           
Survey status           
Death  4.263 *** 3.139 *** 4.131 *** 1.351 *** 2.586 *** 
Attrition  1.001  1.077  1.078  0.042  1.022  
Proxy (time variant) 2.264 *** 2.160 *** 2.177 *** 0.766 *** 1.801 *** 
           
Random effect           
Variance 2.863 *** 2.721 *** 2.508 *** 2.465 *** 1.652 *** 
Intercept 0.053 *** 0.049 *** 0.047 *** 0.048 *** 0.037 *** 
Linear slope 0.002 *** 0.002 *** 0.002 *** 0.002 *** 0.001 *** 
Quadratic slope           
Covariance 0.030  0.027  0.016  0.018  0.033  
Intercept x linear slope 
-
0.026  
-
0.025  
-
0.024  
-
0.025  
-
0.021  
Intercept x quadratic slope 
-
0.006  
-
0.005  
-
0.005  
-
0.005  
-
0.004  
Linear x quadratic slope           
Level 1 residual 0.470 *** 0.472 *** 0.481 *** 0.478 *** 0.498 *** 
***p<0.001; **p<0.01; *p<0.05; +p<0.10; ERR: Estimated Rate Ratio 
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Appendix B: Average mobility disability trajectory using HLM® negative binomial multilevel poisson regression 
 
   M1    M2   M3   M4   M5   
 ERR Sig ERR Sig ERR Sig ERR Sig ERR Sig 
           
Fixed effects           
For intercept           
Intercept 1.027  0.957  0.625 *** 0.537 *** 0.740 *** 
Age at diagnosis   1.026 *** 1.051 *** 1.053 *** 1.043 *** 
Birth cohort (age in 1995)     0.971 *** 0.967 *** 0.979 *** 
Female     1.645 *** 1.605 *** 1.418 *** 
Non-Hispanic black     0.981  0.917  + 0.916 * 
Hispanic     1.133 * 0.975  0.916  + 
Other race     1.057  1.056  1.039  
Less than High school        1.514 *** 1.203 *** 
High school graduate       1.207 *** 1.096 * 
           
For linear slope           
Linear slope 1.063 ** 1.063 *** 1.083 *** 1.098 *** 1.055 *** 
Age at diagnosis   1.001 ** 1.001  1.001  1.001  
Birth cohort (age in 1995)     1.000  1.001  1.001  
Female     0.977 *** 0.978 *** 0.988 * 
Non-Hispanic black     0.994  1.001  1.004  
Hispanic     1.015  + 1.030 ** 1.023 * 
Other race     0.963  + 0.962  + 0.983  
Less than High school        0.966 *** 0.977 ** 
High school graduate       0.985  + 0.987  + 
           
For quadratic slope           
Quadratic slope 1.001  1.001 * 1.002  + 1.001  1.002  
Age at diagnosis   1.000  1.000  1.000  1.000  
Birth cohort (age in 1995)     1.000  1.000  1.000  
Female     1.000  1.000  1.000  
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Non-Hispanic black     1.001  1.001  1.000  
Hispanic     0.997  + 0.997 * 1.000  
Other race     0.995  0.996  1.002  
Less than High school        1.002  0.999  
High school graduate       1.001  0.996  
           
Time variant variables           
Married         0.972  
Self-rated health         1.258 *** 
Comorbidities         1.169 *** 
CESD         1.053 *** 
Treatment burden         1.038 ** 
BMI         1.021 *** 
           
Survey status           
Death  2.135 *** 1.842 *** 2.157 *** 2.075 *** 1.569 *** 
Attrition  1.040  1.082  1.095  + 1.078  1.058  
Proxy (time variant) 1.416 *** 1.359 *** 1.378 *** 1.369 *** 1.193 *** 
           
Random effect           
Variance           
Intercept 0.895 *** 0.895 *** 2.157 *** 0.753 *** 1.651 *** 
Linear slope 0.005 *** 0.005 *** 1.095  + 0.005 *** 0.037 *** 
Quadratic slope 0.00002  0.00002  1.378 *** 0.00002  0.001 *** 
Covariance -0.019  -0.019  2.157 *** -0.015  -0.006  
Intercept x linear slope -0.002  -0.002  1.095  + -0.002  -0.001  
Intercept x quadratic slope -0.0002  -0.0002  1.378 *** -0.0002  -0.0001  
Linear x quadratic slope 0.583  0.583  0.589 *** 0.586  0.606  
***p<0.001; **p<0.01; *p<0.05; +p<0.10; ERR: Estimated Rate Ratio 
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Appendix C: Sample selection 	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Appendix D: Differences in study timelines between Chiu & Wray (2010)12 and the current study 	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
12 Chui C., & Wray, L. A. (2010). Physical disability trajectories in older Americans with and without diabetes: The role of age, 
gender, race or ethnicity, and education. The Gerontologist, 51(1), 51-63. doi: 10.1093/geront/gnq06 	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Appendix E: Fixed effects from the HLM models for diabetes duration, age at diagnosis, and cohort on physical, mental, and 
cognitive health 	  
Model ADL/IADL Disability  
(0-11) 
 Cognitive function  
(0-35) 
 Depressive Symptoms 
(0-9) 
 At 
diagnosis 
Linear 
change 
Quadratic 
change 
 At 
diagnosis 
Linear  
change 
 At 
diagnosis 
Linear 
change 
Diabetes duration 0.824*** 0.110*** 0.006*** 
 
21.051*** -0.364***  1.621*** 0.023*** 
          
Diabetes duration 0.652*** 0.097*** 0.008*** 
 
20.822*** -0.443***  1.632*** 0.025*** 
Age at diagnosis 0.060*** 0.008*** 0.0001*  -0.269*** -0.007  -0.0004 0.002* 
          
Diabetes duration 0.415*** 0.100*** 0.009*** 
 
20.736*** -0.473***  1.620*** 0.022** 
Age at diagnosis 0.107*** 0.008*** -0.0004  -0.413*** -0.034***  -0.004 -0.0002 
Birth cohort -0.049*** 0.001 0.001+  0.122*** 0.021**  0.004 0.002 	  
Models adjust for attrition (0=no), death (0=no), and proxy interview (0=no) 	  
